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Abstract 
Oxidative stress has been associated with a wide range of diseases, including 
cardiovascular diseases, Alzheimer’s disease, atherosclerosis, Parkinson’s 
disease and cancer. It also plays a role in the ageing process. 
Hyperhomocysteimia is commonly found to be associated with these diseases. 
The hyperhomocysteimia is a result of a deficiency in both folate and cobalamin.  
Folate is known to reduce Hcy and protect cells from apoptosis, but there are no 
studies investigating the impact of cobalamin on apoptosis induced by oxidative 
stress or the mechanism(s) of the protection. The aims of the research are to 
investigate the protective role of cobalamin and the possible mechanism(s) for this 
protection. It also examines the protective role of novel cobalamin and 
investigates their superior protection. The methods used in this research for 
apoptosis detection we used caspase-3 and the annexin-V, while for necrosis we 
used PI staining, where cell viability were detected using MTS assay. We also 
measured the generation of superoxide by Lucigenin-enhanced 
chemiluminescence and reactive oxygene species by using the redox active prob 
DCFH-DA. Moreover, the intracellular proteins were measured via staining with 
specific fluorescent-conjugated antibodies were detected using flowcytometry. Our 
result demonstrated that 25M of cobalamin protects cells from apoptosis. The 
protection by cobalamin was associated with induction of iHsp72 and iHO-1, and 
these are shown to be essential for the protection. Furthermore, our research 
demonstrated a novel mechanism of cobalamin-apoptosis protection involving 
induction of NfkB, ERK1/2 and AKT signal transduction pathways. In order to 
protect cells from apoptosis induced by oxidative stress, cobalamin induces the 
pNfkB which in turn regulate the iNOS and HO-1 induction. Cobalamin also 
induces the pERK1/2 which regulates the induction of Hps72 and Nrf2. And finally, 
pAKT induced by cobalamin which regulate the Nrf2 and HO-1 induction. The 
inhibition of any of theses pathways leads to loss the protection. The GSCbl and 
NACCbl provide a superior protection against oxidative stress, this protection 
involved induction of the signal transduction pathways and Hsps. To conclude; 
cobalamin provides protection against cells death induced by oxidative stress. 
Cobalamin achieves this by multiple pathways which include direct antioxidant 
stimulation and induction of signal transduction pathways. Different cobalamin 
 vii 
derivatives have superior protections. These finding are a useful pharmaceutical 
tool in the treatment of the oxidative stress related diseases.  
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1. Introduction: 
 
1.1 Background to study: 
Oxidative stress is associated with a variety of diseases such as cardiovascular 
diseases, which are one major cause of mortality in Europe as cardiovascular 
diseases statistics in 2008 showed that nearly half of all deaths in Europe (48%) 
caused by cardiovascular disease. It was recently reported that one of the factors 
leading to oxidative stress is homocysteine (Hcy), which is also considered as an 
independent risk factor for vascular diseases (Jacobsen, 2000). Hcy is a sulphur-
containing intermediate product, which is a result of the normal metabolism of 
methionine. A reduction in folate or cobalamin (vitamin B12) supply should lead to a 
reduced methionine synthase activity, and as a result reduced conversion of Hcy to 
methionine and cysteine and increases the cellular level of Hcy. Hyperhomocysteimia 
leads to cell death by either apoptosis or necrosis (Mujumdar et al., 2001; Zhang et al., 
2001). Apoptosis is a programmed cell death while necrosis is non- physiological cell 
death. Numerous studies have reported that the majority of oxidative stress related 
disease mortality is associated with the increase in apoptotic cells as a result of high 
level of Hcy (Cattaneo, 1999; Malinow et al., 1989; Verhoef et al., 1996; Clarke et al., 
1998; Miller, 1999; Blandini et al., 2001; Duan et al., 2002; Kuhn et al., 1998; Yasui et 
al., 2003). The cellular response to oxidative stress involves upregulation of specific 
proteins, including heat shock proteins (Hsps) (Huot et al., 1991; Mehlen et tal., 
1993). Hsps are known as molecular chaperones, with roles which include repair of 
denatured proteins and protein transport across intracellular membranes. It has also 
been reported that the upregulation of the Hsps under different stressor protects the 
cells from the damage induced by a variety of stressors (Musch et al., 1996; Otani et 
al., 1997; Ren et al., 2001). The upregulation of Hsps is controlled by a variety of 
signal transduction pathways dependent on the stressor.  
 
The work in this thesis aims to evaluate the protective effect of cobalamin provided 
against apoptosis and necrosis induced by oxidative stress, and to characterise the 
molecular mechanisms and the possible involvement of Hsps. This study will also 
investigate the protection efficiency of glutathionylcobalamin (GSCbl) and N-acetyl-L-
cysteinylcobalamin (NACCbl). Increased understanding of these mechanisms may 
lead to new tools for treatment and drug design that could lead to preservation and 
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restoration of health. The works reported in this thesis have been carried out on 
various cell types, using cell culture methods and blood taken from healthy volunteers. 
A mechanistic-based approach has been employed to study cell death and the 
protection from cell death induced by oxidative stress, using pharmacologically 
relevant concentrations of oxidants and antioxidants. 
 
1.2 Oxidative stress and diseases    
Oxidative stress is associated with several diseases, such as Parkinson’s disease 
(Miller, 1999), Alzheimer’s disease (Scalabrino, 2005), cardiovascular diseases 
(Forouhi et al., 2006), stroke progression (Alexandrova et al., 2005), diabetes 
(Szabo, 2005), atherosclerosis and cancer (Schwartz et al., 1993) .  The majority of 
oxidative stress related diseases are associated with mitochondrial dysfunction 
(Bostantjopoulou et al., 2005; Blennow et al., 2006; Alexandrova et al., 2005), which 
triggers a cascade of events resulting in apoptosis and necrosis which in turn lead to 
progression of the disease and organ dysfunction  (Kim-Han et al., 2005; Pamplona 
et al., 2006).  There is not as yet a full understanding of cell death pathways induced 
by reactive oxygen species (ROS) generation, and therefore the means to decrease 
the damaging effects of oxidative stress in disease pathologies is limited. 
 
1.3 Oxidative stress generation:  
Oxidative stress is caused by imbalance of antioxidant generation and ROS, which plays 
a vital role in vascular physiology and pathology. The ROS family includes; superoxide 
(O2
-), nitric oxide (NO), the hydroxyl radical (·OH), hydrogen peroxide (H2O2), 
hypochlorous acid (HOCl), peroxynitrite (ONOO‾) and single oxygen (1O2). Under stress 
and pathological conditions, the production of ROS is higher than in normal conditions 
(Behrendt et al., 2002; Barja 2004; Bitar, et al., 2005; Frank et al., 2005; Lyle et al., 
2006). The production of O2
- mainly occurs within the mitochondrial of a cell, as the 
mitochondrial electron transport chain is the main source of ATP in mammalian cells, so 
the redox status get to be maintained (Kovacic et al., 2005). In all cell types, O2
-· can be 
produced by enzymes such as NADPH oxidase, xanthine oxidase, cyclooxygenases, 
NO synthases, cytochrome P450 monooxygenases and enzymes from the mitochondrial 
respiratory chain (Griendling et al., 1997; Atarod et al., 2004; Ceriello et al., 2004). O2
- is 
reduced to uncharged H2O2 by superoxide dismutase (SOD), and H2O2 in the presence 
of catalase or glutathione peroxidase is converted into water and oxygen (Valko et al., 
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2006). ROS levels are elevated in many vascular disease states and also associated 
with a reduction of antioxidants which reduces the ability to scavenge oxygen-derived 
free radicals. All of theses factors contribute to generations of oxidative stress (Touyz, 
2004). 
 
1.4 Hydrogen peroxide (H2O2): 
H2O2 is one of the abundant ROS which plays a different role in the cellular system such 
as signalling (Davies, 1999). After dismutation of super oxide, H2O2 can be generated 
directly or indirectly by NADPH oxidase, which is located in the mitochondrial respiratory 
system. H2O2 is regulated by cellular glutathione peroxidase (cGPx) and catalase 
(Dringen et al., 2005).  
 
1.5 Homocysteine (Hcy) 
Hcy is an amino acid formed from S-adenosyl-methionine (Herman et al., 1999; 
Finkelstein et al.,2000; Mattson et al 2002), which is converted to S-adenosel-Hcy 
(Figure1.1). Subsequent hydrolysis of S-adenosel-Hcy leads to Hcy formation which 
then may be transformed to cysteine by vitamin B6 and cystathionine β-synthase 
(CβS). Alternately, Hcy can be remethylated and converted back to methionine by 
folate and cobalamin dependent reaction catalysed by methionine synthase (MS). 
The side chains of all amino acid residues of proteins, in particular cysteine and 
methionine residues of proteins, are susceptible to oxidation by the action of ROS 
(Stadtman, 2004).  
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Figure 1.1: Major pathways of Hcy metabolism. Hcy is generated in a cycle through S-
adenosylmethionine and S-adenosylhcy. Remethylation of Hcy back to methionine is carried 
out by cobalamin-dependent methionine synthase (Cbl-MS). Hcy is also converted to 
cysteine, initiated by B6-dependent cystathionine -synthase (CS). The folate cycle 
generates methyltetrahydrofolate (MTHF) for the remethylation of Hcy back to methionine. 
Each molecule in the diagram was given its unique colour and form. The colour of the 
molecule changed to black when the methyl group was added. Other abbreviations:  Ado, 
adenosine; THF, tetrahydrofolate.  
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As shown in (Figure 1.1) Hcy metabolism is dependent on folate and cobalamin and 
any deficiency in them might lead to hyperhomocysteinemia (Jacobsen, 1998; 
Selhub,1999; Chambers et al., 2000; Jacobsen, 2000; Selhub et al., 2000; Herrmann 
et al., 2002; Lee et al., 2003; Mattson & Shea, 2003;; McCully, 2005). Defects in the 
MS or CβS genes also result in hyperhomocysteinemia (Carmel et al., 2003). 
Moreover, the genetic variation of 677C3T in the gene coding of the enzyme 
methylenetetrahydrofolate reductase which is required in the Hcy-methionine cycle 
for the formation of 5- methylenetetrahydrofolate. The carriers of the TT genotype 
have high level of the Hcy (Frosst et al., 1995).  
 
It has been reported recently that an increase of the plasma Hcy level has been 
classified as a risk factor of several age related diseases, including vascular and 
neurogenerative diseases, arthrosclerosis and diabetes (Bousser & Ferro, 2007; 
Mattson et al., 2002; Seshadri et al., 2002; Hoffmann et al., 2001; Abdella et al., 
2002; McCaddon et al., 2006; Lentz, 2005). Moreover, Hcy metabolism might be 
affected by different biological, environmental or pathological factors such as aging, 
inflammation, renal insufficiency and smoking (Mattson et al., 2002). 
 
Hyperhomoctyemia may lead to cell death either by apoptosis or necrosis as has 
been demonstrated by in vivo and in vitro studies (Mujumdar et al. 2001; Zhang et al. 
2001). Several studies have demonstrated the effect of Hcy on cells, such as high 
levels of Hcy induce apoptosis in primary human bone marrow stromal cells, HS-5 
cell line (Kim et al., 2006), H9C2 cardiomyocytes (Levrand et at., 2007) and 
lymphocytes (Picerno et at, 2007).The induction of apoptosis by Hcy is caspase-
dependent including activation of caspase-9 and casvvpase-3, and Hcy also 
increases cytochrome c release into the cytosol, indicating that Hcy also induces 
apoptosis via the mitochondria pathway (Tyagi  et al., 2006). Furthermore, it has 
been demonstrated that moderate levels of H2O2 should result in cells dying through 
apoptosis, while high concentration causes necrosis cell death (Lennon et al., 1991; 
Dypbukt et al., 1994; Davies, 1999; Hampton & Orrenius, 1997; Gardner et al., 1997; 
Lee & shacter, 1999). The induction of apoptosis by H2O2 is associated with 
activation of caspase-3, caspase-9 and phospsotidylserine appearance on the 
surface of the cells and release of cytochrome c (Wang, 2001). 
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1.6 Mechanism of cell death: 
There are two forms of cell death known as apoptosis and necrosis. They are 
characterised according to morphological and biochemical features (Kerr et al., 
1972).  
 
1.6.1 Apoptosis: 
Apoptosis is known as a programmed cell death (PCD), which is a regulated 
physiological type of death that gets rid of senescent, abnormal and potentially 
harmful cells (Schwartz et al., 1993). Apoptotic cell death is required for cell and 
tissue development as well as cellular defence, and occurs during normal 
morphogenesis and as a result of pathogenic infections or any excessive stressor 
causing cell damage. Apoptosis is therefore helping to remove potentially harmful 
cells affected by disease or toxic agents (Fiers et al., 1999). 
 
Apoptotic cell death can be triggered by two known pathways: the mitochondrial or 
intrinsic pathway, which is activated by  internal cellular signals; the death receptor or 
extrinsic pathway, activated by external signals; (Hengartner, 2000; Danial et al., 
2004; Nicotera et al., 2004; Beere, 2005; Ciriolo, 2005; Berger et al., 2006; Hail et 
al., 2006).  Generally, apoptosis is characterised by membrane blebbing, cell 
shrinkage, nuclear condensation, breakdown of nuclear DNA, and the formation of 
apoptotic bodies (Schweichel et al., 1973).  
 
Apoptotic cell death is classically associated with the activation of proteases known 
as caspases; the caspase family consists of 14 members. They are broadly 
classified as either initiator caspases or effector caspases (Table 1.1). Their names 
reflect the active cysteine group and the feature cleave of their targets at aspartate 
residues (Alnemri et al., 1996). When caspases are activated they lead to the 
cleavage of different types of intracellular proteins, including major structural 
elements of the cytoplasm and nucleus, components of the DNA repair machinery 
and a number of protein kinases (Earnshaw et al., 1999). 
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Table 1.1: Classification of the caspases according to their function 
Types Names Function 
  
Initiator 
Caspase-2 Cleavage of the inactive forms of 
the effector caspases. Caspase-8 
Caspase-9 
Caspase-10 
 
Effector 
Caspase-3 Cleavage of other protein 
substrates within the cells to 
trigger apoptosis. 
Caspase-6 
Caspase-7 
           Adapted from (Alnemri et al., 1973) 
 
The intrinsic and extrinsic pathways involve activation of caspases (Reed, 2000; 
Strasser et al., 2000). The extrinsic pathway is activated by members of the tumor 
necrosis factor-family (TNF) of cytokine receptors such as TNFR1, Fas and TRAIL 
receptors. Stimulation of these receptors leads to the activation of initiator caspases, 
specifically caspase-8. Once caspase-8 is activated it cleaves and activates effector 
caspases such as caspase -3, -6 or -7, which leads to apoptosis. The intrinsic 
pathway is activated by release of cytochrome c from the mitochondria into the 
cytosol. The cytochrome c then binds to Apaf1 resulting in the activation of the 
initiator caspase-9, which then cleaves and activates caspase-3, and apoptosis 
occur. The extrinsic pathway is suppressed in the presence of the caspase inhibitor 
known as zVAD-Fmk, which enhances mitochondrial membrane potential (ΔΨm) that 
maintains the plasma membrane integrity during apoptotic processes ensuring that 
the intracellular contents remain in the cell, thus restricting any potentially harmful 
inflammatory immune responses (Banki et al., 1999). In contras, intrinsic pathway is 
blocked by anti-apoptotic Bcl-2 family proteins, which prevents cytochrome c release 
(Facchinetti et al., 2002; Yamakawa et al., 2000; Chandra et al., 2000). It has been 
reported that H2O2 induce apoptosis via extrinsic and intrinsic pathways in neuronal 
cells (Yamakawa et al., 2000; Chandra et al., 2000; Facchinetti et al., 2002). 
 
 
1.6.2 Necrosis: 
Necrosis is a non-physiological type of death is known as a passive mechanism 
(Loscalzo, 1996). Necrosis takes place when cells under severe stress or exposed to 
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cytotoxic agents sustain cell injury (Patel et al., 2000). Necrotic cell death is 
characterize by cell swelling and interruption of the cell membrane, leakiness of the 
cell membrane leading to loss of cell membrane integrity and of cellular contents, cell 
collapse (Majno et al., 1995; Leist et al.,1997; Nicotera & Melino, 2004; Wilson et al., 
2005). The release of the cellular content has the potential to lead to a harmful 
inflammatory response. 
 
1.7 Folate and cobalamin 
 
1.7.1 Folate (Vitamin B9) 
Folate is also known as folic acid or vitamin B9. It has essential cellular activities 
such as  nucleotide synthesis, conversion of 2′-deoxyuridine-5′-phosphate (dUMP) to 
2′-deoxythymidine-5′-phosphate (dTMP) and metabolism of Hcy to methionine 
(Fenech et al., 2001). The reduction of folate leads to formation of dihyrofolate 
(DHF), and further reduction by dihydrofolate reductase catalyses resulted in 
formation of tetrahydrofolate (THF). NADPH is required in the synthesis of both steps 
(Figure1.2). THF can be converting to methylene-THF by the addition of methylene 
groups. A reduction of methylene-THF by NADPH leads to formation of methyl-THF. 
In turn, methyl-THF is important cofactor as a methyl donor transforming cobalamin 
to methylcobalamin which is essential in the Hcy metabolism (Lucock et al., 1996).  
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Figure 1.2: folate cycle. Dihydrofolate (DHF) is resulted from a reduction of folate by 
NADPH and further reduction form teterahydrofolate (THF). The additions of methylene to 
THF by conversion of serine to glycine produce methylenetetrahydrofolate (MethyleneTHF). 
By methyltetrahydrofolate trasferase (MTHFR), methyleneTHF converted to 
methyltetrahydrofolate (MTHF) that acts as a methyl donor to convert Hcy to methionine and 
cobalamin (Cbl) and methion synthesis (MS). Each molecule in the diagram was given a 
unique colour and form, and subsequently the colour has changed according to the process 
such as the black colour was added when the molecule had methyl group on it. 
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1.7.2 Cobalamin (Vitamin B12) 
Cobalamin is the largest and most complex of the vitamins which contains a cobalt 
metal ion (Figure 1.3). It was first isolated in 1950s by Dorothy Hodgkin from liver 
and bacterial broths. The cobalamin derivatives are adenosylecobalamin (AdoCbl), 
methylcobalamin (MeCbl), aquacobalmin (H2OCbl) and sublphitocobalamin 
(SO3Cbl), hydroxycobalamin (HOCbl) and nitrocobalamin (NO2Cbl) (Smith et al., 
1952; Gimsing & Nexo, 1983; Anes et al., 1994). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Structure of cobalamin. Reproduced from C. Birch PhD thesis 
(2007). 
 
As shown in Figure1.2 by remethylation process, methyl-THF converts cobalamin to 
meCbl that transform Hcy to methionine, and this step required MS enzyme (Lucock 
et al., 1996 & Refsum, 2001). The generation of methionine is essential for the 
synthesis of S-adenosylmethionine, which is required by many biological methylation 
reactions within DNA and RNA (Shane, 2000).   
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1.7.3 Glutathionylcobalamin (GSCbl) and N-acetly-L-Cysteinlcobalamin (NACCbl) 
Recently attention has been drawn to thiolatocobalamins – principally GSCbl and 
NACCbl. Glutathione can be found in cells at concentration up to 10mM (Zhao et al., 
1997), and it can interact with H2OCbl
+ that is formed upon the removal of -ligand 
from MeCbl and AdoCbl and finally resulting in formation of GSCbl (Pezacka, 1993). 
Since GSCbl is more active than other cobalamins in terms of support of MS activity, 
so GSCbl is the preferred substrate for the reductase enzymes reaction that 
transform the vitamin to its metabolically active form (Pezacka et al., 1990). GSCbl 
might be more efficient than other cobalamins in reducing and treatment of diseases 
associated with hyperhomocysteinemia and oxidative stress, such as Alzheimer’s 
disease (McCaddon & Hudson, 2007). However, McCaddon and Davies in 2005 had 
suggested that combination of NAC and H2OCbl
+ has a clinical benefit in Alzheimer’s 
patients.  NACCbl synthesis has recently been reported by combination of the NAC 
and HOCbl.HCl, the NAC ligand form Co-S bound with cobalamin by binding to the 
sulphur atom (Suarez-Moreira et al., 2006). So NACCbl might provide a protection 
against oxidative stress. Interestingly GSCbl and NACCbl provided a significant 
protection, superior to that given by cobalamin, against cell death induced by Hcy 
(Birch et al., 2009). So while the thiolatocobalamins has suggested having a 
protective role against oxidative stress, the mechanism of the protection is not fully 
understood yet.  
 
1.8 Protective role of folate and cobalamin: 
Neither folate or cobalamin can be synthesised in mammals, so a rich diet of these 
cofactors is necessary (Liu et al., 2006). As previously shown in Figures 1.1& 1.2; 
folate and cobalamin are essential for the Hcy metabolism (Yamada et al., 2006) an 
imperfection in Hcy metabolism caused by folate and cobalamin deficiency may lead 
to oxidative stress and endothelium dysfunction in the microcirculation and induces 
apoptosis in vitro (James et al., 1994; Koury et al., 1997; Huang et al., 1999; 
McCaddon, 2006). Hyeprhemocytemia may also result from neutrinos reasons as 
populations with folate-lack-diet have a different Hcy level than population with rich-
folate-diet (Wallace et al., 2009).  Moreover, the lack of methyl donor precursors in 
the diet, have been monitored to induce DNA hypomethylation (Liu et al., 2006). It 
has been suggested that DNA hypomethylation is essential for apoptosis induction 
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which leads to induce SLE-like autoimmune diseases (Wen et al., 2007). DNA 
hypomethylation can also be resulted from hyperhomocysteimia as it is an 
independent risk factor of atherosclerosis (Jiang et al., 2007).   
 
In 1997, Ward and colleagues showed that 0.2mg -0.4mg/d of folate provides a 
significant reduction of the Hcy. Moreover, there are several studies demonstrated 
the association of folate and cobalamin with a variety of diseases such as 
Alzheimer’s disease and increased risk of vascular diseases (Ashfield-Watt et al., 
2001; Bailey, 2003; Carmel et al., 2003; Allen, 2004; Bailey, 2005; Antoniades et al., 
2006; de Lau et al., 2006). A recent study by Luchsinger et al., 2007, suggested that 
increasing folate intake for people > 65y without dementia, over a period of ~6y 
would decrease the risk of Alzheimer’s disease. Furthermore it has been proposed 
that oral supplementation of folate and cobalamin can reduce hyperhomocysteimia 
and provide a direct protective effect for the vessel wall (Chambers et al., 1999; Woo 
et al., 1999; Fenech, 1999; Doshi et al., 2002; Vermeulen et al., 2000). Folate and 
cobalamin treatments suppress Hcy-induced oxidative stress and inflammatory 
responses in macrophages (Au-Yeung et al., 2006), and reduce Hcy level and 
caspase-3 cleavage in the neurogenerative disease amyotrophic lateral sclerosis 
disease (Zhang et al., 2008). It has been suggested that folate and cobalamin 
reduced hyperhomocysteimia in cardio vascular patients (Quinlavan et al., 2002).  
 
It is obvious that cobalamin has a significant protective role despite being known as a 
cofactor enzyme in the Hcy metabolism cycle Figure 1.1. The protection mechanism 
of cobalamin, however, remains poorly understood. 
 
1.9 Heat shock proteins: 
The heat shock response was first identified in 1962 by Ritossa when Drosophila 
melanogaster larvae were subjected to a 30C heat stimulus and found to increase 
the expression of certain genes in the salivary gland cells. These genes were later 
shown to lead to an increase in the expression of proteins with molecular weights of 
27 and 70 kDa (Tissieres et al., 1974) and these proteins are known as heat shock 
proteins (Hsps). Several studies have demonstrated that Hsp expression is highly 
conserved in most of prokaryotes and eukaryotes, (Boorestein et al., 1994; Hartl, 
1996). Hsps are up-regulated under different environmental and physiological 
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stressors such as heat, heavy metal exposure, oxidative stress infection and 
ischemia (Lang et al., 2000; Menoret et al., 2002; Pockley, 2003; Ireland et al., 2004; 
Binder et al., 2004).  
 
The Hsps are known to function as molecular chaperones within the cell by helping 
the correct folding of denatured proteins, prevention of improper protein aggregation, 
mediating transport of proteins across intra-cellular membranes, assistance to the 
correct folding of newly synthesised proteins, and are capable of repairing damage 
(Bukau & Horwich, 1998; Mayer& Bukau, 1998; Lindquist et al., 1988; Beere, 2005). 
Hsps assist the stabilization and correct folding of polypeptides through their binding 
to the hydrophobic amino acid side chain of partially unfolded polypeptides following 
heat stress and therefore prevent aggregation (Hartl, 1996; Tavaria et al., 1996). 
Furthermore, Hsps have the ability to provide vital protection in cellular processes by 
removing damaged intracellular proteins and maintaining the correct proteins 
configuration against any environmental and physiological effects (Tytell et al., 
2005). The response of the cellular system to stress is not derived from the chemical 
and the physiological character of the stress but is also due to accumulation of 
denatured proteins which act as a signal to induce Hsp gene expression (DeMaio, 
1999; Kültz, 2005; Diller, 2006; Wheeler et al., 2007). 
 
Hsps are classified according to their molecular weight in Kilo Dalton (KDa) and gene 
sequences homology as follows;  the small Hsp family is between (Hsp10, Hsp27), 
HO-1, Hsp60, Hsp70, Hsp90 and Hsp100. They are located in different locations 
within the intracellular and their functions varies as shown in Table1.2 
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Table 1.2: Classification of Hsps, their location and function. 
Name Location Function 
 
                                         
                                       Small Hsps 
Hsp10 Mitochondria Cofactor for Hsp60 
Hsp27 Cytoplasm/nucleus Cytoskeleton stabilization 
                                         
                                     Hsp32 (HO-1) 
Hsp32 
(HO-1) 
Microsome 
Oxidative stress inducible, tissue 
protective 
HO-2 Microsome Non-inducible 
                                          
                                       Hsp60 
Hsp60 Mitochondria Molecular chaperone 
                                          
                                        Hsp70 
Hsp72 Cytoplasm/nucleus Stress inducible, protective 
Hsp73 Cytoplasm/nucleus 
Constitutively expressed molecular 
chaperone 
                                          Hsp90 
Hsp90α Cytoplasm Stress inducible chaperone 
Hsp90β Cytoplasm Molecular chaperone 
           Adapted from (Fink, 1999; Pockley, 2003) 
 
 
1.9.1 Hsps Nomenclature 
Hsps are classically named according to their molecular weight but are assigned to 
the different families based on their sequence homologies.  Recently, new 
nomenclature for the Hsps has been proposed, and agreed by the HUGO Gene 
nomenclature committee, as shown in Table1.3.  The study of this thesis is carried 
out before the new nomenclature, so we will be using the old nomenclature to report 
the work of this thesis.  
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Table 1.3 Nomenclatures of the Hsps 
Protein name Old name 
Small Hsps family  HSPB family 
Hsp27 HSPB1 
Hsp70 family HSPA family 
Hsp72 HSPA1A 
Hsp73 HSPA8 
Hsp90 family HSPC 
Hsp90α HSPC2 
Hsp90β HSPC3 
Hsp32 HO-1 
           Adapted from (Kampinga et al., 2009) 
 
 
1.9.2 Hsps regulation and expression: 
The cellular response to the heat shock is regulated by transcription factors known 
as heat shock factors (HSF). HSF1 plays a central role as transcription factor to 
regulate the stress response (Uchiyama et al., 2007). It has been reported that HSF1 
is required to regulate the expression of Hsp27 and Hsp72 under stress conditions 
(Christians et al., 2002; Ahn et al., 2003; Trinklein et al., 2004). The HSF1 is found 
as monomer bound to Hsps and other chaperone proteins under non-stress 
conditions (Shi et al., 1998). Under stress conditions, HSF1 is traslocated to the 
nucleus and converted to trimer via their leucine zipper domains. The trimer binds 
with Heat shock elements (HSEs) that are located within the promoter regions of the 
Hsp genes, resulting in transcriptional activation and synthesis of Hsps (Zou et al., 
1998; Uchiyama et al., 2007).  Moreover, the HO-1 can be regulated at the 
transcriptional level, the promoter of the HO-1 gene (the 5′ distal flanking region) has 
several response elalement located in it including  NF-κB, and HSF-1 (Maines,1997; 
Choi et al., 2004). 
 
There is a negative feedback mechanism control the expression of the Hsps, when 
the cellular level of the Hsps increase, Hsp72 or other chaperone protein such as 
Hsp90, relocate to the nucleus and bind to the HSF-1 trans-activation domain by 
which the transcription of Hsps is suppressed. 
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1.9.3  Hsp27 
Heat shock protein 27 (Hsp27), with a molecular weight of 27kD in human and 25kD 
in rodents, is an adenosine triphosphate–independent molecular chaperone that can 
facilitate the repair of degradation and damaged proteins, regulate actin cytoskeleton 
organization and modulate redox parameters potentially produced in stressed cells 
(Hout et al., 1996; Mehlen et al., 1996; Ehrnsperger et al., 1997).   
 
Recently it has been suggested that overexpression of Hsp27 provides protection 
from oxidative stress in different cell lines; H9c2 cells, hippocampal progenitor cells, 
HeLa cells and breast cancer cells (Casado et al., 2007; Son et al., 2005; Tsuchiya 
et al., 2005). These studies also demonstrated that Hsp27 has an anti-apoptosis 
effect by reducing generation of ROS, prevent the loss of membrane potential and 
suppressing the release of cytochrome c (Mehlen et al., 1995; Ito et al., 1998; 
Concannon et al., 2001). The protective role of Hsp27 might be due to its ability to 
regulate the redox status in the cells through maintaining antioxidant enzyme activity 
such as glutathione reductase and glutathione transferase (Wheeler et al., 2007). 
 
1.9.4 Hemoxyganse-1 (HO-1) 
Hemoxygenase-1 (HO-1), also known as Hsp32, is an enzyme that breaks down the 
heme molecule (Fe-protoporphyrin IX) by releasing the chelated iron from the 
tetrapyrrole macromolecule to form Carbon monoxide (CO) and biliverdin IXα (BV) 
isomer (Balla et al., 1992; Yamaguchi et al., 2002; Kravets et al., 2004; Maines, 
2005). All the outcome products of HO-1 activity have antioxidant properties (Ryter et 
al., 2002).  
 
The initial response of the cells to oxidative stress is up-regulation of HO-1 which has 
an anti-inflammatory, anti-apoptotsis, anti-proliferation and cytoprotective effect 
(Maines, 1997; Yamada et al., 2000; Tulis et al., 2001, Shibahara 2003; Maines et 
al., 2005). Moreover, there are several studies demonstrated that HO-1 has a role in 
maintaining antioxidant homeostasis during cellular stress (Alam & Cook, 2003; Choi 
et al., 2003; Otterbein et al., 2000). 
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There are negative and positive feedback mechanisms regulating the induction of 
HO-1.  When the cells exposed to a stressor such as hypoxia or heat, HO-1 is 
upregulated to protect the cells from damage and produces CO and BV (Shibahara, 
2003). However, the accumulation of CO and BV can be toxic, but the transcription 
factor BACH-1 is known to suppress the induction of HO-1 and prevent the 
accumulation of BR and CO (Sun et al., 2002; Shibahara, 2003).  Moreover, HO-1 
can be regulated at transcriptional level and most of the response elements of HO-1 
gene located in the promoter at 5′ distal flanking region which include the binding site 
of transcription factors such as HSF-1 and Nf-κB (Maines, 1997; Choi, et al. 2004). 
 
Several studies have demonstrated the cytoprotection role of HO-1 against oxidative 
stress (Siow et al., 1999; Prohászka, et al., 2004). However, inhibition of HO-1 is 
believed to induce cell death (Otterbein et al., 2000; Soares et al., 2002). It has been 
shown by Yet and co-worker in 2003, that depletion of HO-1 in mice leads to an 
advanced atherosclerotic lesion development. The induction of HO-1 has been 
indicated in several diseases such as Alzheimer’s disease, Parkinson’s disease, 
ischemic stroke, atherosclerosis and renal insufficiency (Agarwal et al., 2000; 
Abraham et al., 2005; Bach, 2005; Deshane et al., 2005; Maines, et al. 2005; Morita, 
2005), so a treatment that leads to induction of HO-1 could be a significant approach 
for the treatment of these diseases.  
 
1.9.5  Hsp70 family:  
Hsp70 is the major inducible heat shock protein in many vertebrate cells and it has 
been widely studied among the Hsps families. The Hsp70 family is known to confer 
thermotolerance and also provides a protection against different stress conditions 
including oxidative stress (Minowada et al., 2005; Musch et al., 1996; Musch et al., 
1999). 
 
In mammalian systems, the Hsp70 family includes; the constitutive cytosolic Hsc70 
(Hsp73), the stress induced cytosolic form (Hsp72), Grp78 (BiP) which is located in 
the endoplasmic reticum (ER), and the mitochondrial Grp75 (Gebauer et al., 1997; 
Liu et al., 2005). These proteins contain two domains: the N-terminal domain which 
is also known as the ATPase domain due to its ability to hydrolyse ATP to ADP, and 
the C-terminal domain, which has a substrate binding domain that binds to 
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hydrophobic peptides (Hartl, 1996; Tavaria et al., 1996; Sriram et al., 1997; Hartl & 
Hayer-Hartl, 2002; Ruchalski et al., 2006).  
 
It has been reported that Hsp72 is induced under different stimuli such as 
hyperthermia (Landry, 1989), oxidative stress (Huot et al., 1999; Mehlen et al., 
1993), and by several commonly used anti-cancer drugs (Garrido et al., 1997). The 
overexpression of Hsp72 has been reported in several studies that provide protection 
against apoptosis induced by different stimuli (Samali et al., 1996; Lindquist, 1986; 
Creagh & Cotter,1999; Grasso et al., 2003; Kim et al., 2005; Doulias et al., 2007).  
 
1.9.6 Hsp90 
Heat shock protein 90 (Hsp90) mainly functions as a cellular chaperone (Pratt et al., 
2003). Hsp90 assists proteins to correctly fold and maintains the function of various 
complex chaperone proteins such as Hsp70, Hop (Hsp70 and Hsp90 organising 
protein) and Hsp40.  
 
The Hsp90 family includes; Hsp90β which is required for cell survival and it is 
essential for ATP-dependent refolding of denatured proteins (Pearl et al., 2002). 
Also, it has been reported that Hsp90 is over-expressed in many cancer cells, and it 
has been proposed to have the potential as anticancer treatment (Schilb et al., 2004; 
Whitesell & Lindquist, 2005). 
 
1.10 Signal transduction pathways 
Signal transduction pathways are defined as any process by which a cell converts 
one kind of signal or stimulus into an action or response, so they control essential 
processes in all eukaryotic cells, including gene transcription, protein translation, 
cytoskeletal remodelling, endocytosis, cell metabolism, cell proliferation and survival 
(Cano et al., 1994, Widmann et al., 1999). These processes involve ordered 
sequences of biochemical reactions within the cells. Oxidative stress is known to 
induce apoptosis in different cell types which trigger cell death signaling cascades 
(Martindale et al., 2002). At the same time, oxidative stress can also activate certain 
signaling pathways that provide protection against cell death (Wang et al., 1998; Qin 
& chock, 2003). NfkB, ERK1/2 and AKT are considered as a survival signals, they 
activate anti-apoptosis signaling pathways. JNK and p38, on the other hand, are 
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known as cell death signals pathways inducing the death cascade (inducing 
apoptosis) (Xia et al., 1995; Harper & LoGrasso., 2001; Crossthwaite et al., 2002).  
 
1.10.1 NfkB 
Nuclear factor kappa B (NfkB) is a family of inducible transcription factors present in 
all mammalian cells (Chen & Greene, 2004; Hayden & Ghosh, 2006; Hoffimann et 
al., 2006; Perkins, 2006). The phrase NfkB is referring to a family of inducible dimeric 
transcription factors that recognize a common sequence pattern, the kB site. There 
are seven subunits related to NfkB polypeptides: NfkB1:p105 and p50, NfkB2:p100 
and p52, RelA(p65), c-Rel and RelB, and these subunits can form large numbers of 
homo- and heterodimers (Ghosh & Karin, 2002; Hayden et al., 2006).  
 
Under normal conditions in the cytoplasm, Nf-kB is usually found in an inactive form 
bound to an inhibitory protein known as IKB (Figure 1.4). When cells are exposed to 
a different type of stress, IKB is phosphorylated, resulting in subsequent degradation 
of IkB and translocation of NfkB to the nucleus (Baeuerle, 1998; Mattson et al., 2000; 
Kaltschmidt et al., 2005). 
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Figure 1.4; Activation of NfkB. The phosphorylation of IkB leads to dissociation with NfkB 
and translocation to the nucleus. NfkB then bind to the gene promoter to upregulated gene 
expression of proteins such as inducible nitric oxide (iNOS), cyclooxygenase-2 (COX-2), 
Vascular Cell Adhesion Molecule-1 (VCAM-1), Intercellular Cell Adhesion Molecule-1(ICAM-
1) and glutathione (Glu). Each molecule in the diagram has a unique colour and form, and the 
colour was changed according to the process to yellow when the molecule was 
phosphorelated. 
 
 
 
 
 
 
 
 
 
NfkB 
Stress 
 IkB 
P NfkB  IkB 
P  
P 
NfkB 
 
Phosphorylation 
Degradation  
Activation 
Translocation 
Nucleus  
NfkB 
iNOS 
COX2 
Bcl2XL 
c-FLIP  
A1/Bfl-1  
VCAM-1  
 21 
Recently, several research studies have investigated NfkB activation under different 
stress conditions. The central cellular roles of NfkB are; maintaining tissue 
homeostasis, activation of innate and adaptive immune responses, and control of the 
development of disease through its ability to suppress apoptosis and promote cell 
survival signals (Sun & Karin, 2008; Lin & Karin, 2003).  NfkB activation regulates the 
expression of anti-apoptosis gene proteins such as Bcl-XL, c-FLIP, A1/Bfl-1 (Lin & 
Karin, 2003). Moreover, NfkB is also known to control expression of iNOS and other 
inducible genes such as cyclooxygenase-2 (COX-2), Vascular Cell Adhesion 
Molecule-1 (VCAM-1), and Intercellular Cell Adhesion Molecule-1(ICAM-1) in 
immune and inflammatory responses (Pham et al., 2004; Xia et al., 2001). 
Furthermore, it has been reported that NfkB activation is associated with 
neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, 
Huntington’s disease, and active multiple sclerosis (Bonettie et al., 1999; Mattson & 
Camandola, 2001; Memet, 2006). 
 
1.10.2 Mitogen-Activated Protein Kinases family (MAPK) 
The function and regulation of mitogen-activated protein kinases (MAPK) have been 
highly conserved (Widmann et al., 1999). MAPKs are serine/threonine kinases and 
include extracellular signal regulated kinase 1/2 (ERK1/2), c-Jun N-terminal kinase 
(JNK), and p38 MAPK. These MAPKs are upregulated by kinases and inactivated by 
phosphatases (Hommes et al., 2003). MAPK plays a vital role in the cellular system 
including proliferation, differentiation and cell death (Singh & Czaja, 2006; 
Dhanasekaran et al., 2007). They are triggered by various factors such as growth 
factors, cytokines, oxidative stress and hyperthermia (Aikawa et al., 1997; Chen et 
al., 1998; Kamata & Hirata, 1999; Ng & Bogoyevitch, 2000).  
 
The MAPK signals are triple kinase pathways that include a MKKK (MAPK kinase 
kinase), a MKK (MAPK kinase) and the terminal MAPK (Raman et al., 2007). The 
first well defined MKKK was Raf-1, which is a proto-oncogene serine/theronin protein 
kinase (Figure 1.5). Under stress Ras bind directly to Raf-1 leads to phosphorylation 
and activation of Raf-1(Wellbrock et al., 2004). The phosphorylated Raf-1 activates 
and phosphorylates MAPK (Muslin, 2005). This then leads to phosphrelytion of 
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MKK4/7, MKK 3/6 and MKK1/2 in order to phosphorylate the JNK, P38 and ERK1/2 
respectively.  
 
Generally, it is known that MAPKs are associated with the oxidative stress- signaling 
(Avogaro et al., 2008) and control the mitochondrial pathway of apoptosis (Torres et 
al., 2003; McCubrey et al., 2006). More specifically they promote cell survival, while 
the activation JNK and p38 MAPK is associated with death signaling pathways (Xia 
et al., 1995; Brunet et al., 2001; Harper & LoGrasso, 2001). 
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Figure1.5: Activation of the MAPK family. Under stress, Ras phosphorylate and bid to Raf-
1. The activation of Raf-1 leads to phosphorylation of MEK, which in turn phosphorylate 
MAPK. MKK4/7 activates N-terminal kinase (JNK), MKK3/6 activates P38 and MKK1/2 
activates extracellular signal regulated kinase 1/2 (ERK1/2). Each of them traslocated to the 
nucleas and transcript related genes.  Each molecule in the diagram has its unique colour 
and form, and the colour changed according to the process to yellow when the molecule was 
phosphorelated. 
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1.10.2.1 Extracellular Signal Regulated Kinases (ERK1/2) 
Extracellular signal regulated kinases (ERK1/2) are highly conserved signalling 
pathways. The ERK1/2 is known to be activated by heat shock stimuli, oxidative 
stress and growth factors (Xia et al., 1995; Lapadat, 2002; Kurland et al., 2003; 
Kurland et al., 2003; Monick et al., 2008; Yan et al., 2007; Junttila et al., 2008; 
Johnson & Monick et al., 2008;).  
 
The activation of ERK1/2 requires the activated form of Raf-1 which activates and 
phosphorylates the MKK1/2.  In turn, the ERK1/2 was phosphorylated on the 
threonine and tyrosine residue (Kurland et al., 2003; Monick et al., 2008). Activation 
of the ERK1/2 has several cellular functions such as; regulation of cell growth and 
proliferation, cell death protection (Figure 1.5). Moreover, the role of ERK1/2 to 
promote cell survival also has been demonstrated under oxidative stress in different 
cell types such as osteoblastic cells (Yung et al., 2007) and SH-SY5Y neuroblastoma 
cells (Ruffel et al., 2004) rat PC12 cells (Guyton et al., 1996) and primary cortical 
neurons (Crossthwaite et al., 2002). 
 
1.10.2.2 JNK and P38 
The c-Jun N-terminal kinase (JNK) and P38 are members of the MAPK family. There 
are different stimuli triggering these pathways such as; growth factors, cytokines, 
heat shock and oxidative stress (Hibi et al., 1993; De´rijard et al., 1994; Westwick et 
al., 1994; Davis, 1994; Prasad et al., 1995; Cano et al., 1994). As shown in Figure 
1.5, the activation of the JNK and P38 is required for the phosphorylation of Raf-1 
that leads to activation and phosphorylation of the MAPK. MKK4 and MKK7 are 
required in order to phosphorylate JNK, and MKK3 and MKK6 are needed for P38 
activation (Dhanasekaran & Reddy, 1998).  
 
It is believed that activation of JNK and P38 is essential for control of cell proliferation 
(Raingeaud et al., 1995; Miyazawa et al., 1998; Rincon et al., 1998). JNK and P38 
are activated when the cells undergoes apoptosis (Xia et al., 1995; Matsuzaki et al., 
1999; Uchiyama et al., 2004). 
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1.10.3 AKT/PI3 
AkT/PI3 is a serine/threonine protein kinase that is associated with anti-apoptosis 
signal transduction pathways (Hatano & Brenner, 2001). Upon a variety of stimuli 
such as oxidative stress, Akt/PI3 is activated by phosphorylation at Thr 308 and Ser 
473, (Figure 1.6). The phosphorylation of AKT/PI3K mediates Nrf2 translocation to 
the nucleus (Kang et al., 2002). Moreover, the PI3K cascade controls the regulation 
of antioxidant response element (ARE) dependent genes in H4II rat hepatoma cells 
(Kang et al., 2001), and in IMR-32 human neuroblastoma cells (Lee et al., 2001). 
Several studies shows that AKT/PI3K has the ability to upregulate HO-1  under 
oxidative stress conditions (Martin et al., 2003; Pischke et al., 2005; Salina et al., 
2003; Chung et al., 2005).  
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Figure1.6: Activation of AKT/Nrf2 pathways. Under stress, PI3 phosphorelated and 
consequently leads to phosphorylation of AKT. The phosphorylate AKT activate the Nuclear 
factor erythroid 2-related factor 2 (Nrf2), which then traslocated to the nucleus to bind with 
promoter gene of antioxidant response element (ARE). Each molecule in the diagram has its 
unique colour and form, and the colour changed according to the process to yellow when the 
molecule was phosphorelated. 
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1.10.4 NRF2 
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a critical transcription factor that 
belong to the Cap‘n’Collar family, basic leucine zipper transcription factors. As shown 
in Figure 1.6, Nrf2 has the ability to bind and activate the ARE, antioxidant enzymes 
and other stress-inducible genes in response to oxidative or electrophilic stress (Itoh 
et al., 2005; Chan &Kan, 1999; Chan et al., 2001; Kim et al., 2001; Kwak et al., 
2002).  
 
ARE is a cis-acting enhancer sequence which regulates the transcriptional activation 
of many antioxidant and detoxification-related genes that contain the ARE in their 
promoters under oxidative stress (Rushmore et al., 1991). Genes that are ARE 
regulated include glutathione transferase, HO-1, SOD, and thioredoxin (Lee et al., 
2003). As a result, the ARE is involved in controlling the cellular redox status and the 
provision of protection to the cell against oxidative stress (Hayes & McLellan, 1999) 
 
Nrf2 activity can be regulated at several levels: transcription, degradation, 
translocation, and via post-translational modifications such as phosphorylation 
(Huang et al., 2000; Kong et al., 2001; Kwak et al., 2003; Zhang & Hannink, 2003; 
Nioi & Hayes, 2004). The activation of Nrf2 can be triggered by different stimuli 
(Nguyen et al., 2003).  Normally, Nrf2 presents in the cytoplasm as an inactive 
complex form with Kelch-like ECH-associated protein 1 (Keap1) (Kobayashi & 
Yamamoto, 2005). Activation of Nrf2 occurs upon alteration in the intracellular redox 
state or when cells are exposed to compounds that possess the ability to oxidize or 
covalently modify thiol groups or other exogenous stressor (Dinkova-Kostova et al., 
2001). As shown in (Figure1.6), the Nrf2-Keap1 complex is discharged leading to 
release of the Nrf2 that can then  translocate into the nucleus and bind to the ARE to 
induce expression of defensive proteins (Kobayashi & Yamamoto, 2005; Cullinan et 
al., 2004; Furukawa & Xiong 2005; Kobayashi et al., 2004; Sun et al., 2007), such as 
the glutathione peroxidase-2, and HO-1 genes  (Chan & Kwong, 2000; Cho et al., 
2002; Hayes et al., 2000; Kwak et al., 2001; McMahon et al., 2001). However, 
recently it has been proposed that several signal transduction pathways, including 
MAPKs and NfkB pathways are required for activation of Nrf2 nuclear translocation 
(Kong et al., 2001; Huang et al., 2000; Numazawa et al., 2003; Nakaso et al., 2003).  
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1.10.5 iNOS 
The iNOS is the inducible form of nitric oxide synthase (NOS), which is a member of 
the nitric oxide synthase family present in macrophages and other cells. The NOS 
family includes the constitutive form present in neurons (nNOS) or endothelial cells 
(eNOS) and iNOS. The constitutive NOS form is a calcium-dependent enzyme, while 
iNOS is inducible calcium-independent enzyme. NOS are mainly responsible for 
nitric oxide (NO) generation. NO is a highly reactive nitrogen radical associated with 
different biological processes, such as regulating platelet aggregation and leukocyte 
adhesion, mediating the excessive vasodilatation and cytotoxic actions of 
macrophages against microbes and tumor cells, and acting in neurotransmission, 
(Moncada et al., 1991; Nathan & Xie,1994). However, the free radical (NO.) can act 
as a cytotoxic agent in pathological processes, especially in inflammatory disorders 
(Alderton et al., 2001; Bogdan, 2001; Dawn & Bolli, 2002; Moncada & Higgs, 1991). 
 
NO synthesis requires L-arginine, the electron donor NADPH, oxygen, and cofactors 
heme, FMN, FAD and tetrahydrobiopterin (H4B) (Alderton et al., 2001; Mayer and 
Hemmens, 1997; Stuehr et al., 1991). The oxidation of L-arginine by NADPH and 
oxygen leads to formation of an intermediate product Nw-hydroxy-L-arginine 
(NOHarginine), followed by another oxidation step resulting in formation of L-citrulline 
and NO (Figure1.7).   
 
         
Figure 1.7: Generation of NO.  
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The iNOS is a bi-domain protein consisting of a C-terminal half, which acts as a 
reductase domain that contains the binding sites for CaM, NADPH, FAD and FMN; 
and the N-terminal half of the enzyme acts as an oxygenase domain that contains 
the binding sites for heme, H4B, and L-arginine (Sennequier & Stuehr, 1996). The 
iNOS can be induced in response to cytokines, bacterial products or infection in 
different cell types, including endothelium, hepatocytes, monocytes, mast cells, 
macrophages and smooth muscle cells (Nathan,1992; Jaffrey & Snyder,1995; Mayer 
& Hemmens, 1997; Alderton et al., 2001). Moreover, its believed that iNOS is a vital 
factor in the regulation of vascular disease (Kirkeboen & Strand, 1999; Ortega Mateo 
et al., 2000). However, it has been suggested that there is an associations between 
hyperhemocytemia and iNOS in atherosclerosis (Yla-Herttuala et al., 1986). So the 
overproduction of iNOS can provide either protective or damaging effects, which 
depend on the cell type. (Cosentino et al., 1998; Huk et al., 1998; Marla et al., 1997; 
Blatter et al., 1995; Bogdan, 2001).  
 
The iNOS can be regulated at the transcriptional level via NfkB pathway (Xia et al., 
2001). Upon stimulation such as by Lipopolysaccharide (LPS), cytokines, interferon-γ 
(IFNγ), and tumor necrosis factor-α (TNFα), NfkB is phosphorylated and then  
traslocates to the nucleus to facilitate the iNOS gene expression (Huang et al., 1998; 
Marks-Konczalik et al., 1998; Obermeier et al., 1999). However, iNOS can be 
regulated by different signal pathways that activate transcription factors such as 
protein kinase C (PKC), tyrosine kinase, JNK, raf-1 protein kinase, and MAPK. This 
activation is dependent on the stimulus and cell type (Lahti et al., 2002; Marks-
Konczalik et al., 1998; Momose et al., 2000; Muller et al., 2001; Wang et al., 1999). 
 
The activation of NfkB-IkB binding is the negative feedback mechanism that control 
iNOS expression by NO production in macrophages and hepatocytes (Aktan, 2004). 
Overproduction of the iNOS leads to inhibition of the NfkB activation through 
stabilization of IkB and increased transcription of the IkB gene (Peng et al., 1995b). 
Furthermore, it has also been suggested that exposure of human vascular 
endothelial cells to NO-generating compounds such as sodium nitroprusside (SNP), 
S-nitroso-N-acetylpenicillamine (SNAP) and S-nitrosoglutathione (GSNO), leads to 
inhibition of NfkB-IkB disassociation, inactivation of NfkB (Peng et al., 1995a). The 
binding of the NfkB-IkB is controlled by the redox state of the cysteine residue C62 in 
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the NfkB p50 subunit (Kumar et al., 1992; Matthews et al., 1992; Toledano et al., 
1993; Hayashi et al., 1993; Matthews et al., 1993), which is found within the a 
polypeptide loop, and specifically binds to IkB (Ghosh et al., 1995; Müller et al., 
1995). 
 
Recently, it has been suggested that cobalamin regulates the iNOS activity through 
OHCbl directly scavenging NO leading to inhibition of the NOS activity (Weinberg et 
al., 2005). Also CN2-Cbl interacts directly with iNOS and therefore inhibits activity. 
On the other hand, MeCbl and AdoCbl have no inhibitory activity (Weinberg et al., 
2009). It has recently been hypothesized that cobalamin might induce the iNOS 
activity (Wheatley, 2007) but to date there are no data to support this hypothesis.  
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1.11 Aims and objectives: 
The role of cobalamin in the oxidative stress protection and the mechanism of the 
protection are not fully understood.  
 
The thesis aims to examine the protective role of cobalamin against cell death 
induced by oxidative stress, and investigate the possible mechanism(s) of the 
protection. Furthermore, it examines the novel cobalamin protection against cells 
death induced by oxidative stress and investigates the mechanism(s) of their 
superior protection.  
 
The objectives of this thesis are: 
 Determine the mechanisms of cell death induced by oxidative stress in different 
cell types. 
 Invitigate protective role of cobalamin against cell death induced by oxidative 
stress in different cell lines. 
 Investigate the possible mechanisms of the protection provided against oxidative 
stress by: 
-Examine the possible involvement of the Hsps in the cobalamin protection.  
-Examine involvement of signal transduction in the cobalamin apoptosis 
protection  
 Examine the efficiency of novel cobalamins in the oxidative stress protection and 
the mechanism(s) of their superior protection. 
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Chapter 2 
Materials and Methods 
 
2.1 Equipment 
1.5 mL Microcentrifuge Tubes 
 Thermo Fisher Scientific Inc.                    Part no. TUL-918-014G 
 
12-well Cell Culture Plates 
 Thermo Fisher Scientific Inc.                    Part no. TKT-520-070H 
 
15 mL Centrifuge Tubes 
 StarLab.                     Part no. E1415-0200 
 
25 cm2 Cell Culture Flasks 
 Thermo Fisher Scientific Inc.                    Part no. TKT-130-050P 
 
48-well Cell Culture Plates     
 Thermo Fisher Scientific Inc.                    Part no. TKT-522-070S 
 
96-well Cell Culture Plates 
 Thermo Fisher Scientific Inc.                   Part no. DPS-130-010N 
  
BD Eclipse Blood Collection Needle, 21g 
 Southern Syringe Services Ltd.                  Part no. 268609 
 
 BD Vacutainer® One Use Holder 
        Southern Syringe Services Ltd.                        Part no. 364815 
 
       BD Vacutainer® Whole Blood Tube, K2EDTA, 10 mL 
         Southern Syringe Services Ltd.                     Part no. 367895 
 
        BD Vacutainer® Whole Blood Tube, K2EDTA, 6 mL 
         Southern Syringe Services Ltd.                       Part no. 367873 
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         Bio-Rad ChemiDoc XRS Molecular Imaging System  
                     Bio-Rad Laboratories Ltd.               Part no.170-8070 
 
 Bio-Rad Radiance 2100 AGR-3Q AOFT confocal microscope (Argon   
488,Green He/Ne 500, Red Diode 535) with following lasers: Argon 
(514,488,476,457), Green (543), Red (637) Blue (405) 
 
          Bio-Tek Synergy™ HT Multi-Detection Microplate Reader 
            Labtech International Ltd.  Part no. SIAFR 
 
          Bright-Line™ Hemacytometer 
            Sigma-Aldrich Ltd.   Part no. Z359629 
 
         Circulating Water Bath 
           Wolf Laboratories Ltd.   Part no. GD100-P5 
 
          E100 Binocular Microscope 
          Jencons (Scientific) Ltd.   Part no. 450-951 
 
          BD FACS Canto™ Flow Cytometer 
                     BD Biosciences™.               Part no. 337175 
 
          Hermle Z323K Refrigerated Centrifuge 
               VWR International Ltd.    Part no. 521-0221  
    Including: 
  Swing-out Rotor (8 X 15 mL)  Part no. 521-0189 
  Fixed-angle Rotor (24 X 1.5 mL)  Part no. 521-0201 
  Fixed-angle Rotor (8 X 50 mL)  Part no. 521-0194 
   
     High Speed Mini Orbital Shaker 
        Wolf Laboratories Ltd.    Part no. SSM5 
 
    HTS Transwell-96 Well Permeable Support System 
  Thermo Fisher Scientific Inc.             Part no. HTS-106-050J 
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    Inverted TE2000-U Microscope System  
  Nikon Corporation Ltd: 
      Eclipse TE2000-U Basic Unit              Part no. MEA51010 
      Eposcopic Fluorescence Attachment (Hg)      Part no. MEE54000  
     CFI Plan Fluor ELWD Objectives  
                                                           Part nos. MRH38220/MRH38420/MRH18620 
      Hamamatsu Orca – 285 Digital CCD Camera  
                                                                                        Part no.1HMOC285 
  Coolpix Digital Colour Camera             Part no. 85400RUK 
  IPLAB Suite Software   Part no. 1SCSUITE 
 
   Microplate 96 well V bottom polystyrene clear 0.415 mL 
    Thermo Fisher Scientific Inc.  Part no. FB-56424 
 
         Microplate 384 well square shape polystyrene solid black 
                    Thermo Fisher Scientific Inc.  Part no. FB-58050 
 
        Microscope slide Polysine adhesion glass 25mm x 75mm x 1mm 
     Thermo Fisher Scientific Inc.  Part no. MNJ-800-010F 
 
        Nunc Immuno Maxisorp 96-well Plates 
    Thermo Fisher Scientific Inc.   Part no. DIS-971-030J 
     
         Nitrocellulose Membrane, 0.45 µm  
              Bio-Rad Laboratories Inc.                                  Part. No. 162-0115 
 
           Sigma 1-14 Microcentrifuge 
  Wolf Laboratories Ltd.              Part no. 10016 
 
           Temperature-controlled, Stirred Water Bath, GD100-S5 
  Thermo Fisher Scientific Inc.              Part no. BLE-650-010G 
 
           Vortex Mixer, mini 
               Thermo Fisher Scientific Inc.   Part no. GBI-900-010E 
 34 
2.2 Reagents 
 
            Actinomycin D  
               Sigma-Aldrich Ltd.                                           Part no. A9415 
 
Annexin V: FITC Apoptosis Detection Kit I (100 Tests) 
  BD Biosciences™.    Part no. 556547 
 
Antibiotic/Antimycotic Solution (100X) 
            Sigma-Aldrich Ltd.    Part no. A-5955 
 
        Anti-Goat IgG (whole molecule)–FITC antibody produced in rabbit  
               Sigma-Aldrich Ltd.    Part no. F-2016 
 
               Anti-Rabbit IgG (whole molecule)–FITC antibody 
                Sigma-Aldrich Ltd.    Part no. F-0382 
 
         Anti-Nrf2 Goat IgG polyclonal antibody 
                      Santa cruz biotechnology, INC.                Part no. sc-30915 
 
            Anti- pNfkB Rabbit IgG monoclonal antibody 
                      Santa cruz biotechnology, INC.                Part no. sc-3033 
 
            Anti- pERK1/2 Rabbit IgG monoclonal antibody    
                       Santa cruz biotechnology, INC.               Part no. sc-101760 
 
            Anti- pAKT Rabbit IgG monoclonal antibody 
                     Santa cruz biotechnology, INC.                Part no. sc-4058 
 
            Anti- iNOS rabbit IgG monoclonal antibody 
                    Santa cruz biotechnology, INC.                 Part no. sc-2977 
 
             Bay-117082 
                 Sigma-Aldrich Ltd.    Part no. B-5556 
 35 
BD FACS Lysing Solution 
             BD Biosciences™    Part no. 349202 
 
Bovine Serum Albumin 
       Sigma-Aldrich Ltd.    Part no. A-7906 
 
     Caspase-3, Active Form (100 Tests) 
            BD Biosciences™.    Part no. 559341 
 
 
CellTiter® Aqueous One Solution Cell Proliferation Assay 
         Promega UK Ltd.    Part no. G3580 
 
Methylcoabamin 
             Sigma-Aldrich Ltd.    Part no. M-9756 
 
 
Coomassie (Bradford) Protein Assay Kit 
  Pierce Biotechnology.    Part no. 23200 
 
Dulbecco’s Phosphate Buffered Saline (DPBS)  
                 Cambrex Corporation.                                    Part no. BE17 – 513F 
 
  E6.1, Human Leukemic T cell lymphoblast Cell Line,  
           European Collection of Cell Cultures ECACC      Part no. 88042803 
 
 
   Enzolyte™ Rh110 Caspase-3 Assay kit 
              Anaspec Inc.               Part no. 71141 
        Ethylenediaminetetraacetic acid, anhydrous (EDTA)  
                         Sigma-Aldrich Ltd.                                  Part no. E-6758 
 
         EMEM media 
                          Lonza                                                    Part no. 12-611F 
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   Fixation/Permeabilization Solution (250 Test) 
                        BD Biosciences™.   Part no. 554722 
 
        Foetal Bovine Serum (FBS) (75 mL) 
            Cambrex Corporation.   Part no. 14-810F 
          
         Folic acid 
                           Sigma-Aldrich Ltd.                                Part no. F-7876 
 
         Formaldehyde Solution 37 wt. % in H2O (500 mL) 
                       Sigma-Aldrich Inc.    Part no. 533998  
 
 
         HEPES (50 G) 
                         Sigma-Aldrich Ltd.   Part no. H-3375 
 
         Histopaque®-1077 Hybri-max Solution 
           Sigma-Aldrich Inc.   Part no. H-8889 
 
         Hsp27 Mouse Monoclonal Antibody: FITC conjugate (100 µg) 
                       Cambridge Bioscience.  Part no. SPA-800FI 
 
         HO-1  Mouse Monoclonal Antibody: FITC conjugate (100g) 
                          Cambridge Bioscience                          Part no. OSA-111HI  
 
         Hsp72 Mouse Monoclonal Antibody: FITC conjugated (400 µg) 
                             Cambridge Bioscience.  Part no. SPA- 810FI 
 
         Hsp90 Mouse Monoclonal Antibody: PE Conjugate (100 µg) 
                        Cambridge Bioscience.  Part no. SPA-830PE 
 
         Hydrochloric Acid 
            Sigma-Aldrich Inc.   Part no.H-1758 
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         KNK423, Heat shock protein inhibitor II, 
                      Calbiochem,                                              Part no. 373265 
 
        LY-249002, AKT/PI3 inhibitor 
                      Sigma Aldrich Inc.              Part no.L-9908 
 
           Paraformaldehyde powder 95%  
                        Sigma-Aldrich Ltd.   Part no. 158127  
 
             Propidium Iodide Minimum 95% (HPLC)    
                       Sigma-Aldrich Inc.                                    Part no. P-4170 
                
          RPMI-1640 Medium (500 mL) 
       Cambrex Corporation.              Part no. BE12-702F 
   
          RPMI-1640 Medium, Phenol Red-Free (500 mL) 
        Cambrex Corporation.   Part no. BE12-918F 
           
         SB202190, P38K inhibitor 
             Sigma Aldrich Inc.                                              Part no.S-7067 
 
         SensoLyte Homogeneous Rh110 Caspase-3/7 Assay Kit  
                Cambridge Bioscience.   Part no. ANA-71141 
 
         Sodium Bicarbonate 
               Sigma-Aldrich Ltd.               Part no. S-6297 
 
         Sodium Carbonate    
                Sigma-Aldrich Ltd.               Part no. S-7795 
 
         Sodium Chloride 
              Sigma-Aldrich Ltd.               Part no. S-7653 
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         Sodium Hydroxide 
                   Sigma-Aldrich Ltd.               Part no. S-8045  
 
         SP600125, JNK inhibitor 
           Sigma-Aldrich Ltd.                                               Part no. S5567 
 
          SK-hep1 cells line 
          ECACC (European Collection Cell Culture)        Part no.91091816 
 
        Triton® X-100 
     Sigma-Aldrich Ltd.             Part no. T-8787 
 
         Tween® 20  
           Sigma-Aldrich Ltd.                                             Part no.  P-1379 
     
         U0126, ERK1/2 inhibitor 
            Sigma-Aldrich Ltd.                                            Part no. U120 
 
 
         Wortmanin, Nrf2 inhibitor 
               Sigma-Aldrich Ltd.                                         Part no. 95455  
 
2.3 Buffers 
 
2.3.1 Freeze media solution (v/v) 
10 ml of DMSO was diluted into 40ml of FBS; the solution was kept cold at 4°C 
during the whole freezing process. 
 
2.3.2 MTS Working Solution (w/v)  
MTS Stock solution was prepared by dissolving 0.042g of MTS powder in 21ml 
DPBS and pH was adjusted to 6.5 with 1M HCl. The Phenazyl-Etho-Sulfate (PES) 
stock solution was prepared by dissolving 0.0092g of the powder in 10ml DPBS. The 
MTS working solution was obtained by adding 1ml of PES stock solution in each 
20ml of MTS Stock solution and then the solution was stored at -20°C. 
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2.3.9  pH solutions  
                 1M HCl (v/v) 
  A volume of 9.8 ml of 37% hydrochloric acid (HCl) was mixed with                       
dH2O to obtain up to 100 ml of solution, which was stirred until dissolved. 
 
                1M NaOH (w/v) 
   4g of sodium hydroxide (NaOH) was added to 80ml of dH2O and stirred until 
dissolved. The solution was then made up to 100 ml with dH2O.  
 
2.3.10  4 % Paraformaldehye (PFA) buffer 
2g of Paraformaldheyde (PFA) and 100µl of 5M sodium hydroxide (NaOH) were 
diluted in 40ml of phosphate buffer saline (PBS); the solution was stirred and heated 
at 56°C in a water bath until PFA was completely dissolved. The pH  was adjusted 
with 100µl 5M HCl to 7.4, and then filled up to 50 ml final volume with PBS and 
stored  at 4°C for maximum a week. 
 
2.3.11 15M Phosphate buffered saline,  pH 7.4 (PBS) (w/v) 
8g of Sodium chloride (NaCl), 0.2g of potassium chloride (KCl,), 0.24g of potassium 
dihydrogen orthophosphate (KH2PO4) and 1.44g of sodium dihydrogen 
orthophosphate (Na2HPO4) were added to 1L of dH2O and pH adjusted to 7.2. 
      
2.3.12 Propidium Iodide stock solution (1mg/ml) (w/v) 
0.001g of Propidium iodide (PI) dissolved in 1ml DPBS. 100μg/ml stock solutions 
was prepared and stored at -20°C into single use aliquots. 
 
 
2.3.13  Blood cells Lysing Buffer 10X solution (w/v) 
8.02g of ammonium chloride (NH4Cl), 84g of sodium carbonate (NaHCO3,) and 0.37g 
EDTA disodium were dissolved in 50 ml of dH2O. The 1X working dilution was 
obtained by diluting 1/10 the concentrated solution with dH2O. 
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2.3.14 Tissue culture media (v/v) 
 10% FBS was added to RPMI 1640 or EMEM media and stored at -   20°C. The  
 
media was regularly transfer to 24 well plates and examined under light microscope 
for infection and integrity of the culture media.  
    
2.3.15 Wash buffer 1X 
5ml of foetal bovine serum (FBS) was diluted in 100ml PBS 
 
All chemicals unless otherwise indicated are obtained from Sigma-Aldrich 
Company Limited, Poole, Dorset, UK. 
 
 
2.4 Method 
2.4.1 Cell culture: Sk-Hep1 
Sk-hep1 is carcinoma liver endothelial cells. The cells were purchased frozen. The 
cryostats containing the cells were removed from the cryostat, soaked with alcohol 
and placed in a 37°C water bath immediately. The vial opened and the contents 
were placed in a 25cm2 flask containing 5ml of pre-warmed EMEM media with 10% 
serum. The cells were then counted with the haemocytometer and cell density was 
adjusted to 3-9x105cells ml-1. Cells were kept at 37°C in the incubator with 5% CO2. 
A cell viability test was performed after 24h using trypan blue assay on 
haemocytometer. The cell line was passage every 3 days and viability was always 
tested by trypan blue assay. 
 
Cells were sub-cultured 1:2 in culture flask at density, as required for the experiment. 
For passaging the Sk-Hep1 cells, medium was removed and cells were washed with 
1 ml of trypsin/EDTA 0.4% solution. 1ml or 2ml of trypsin/EDTA 0.4% solution per 
25cm2 or 75cm2 flasks respectively added. After 90s trypsin removed. The digestion 
was stopped after further 3 min by the addition of 5ml of fresh EMEM media. For the 
experiment cells were grown in monolayer until approximately 90% confluent in 6-96-
well plates. Cells were cultured at 37°C in 5%Co2 humidified Heracell incubator.  
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2.4.2 Cell culture: Jurkat 
One of the cells line was used in this study was derived from blood malignancies: the 
E6.1 Jurkat is human leukemic T-cell lymphoblast cell line and it is a suspended cell.  
Briefly the cells were purchased frozen and, the cryostats containing the cells were 
removed from the cryostat, soaked with alcohol and quickly placed in a 37°C water 
bath. The vial was quickly opened and the contents were placed in a 25cm2 flask 
containing 5ml of pre-warmed PRMI 1940 media with 10% serum. The cells were 
then counted with the haemocytometer and cell density was adjusted to 3-9x105cells 
ml-1. Cells were kept at 37°C in the incubator, 5% CO2. The cell viability test was 
performed after 24h using trypan blue assay on haemocytometer. The cell line was 
passage every 3 days. For experimental use cells were plated in 6-12-24 well plates 
and the cells were sub cultured at density required for the experiment use.  
 
2.4.3 Freezing storage and thawing of sk-hep1 and Jurkat 
For long-term storage cells were kept at low density at 5x105 cells/ml, in which cells 
were in the log phase of the growth curve and hey were actively growing. SK-Hep1 
cells were detached with trypsin/EDTA 0.4% solution, and centrifuge at 218g for 5 
min, for the Jurkat cells; cells were centrifuged at 400xg for 5min at 25°C. The 
culture media was removed and cell pellet was re-suspended in 1ml of freeze media. 
The cells suspension was transferred to cryostats and frozen immediately at -20°C 
for 24hr, then at -80°C for 7 days, prior to storage at -196°C in liquid nitrogen. This 
procedure was performed in order to ensure gradual freezing of the cells to avoid ice 
–crystal formation within the cell structure.  
 
For thawing, cells were defrosted in 37°C water bath and the cell suspension was 
immediately transferred to a 25cm 2 cell culture flask containing 9ml fresh complete 
media. Cells were cultured at 37°C in a 5 CO2 humidified Heracell incubator. 
 
2.4.4 Whole blood collection 
The venous blood provided for these studies came from healthy voluntary people 
(non-smoker, clear from any infection and no alcohol). The blood samples were 
collected by venepuncture in 7ml K2 EDTA vacutainers. 
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2.4.5 Whole blood isolation 
Whole blood was washed with two volumes of DPBS and centrifuged at 500g for 5 
min at 25°C. The supernatant was discarded and the red blood cells were lysed 
using 1x lysing buffer. The lysed whole blood was then centrifuged at 500xg for 5 
min and the supernatant discarded. The cell pellet was washed with DPBS and the 
cells counted using the trypan Blue exclusion. The experiments were performed 
when the percentage of dead cells was <1%. Concentration of the viable cells was 
adjusted to 1x106 cells/ml and the cells were centrifuged at 500xg for 5 min. 
Supernatant was discarded and cells were re-suspended with 1 ml of wash buffer 
(DPBS 5%FCS) and kept on ice for flow cytometry analysis. 
 
2.4.6 Trypan blue exclusion test cell viability 
 The dye exclusion test is employed determine to determine the viability and cell 
counts. It is based on the principle that Trypan Blue is a non-permeable cell 
membrane DNA dye, so the viable cells will not interact with dye whereas dead cells 
or necrotic cells allow the dye to stain the DNA inside the cells. As a result viable 
cells would appear clear white whereas dead cells would show up blue. Cells 
suspended in media were diluted 1:1 with Trypan Blue, and then 50μl of the 
suspension mixture was loaded in to both chambers of the haemocytometer. Cells 
were counted in the 0.04 mm centre square and four 0.04 mm corner squares, as 
presented in the (Figure 2.1) Cell number/ ml was obtained using the following 
formula: 
Cells/ml= Cell count x 5 x dilution factor x 10000 
When the dead cells percentage exceeded 5% cells were discarded and not used for 
the experiments. 
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                                  Figure 2.1: Haemocytometer 
 
 
2.4.7 Sterilisation of equipment 
Filter units containing 0.2 filters were autoclaved for filter serialisation of all reagents 
used under experimental conditions in culture media. 
 
 
2.4.8 Treatment’s Solution preparation 
2.4.8.1 Hydrogen peroxide: The stock solution was 8.8M, diluted to 100mM, 
10mM, 1mM and 0.1mM in media and Stored at 4°C. 
 
2.4.8.2 Homocysteine: The stock solution made out in 1M HCl at concentration 
100mM. The stock diluted to 1mM, 500M, 250M, 125M, 65M, 
31.25M and 13M in media on the same day of the experiments 
because the Hcy is not stable in the media. 
 
 
2.4.8.3 Folic acid: The stock solution made out in 1M NaOH at concentration 
100mM. The stock diluted to the required concentration in media and 
store at -20°C. 
             
             
             
             
             
             
             
             
             
             
             
             
             
0.04 square mm 
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2.4.8.4 Cobalamin 
Stock of 1M prepared with ethanol, and then the stock diluted with media to the 
required concentration 200M, 100M, 50M, 25M, 12.5M, 6.25M and 
3.125M. Store at -20°C. 
 
2.4.9 MTS assay: Cells viability 
The cell viability in proliferation was performed using a colorimetric assay from 
Promega; CellTiter ® MTS Aqueous solution. The solution contain a tetrazolium 
compound called MTS (3-(4,5-dimethylthiazol-2yl)-5-(3-carcoxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium) and an electron coupling agent PES (Phenazyl-Etho-
Sulphate). MTS solution is bio-reduced by dehydrogenases enzymes in metabolically 
active cells, into formazan detected by colure developed at 490nm using a Bio-Tek 
Synergy H.T Multi-detection Microplate Reader, ruining KC-4 v3.4 software. Test 
conditions were as follows:  
 
For the SK-Hep1 cells, 100l cells were plated on 96-well plate at approximately 
5x105 cells per well and cultured for 24hr. The cell media was removed from test 
wells and replaced with 100l media containing various concentrations of test 
compounds. Plates were incubated for indicated time.   
 
For the Jurkat cells, cells were seeded on 12-24 well plate on the day before at cell 
density 1x105. Then cells treated with media containing various concentrations of 
test compounds and incubated for indicated time. After the incubation time 100l of 
Jurkat cells transferred to black 96-well plate. 
 
After incubation time for both cells lines, 20l of MTS solution was added to each test 
well. Cells were incubated at 37°C with 5% CO2 for the required time (2.5 hours for 
Jurkat and 1 hour for SK-hep1). The absorbance was measured at 490nm and 
comparison with control was performed. Controls were included a blank control; 
media, positive control; viable cells and negative control; dead cells killed by 
microwave irradiation for 10sec. 
. 
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2.4.10 Caspase-3/7 fluorimetric assay: 
The activation of downstream caspas-3, which is an effector of caspase, have  the 
ability to cleave poly-(ADP ribose) polymerase (PARP), DNA-dependent protein 
kinase (DNA-PK), topoisomerases, and protein kinase C. This activity determined 
with an assay using the synthetic peptide substrate DEVD (asp-glu-val-asp). The 
DEVD substrate is labelled with a fluorophor, 7-amino-4-methylcoumarin (AFC), 
allowing the detection of the cleavage of caspase-3. The release of this flurophore 
resulted in a shift from blue to green fluorescence, measured at an extinction 
wavelength of 390nm and an emission wavelength of 505nm. (Ex=496nm/, 
Em=520nm/) as described by the manufacture. The reaction has a linear 
progression over approximately two hours, provided the enzyme is saturated with 
substrate. Caspases need a thiol group for their catalytic function; therefore they are 
susceptible to changes in redox potential. This can allow the thiol group to be 
oxidized by agents such as air, oxygen and traces metal ions. To counteract this 
effect, the substrate buffer contains dithiotheritol (DTT) as reducing agent. 
 
Briefly cell incubated under test condition of the experiment, and then 100μl of Jurkat 
cells were transferred into a 96-well black plate while sk-hep1 were seeded in the96-
well black plate . The entire reagents needed were thawed at 25°C and a working 
solution of the substrate was prepared by diluting 5ml assay buffer with 200l DTT 
and 50l caspase-3 substrate solution. The 20μl of working solution was added to 
each cell well and incubate for 1hour at 37°C.  The result compared to controls; 
negative control: no treated cells, blank; media. 
 
2.4.11 Caspase-3 assay FC: 
Active caspase-3 was also tested using a polyclonal anti- active form of caspas-3-
FITC conjugated rabbit antibody. Cells were treated under test condition then 
washed with wash buffer and centrifuged at 500xg for 5 min at 25°C.  Cell pellet re-
suspended in 70μl of fix/perm and incubated at 4°C for 20 min to allow the cells to fix 
biochemistry reaction inside the cells and permeabilise the cells membrane. The cell 
suspension was then washed with wash buffer, centrifuged at 500xg for 5 min at 
25°C. Then cells pellet were incubated with 20μl/1x106cells/ml caspase-3-FITC 
conjugated antibody and incubated for 40 min at 4°C in dark. The unbound antibody 
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was washed with wash buffer, centrifuged at 500xg for 5 min at 25°C, the pallet then 
re-suspended with fresh DPBS buffer. Cells were analysed on the FACS Canto dual 
laser flow cytometry in the FITC channel. 
 
2.4.12 Necrosis detection with Propidium Iodide fluorescent assay: 
DNA fragmentation is considered to be a characteristic hallmark of necrosis; 
therefore necrotic cells can be detected and quantified by propiduim iodide. PI 
interacts with DNA content of the cells. The cells were seeded at concentration of 
0.2-0.7x106cells/ml in black 96-well plate and treated under test conditions. The 
stock solution of propiduim iodide kept at -20°C at 100μg/ml concentration and the 
working solution 5μg/ml was prepared before each analysis in DPBS. The 100l per 
well of working solution was then added and incubated at room temperature for 20 
min in the dark. The PI fluorescence was detected at Ex=535nm/Em=617nm. The 
controls were positive control; cells incubated in the microwaves for 15 seconds, 
negative control; viable cells and blank: media. 
 
2.4.13 Annexin-v and Propidium Iodide: 
 One of the early events of apoptotic cell death is the membrane changing, such as 
loss of membrane asymmetry and attachment. Phosphatidylserine (PS), usually 
present as an internal membrane lipid, when apoptosis occurs, it is traslocated to 
outside the plasma membrane. Annexin V is a 35-36 kDa Ca2+ dependent 
phospholipid-binding protein that has a high affinity for PS, and binds to cells with 
exposed PS. Using this protein conjugated with FITC labelled combined with 
propiduim Iodide PE-labelled, it is possible to distinguish cells the apoptotic cells or 
necrotic cells using flowcytometry. 
 
Cells were treated under test conditions and washed twice with cold PBS which 
centrifuged at 500g for 5 min at 25°C.   And then cells were re-suspended in 1x 
binding buffer at density of 1 x 105 cells/ml, and 5μl of Annexin V-FITC was added 
and incubated for 15 min at 25°C in the dark. Before the analysis 5μl Propidium 
Iodide (PI 5μg/ml) solution was added to the cell. The samples were analysed 
immediately by flow cytometry Annexin V was detected at Ex=490/Em=520nm and 
PI was detected using a >520nm long phase filter; 10000 events were recorded for 
each samples and compensation controls were applied for each experiment. 
 47 
2.4.14 Measurement of  intracellular Protein by FC: 
Cells were treated under test condition and harvest as mentioned previously at 
concentration 1x106cells/ml prior labelling. The cell washed with wash buffer (5% 
FBS in PBS), and centrifuged at 500xg for 5 min. Cells were then fixed and 
permeabilised with 50μl of Fix/Perm solution and incubated for 20 min at 25°C. 
Followed by adding 1ml wash buffer to the cells and centrifuged at 500xg for 5 min 
and supernatant removed. Cells were then labelled for the intracellular (Hsp27, HO-
1, Hsp72 and Hsp90) by adding 1μl of antibody+49μl wash buffer and incubated for 
40 min at 25°C in the dark. The incubation time was followed by a wash with 1 ml of 
wash buffer, centrifuged at 500xg for 5 min and the supernatant discard. Cell pellet 
was re-suspended in 20μl of wash buffer and analysed by the flow cytometry. The 
same dilution applied for measuring Nrf2, NfkB, ERK1/2, AKT and iNOS. 
Compensation controls for each experiment panel was run in the first experiment and 
settings same were applied throughout all the study. 
 
2.4.15 Measurement of Reactive Oxygen species:  
Cells were cultured in 96-well plates for 24hr and then treated with reagents under 
test conditions. The redox active probe 2’7’-dichlorfluorescein-diacetate (DCFH-DA) 
was added to the cells at a concentration of 10mM and then incubated in the dark for 
30min. Following treatment samples were solubilised in NaOH (0.1N). DCFH-DA 
activity was measured at λex=485nm/λem=530nm. 
 
 
2.4.16 Measurement of super oxide generation by Lucigenin-enhanced 
chemiluminescence: 
 
Cells were cultured in white 96-well plates for 24hr and then treated with reagents 
under test conditions. The generation of superoxide (·O2
-), was demonstrated by 
added 5µM Lucigenin to each test well and the plate was incubated for 45min at 37oC 
in dark conditions. Absorbance was measured at 550nm. 
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2.4.17 statistical analyses 
All statistical analyses were performed using Prism™ 5.01 (GraphPad Software Inc., 
San Diego, USA). 
 
Initially all the data were tested to determine if the results were normally distributed. 
Depending on the size of the population, either the Shapiro-Wilk (when n<50) or 
Kolmogorov-Sirnov (when n >50) statistical test was employed. Data were 
considered as normally distributed if p  0.05. 
 
Everywhere the data normally distributed, reported measures one-way or two-way 
analysis of variance (ANNOVA) between samples test was employed adopting a 5% 
level of significance. Post hoc testing was carrying out using the Tukey test or 
Bonferroni test for pairwise comparisons between means.  
 
All data are represented as the mean ± standard deviation (SD). Numbers of 
replicates (n) are shown in parentheses in figure legends where appropriate. 
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Chapter 3 
 
Protection From Oxidative Stress 
 
3.1  Introduction: 
Oxidative stress has been associated with a wide range of diseases, such as 
cardiovascular (Diaz-Arrastia, 2000; Refsum et al., 1998), Alzheimer’s Disease 
(Clarke et al., 1998; Miller, 1999), atherosclerosis, Parkinson’s Disease (Blandini et 
al., 2001; Duan et al., 2002; Kuhn et al., 1998; Yasui et al., 2000) cancer (Jacobson 
et al, 1996), and also plays a role in the ageing process (Jacobson, 1996). Hcy has 
been demonstrated to be an inducer of apoptosis in different cell types such as  
primary human bone marrow stromal cells and the HS-5 cell line (Duk et al, 2006), 
H9C2 cardiomyocytes (Levrand et at., 2007) and lymphocyte cells (Picerno et at., 
2006), (Mujumdar et al., 2001; Zhang et al., 2001). The trigger of apoptosis by Hcy 
was associated with activation of caspase-3, caspase-9 and release of cytochrome 
c, (Liu et al., 2005; Obeid & Herrmann 2006; Duk et al., 2006).  Low concentrations 
of H2O2 have been reported to induce apoptosis and high concentrations induce 
necrosis (Jacobson, 1996; Wol¡, 1994; Vanags et al., 1996). The induction of 
apoptosis induced by H2O2 is associated with caspase-9 and caspase-3 activation 
and with phosphotidylserine appearance on the surface of the cells (Saito et al., 
2006; Hampton & Orrenius, 1997). 
 
Several ways have been suggested to reduce the lethal effects of oxidative stress, 
including reduction of oxidative agents and maintenance of trans-methylation 
pathways (Szeto & Benzie, 2002). Hyperhomocysteinemia is associated with folate 
and cobalamin deficiency results in high levels of apoptotic cells (Selhub et al., 2000; 
Mattson & Shea, 2003). Folate is a methyl donor in one-carbon metabolism, which 
helps to promote the remethylation of Hcy (Lucock et al., 1996), while cobalamin 
acts as a methionine synthase cofactor (Refsum, 2001). Therefore therapy with 
folate and cobalamin can reduce hyperhomocysteinemia by significant inhibition of 
caspase cleaved (Zhang et al., 2008). Moreover, In vivo and in vitro, studies have 
demonstrated that supplementation with folate has a significant effect on reducing 
apoptotic and necrotic cells  (Chambers et al., 1999; Vermeulen et al., 2000; Woo et 
al., 1999; Fenech, 1999), and reduced Hcy in the blood of hyperhomocysteinemic 
patients (B-Vitamin Treatment Trialists', 2006; Rosenberg, 2007; Kazerooni et al., 
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2008; Nagaraja et al., 2008). However there are limited studies investigating whether 
cobalamin has a protection role against oxidative stress.  
 
In this chapter the aim is to investigate mechanisms of cells death under oxidative 
stress and the impact of folate and cobalamin on cell death induced by oxidative 
stress. Different cell models will be used: initially an endothelial cell line - sk-hep-1 
(known to be highly sensitive to oxidative stress), a T-cell lymphoma cell line – 
Jurkat; and primary leukocytes from healthy volunteers (non-smoker, clear from any 
infection and no alcohol consumed). 
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3.2 Methods 
 
All preparations and cell culture experiments were carried out within a class II tissue 
culture hood. 
 
3.2.1 Sk-hep1 cells preparation: 
Cells were passed every 3 days as described in (section 2.4.1). 
 
3.2.2 Jurkat cells preparation: 
Cells were passed every 3 days as described in (section 2.4.2).  
 
3.2.3 Leukocyte cells preparation: 
Blood was taken from healthy volunteers (section 2.4.4), and leukocyte cells were 
isolated as described in (section 2.4.5). Cells were then transferred to 12 or 24 well 
plates and treated under test conditions.  
 
3.2.4 Determine cell viability 
Cells were plated on to a black 96 well cell plate and treated under test conditions 
then cell viability measured by MTS assay as described in (section 2.4.9). 
 
3.2.5 Determination of apoptosis 
Cells were plated on to a black 96 well cell plate and treated under test conditions 
then analysed for apoptosis by caspase-3/7detection (section 2.4.9). 
 
3.2.6 Determination of necrosis: 
Cells were plated on to a black 96 well cell plate and treated under test conditions 
then analysed for apoptosis by caspase-3/7detection (section 2.4.11). 
 
3.2.7 Cells count and viability test by trypan blue exclusion: 
Upon treatment finished, cells were re-suspended in to the media by pipetting. Cells 
were then counted and assessed by trypan blue exclusion (section 2.4.6) 
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3.2.8 Caspase-3 activity via flow cytometry 
Cells were treated under test condition and processed as described in (section 
2.4.10) 
 
3.2.9 Annexin-V and PI 
Cells were treated under test condition and then processed for annexin-V and PI 
analysis as described in (section 2.4.12) 
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3.3 Results 
 
3.3.1 Induction of apoptosis and necrosis in Sk-hep1cells via exposure to 
Hydrogen peroxide and Homocysteine. 
 
In order to investigate the mode of Sk-hep1 cell death, cells were incubated with a 
range of H2O2 and Hcy concentrations for 2 hours. Cell viability reduced significantly 
with increasing concentrations (0-50M H2O2 or Hcy) (p<0.001, as determined by 
ANOVA) (Figures 3.1 & 3.2). Upon further analysis, Tukey pairwise testing showed 
significant reduction in cells viability and reached less than 20% (P 0.001) at 25M 
H2O2 and 10% (P 0.001) at 25M Hcy as compared to the basal values (control – 
state what the controls where here). 
 
Control cells had no detectable caspase-3 activity. However, the H2O2 or Hcy have a 
significant effect on caspase-3 (p<0.001, as determined by ANOVA) (Figures 3.3 & 
3.4). And Tukey pairwise testing showed at low concentrations such at 1.325 of H2O2 
or Hcy caspase-3 activity increased significantly to peak at 3.125M H2O2 or Hcy (P 
0.001), after which activity declined.  
 
There was a significant effect on necrosis activity induced by H2O2 and Hcy 
(p<0.001, as determined by ANOVA) (Figures 3.5 & 3.6). Post-hoc pairwise 
comparison showed at concentrations above 6.25M H2O2 (P 0.001) or 6.25M 
Hcy (P 0.001) that there was a significant increase in necrosis as indicated by PI. 
Also higher concentration such at 50M H2O2 or Hcy resulted in 100% necrosis (P 
0.001) as compared to control cells. 
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Figure 3.1: Effect of oxidative stress on viability of sk-hep1 cells. Cells were treated with 
a range of H2O2 (0-50M) for 2 hours, control cells are non-treated cells. Cell viability was 
determined by MTS® assay at 490nm. Data are means ± SD n=3, p< 0.001 as determined by 
one-way ANOVA. Baseline (control) vs 3.125M (p<0.001), 6.25M (p<0.001), 12.5M 
(p<0.001), 25M (p<0.001) and 50M (p<0.001) as determined by Tukey post hoc. 
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Figure 3.2: Effect of Hcy on viability of sk-hep1 cells. Cells were treated with a range of 
Hcy (0-50M) for 2 hours, control cells are non-treated cells. Cell viability was determined by 
MTS® assay. Data are means ± SD n=3, p< 0.001 as determined by one-way ANOVA. 
Baseline (control) vs 3.125M (p<0.001), 6.25M (p<0.001), 12.5M (p<0.001), 25M 
(p<0.001) and 50M (p<0.001) as determined by Tukey post hoc. 
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Figure 3.3: Effect of Hydrogen peroxide on caspase-3 level in Sk-Hep1. Cells were 
treated with a range of H2O2 concentrations (0-50M) for 2 hours. Control cells are non-
treated cells. Caspase-3 measured at EX=496nm/EM=520nm. Data are means ± SD n=3, p< 
0.001 as determined by one-way ANOVA. Baseline (control) vs 1.325 (p<0.001), 3.125M 
(p<0.001), 6.25M (p<0.001), 12.5M (p<0.001), as determined by Tukey post hoc. 
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Figure 3.4: Effect of Hcy on caspase-3 level in Sk-Hep1. Cells were treated with a range of 
concentrations of H2O2 (0-50M) for 2 hours, control cells were non-treated cells. Caspase-3 
measured at EX=496nm/EM=520nm. Data are means ± SD n=3, p< 0.001 as determined by 
one-way ANOVA. Baseline (control) vs 1.325 (p<0.001), 3.125M (p<0.001), 6.25M 
(p<0.001), 12.5M (p<0.001), as determined by Tukey post hoc. 
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Figure 3.5: Induction of necrosis in Sk-Hep1 by H2O2. Cells were treated with a range of 
H2O2 concentrations (0-50M) for 2 hours, control cells were non-treated cells. Necrosis 
measured at EX=535/EM=617. Data are means ± SD n=3, p< 0.001 as determined by one-
way ANOVA. Baseline (control) vs 6.25M (p<0.001), 12.5M (p<0.001), 25M (p<0.001), 
and 50M (p<0.001) as determined by Tukey post hoc. 
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Figure 3.6: Induction of necrosis in Sk-Hep1 Hcy. Cells were treated with a range of Hcy 
concentrations (0-50M) for 2 hours. Control cells: were non-treated cells. Necrosis measured 
at EX=535/EM=617. Data are means ± SD n=3, p< 0.001 as determined by one-way ANOVA. 
Baseline (control) vs 6.25M (p<0.001), 12.5M (p<0.001), 25M (p<0.001), and 50M 
(p<0.001) as determined by Tukey post hoc. 
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3.3.2 Folate and Cobalamin protect cells (SK-hep1) from apoptosis and necrosis 
induced by oxidative stress: 
3.3.2.1 Folate protects cells (Sk-hep1) from apoptosis and necrosis induced by 
oxidative stress: 
After determining the concentrations required of H2O2 or Hcy to induce apoptosis and 
necrosis in sk-hep1 cells, the effect of folate on cell death induced by oxidative stress 
was investigated. Cells were subjected to a range of folate concentrations (0-100M) 
for 2 hours, none of which caused significant caspase-3 activity detected as 
compared to control cells (non-treated) (P0.05, as determined by one-way ANOVA) 
(Figure 3.7). Also there was no significant necrosis activity observed with folate 
treated cells compared to control cells (P0.05, as determined by one-way ANOVA) 
(Figure 3.8). 
 
Pre-incubation of cells with 30M folate for 2 hours followed by 2 hours incubation 
with a range of H2O2 or Hcy (0-50M) has showed significant effect (P0.001, as 
determined by Two-way ANNOVA) (Figures 3.9 & 3.10). Further analysis with 
Bonferroni pairwise resulted in significant increases in cell viability at ≥3.125M H2O2 
or Hcy (P 0.001), and cells viability reached more than 60% (P 0.001) and 55% 
(P 0.001) at 50M H2O2 or Hcy respectively as compared to control cells (non-
treated). Folate pre-treatment provided a significant protection against 
oxidative stress induced apoptosis (P0.001, as determined by Two-way 
ANNOVA) (Figures 3.11 & 3.12). Furthermore, analysis with Bonferroni pairwise 
showed a significant reduction in the caspase-3 activity at low concentrations 
of H2O2 or Hcy (P 0.001). Caspase-3 reduced by 62% (P 0.001) and 63% 
(P 0.001) at 3.125M H2O2 or Hcy respectively with pre-incubation of folate 
compared to cells treated with H2O2 or Hcy alone. Additionally, folate 
treatment provides a significant protection against necrosis induced by H2O2 
or Hcy (P0.001, as determined by Two-way ANNOVA) (Figures 3.13 & 3.14). 
The analysis with Bonferroni pairwise showed significant induction of caspase by 
6.25M H2O2 or Hcy (P 0.001), after which necrosis activity declined by 61% 
(P 0.001) and 65% (P 0.001) at 25M H2O2 or Hcy compared to H2O2 or 
Hcy alone.  
 58 
 
2 4 8 16 32 64 1280
0
5
10
Folate
folate, M
R
e
la
ti
v
e
 f
lu
o
re
s
c
e
n
t 
u
n
it
s
 
Figure 3.7: Effect of folate on caspase-3 in Sk-hep1 cells. Cells were pre-incubated with a 
range of folate concentrations (0-100M) for 2 hours, control cells were non-treated cells. 
Caspase-3 measured at EX=496nm/EM=520nm.The data presents are means ± SD n=3. p  
0.05 as determined by one-way ANOVA. 
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Figure 3.8: Effect of folate on necrosis activity in Sk-hep1 cells. Cells were pre-incubated 
with a range of folate concentrations (0-100M) for 2 hours, control cells were non-treated 
cells. Necrosis measured at EX=535/EM=617. The data presents are means ± SD n=3. p  
0.05 as determined by one-way ANOVA. 
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Figure 3.9: Effect of folate per-treatment on Sk-Hep1 cells surviving oxidative stress. 
Cells were pre-incubated with 30M folate for 2 hours followed by treatment with a range of 
H2O2 concentrations for 2 hours and control; cells were treated with a range of H2O2 
concentrations (0-50M) for 2 hours. Cell viability was determined by MTS® assay at 490nm. 
Data are means ± SD n=3, p< 0.001 as determined by two-way ANOVA. H2O2 (control) vs 
3.125M (p<0.001), 6.25M (p<0.001), 12.5M (p<0.001), 25M (p<0.001), 50M 
(p<0.001), as determined by Bonferroni post hoc. 
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Figure 3.10: Effect of folate per-treatment on Sk-Hep1 cells surviving oxidative stress. 
Cells were pre-incubated with 30M folate for 2 hours Followed by treatments with a range of 
Hcy concentrations for 2 hours and control cells were treated a with range of Hcy 
concentrations (0-50M) for 2 hours. Cell viability was determined by MTS® assay at 490nm. 
Data are means ± SD n=3, p< 0.001 as determined by two-way ANOVA. Hcy (control) vs 
3.125M (p<0.001), 6.25M (p<0.001), 12.5M (p<0.001), 25M (p<0.001), 50M 
(p<0.001), as determined by Bonferroni post hoc. 
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Figure 3.11: The effect of folate pre-treatment on the caspase-3 activity. Sk-hep1 cells 
were pre-incubated with 30M folate for 2 hours and then treated with a range of H2O2 
concentrations for 2hours. The control cells were treated with H2O2 only. Caspase-3 
measured at EX=496nm/EM=520nm. Data are means ± SD n=3, p< 0.001 as determined by 
two-way ANOVA. H2O2 (control) vs 1.325M (p<0.001), 3.125M (p<0.001), 6.25M 
(p<0.001), as determined by Bonferroni post hoc. 
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Figure 3.12: The effect of folate pre-treatment on the caspase-3 activity. Sk-hep1 cells 
were pre-incubated with 30M folate for 2 hours and then treated with a range of Hcy 
concentrations for 2hours. The control cells were treated with Hcy alone. Caspase-3 
measured at EX=496nm/EM=520nm. Data are means ± SD n=3, p< 0.001 as determined by 
two-way ANOVA. Hcy (control) vs 1.325M (p<0.001), 3.125M (p<0.001), 6.25M 
(p<0.001), as determined by Bonferroni post hoc. 
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Figure 3.13: Effect of folate pre-treatment on necrosis induction in Sk-hep1. Cells were 
pre-incubated with 30M folate for 2 hours and then treated with a range of concentrations of 
H2O2 for 2 hours. The control cells were treated with H2O2 alone. Necrosis measured at 
EX=535/EM=617. Data are means ± SD n=3, p< 0.001 as determined by two-way ANOVA. 
H2O2 (control) vs 6.25M (p<0.05), 12M (p<0.01), 25M (p<0.001), 50M (p<0.001) as 
determined by Bonferroni post hoc 
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Figure 3.14: Effect of folate pre-treatment on necrosis induction in Sk-hep1. Cells were 
pre-incubated with 30M folate for 2 hours and then treated with a range of concentrations of 
Hcy for 2 hours. The control cells were treated with H2O2 alone. Necrosis measured at 
EX=535/EM=617. Data are means ± SD n=3, p< 0.001 as determined by two-way ANOVA. 
Hcy (control) vs 6.25M (p<0.05), 12M (p<0.001), 25M (p<0.001), 50M (p<0.001) as 
determined by Bonferroni post hoc. 
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3.3.2.2 Cobalamin protects cells (Sk-hep1) from apoptosis and necrosis induced by 
oxidative stress: 
Cobalamin had no significant effect on neither caspase-3 nor necrosis activity in sk-
hep1 cells when they were treated with a range of cobalamin concentrations (0-
100M) for 2 hours, when compared to the control cells (P0.05, as determined by 
one-way ANOVA), (Figures 3.15 & 3.16). 
 
In order to optimize concentration required for optimum cell protection from 
apoptosis, Cells were subjected to a range of cobalamin concentrations for 2 hours 
prior treatment with 3.125M H2O2 or Hcy for further 2 hours: which previously had 
been shown to induce apoptosis in sk-hep1 cells. This treatment resulted in a 
significant reduction in caspase-3 as compared to H2O2 or Hcy only (control) (P 
0.001, as determined by two-way ANNOVA) (Figure 3.17).  Further analysis 
by Bonferroni pairwise showed a significant reduction of caspase-3 at low 
concentration of cobalamin (1.325M P 0.01, 3.125M P 0.001, 6.25M P 
0.001, 12.5M P 0.001), and there was a further reduction in caspase-3 up to 70% 
at  25M cobalamin compared to H2O2 or Hcy treated cells (P 0.001). There was 
no further increase in protection provided by higher concentrations; therefore 25M 
cobalamin was an appropriate concentration to be applied to all oxidative stress 
protection studies. SK-hep1 cells pre-incubated with 25M cobalamin for 2 hours 
followed by 2 hours incubation with a range of H2O2 or Hcy concentrations (0-50M) 
resulted in significant effect on caspase-3 (P 0.001, as determined by two-way 
ANNOVA) (Figures 3.18 & 3.19). Post-hoc pairwise comparisons showed 
caspase-3 was less than 30% (P 0.001) and 28% (P 0.001) at 3.125M H2O2 
and Hcy respectively, followed by significant decline of caspase-3 activity at 12.5M 
H2O2 or Hcy as compared to control cells (H2O2 or Hcy alone) . At the same time 
cobalamin treatment provides a significant protection against necrosis (P 
0.001, as determined by two-way ANNOVA) (Figures 3.20 & 3.21). And 
Bonferroni pairwise showed at 6.25M H2O2 and Hcy (P 0.001), necrosis 
decreased up to 40% and 45% at 50M H2O2 and Hcy with pre-incubation of 
cobalamin compared to H2O2 and Hcy alone (P 0.001).  
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Figure 3.15: Effect of cobalamin on caspase-3 in Sk-hep1 cells. Cells were pre-incubated 
with a range of cobalamin concentrations (0-100M) for 2 hours, control cells were non-
treated. Caspase-3 measured at EX=496nm/EM=520nm. The data presents are means ± SD 
n=3. p  0.05 as determined by one-way ANOVA. 
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Figure 3.16: Effect of cobalamin on caspase-3 in Sk-hep1 cells. Cells were pre-incubated 
with a range of cobalamin concentrations (0-100M) for 2 hours, control cells were non-
treated. Caspase-3 measured at EX=496nm/EM=520nm. The data presents are means ± SD 
n=3. p  0.05 as determined by one-way ANOVA. 
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Figure 3.17: Primary study of cobalamin apoptosis protection. Sk-hep1 cells were pre-
incubated with a range of cobalamin concentrations (0-100M) for 2 hours, followed by 
treatments with A. 3.125M H2O2 or B. 3.125M Hcy for further 2 hours. Caspase-3 measured 
at EX=496nm/EM=520nm. Data are means ± SD n=3, p< 0.001 as determined by one-way 
ANOVA. H2O2 or Hcy, (control) vs 1.325M (p<0.001), 3.125M (p<0.001), 6.25M 
(p<0.001), 12.5 M (p<0.001), 25M (p<0.001), 50M (p<0.001),100M (p<0.001),  as 
determined by Tukey post hoc. 
 66 
1 2 4 8 16 32 640
0
100
200
300
H2O2
Cbl+H2O2
H2O2, M
R
e
la
ti
v
e
 f
lu
o
re
s
c
e
n
t 
u
n
it
s
 
Figure 3.18: The effect of cobalamin on the caspase-3 activity induced by H2O2.Sk-hep1 
cells were pre-incubated with 25M cobalamin for 2 hours and treated with a range of H2O2 
concentrations for 2 hours and control cells were treated with H2O2 alone; Caspase-3 
measured at EX=496nm/EM=520nm. Data are means ± SD n=3, p< 0.001 as determined by 
two-way ANOVA. H2O2 (control) vs 3.125M (p<0.001), 6.25M (p<0.001), 12.5M (p<0.05) 
as determined by Bonferroni post hoc. 
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Figure 3.19: The effect of cobalamin pre-treatment on the caspase-3 activity. Sk-hep1 
cells were pre-incubated with 25M cobalamin for 2 hours and treated with a range of Hcy 
concentrations for 2 hours and control cells were treated with Hcy alone, Caspase-3 
measured at EX=496nm/EM=520nm. Data are means ± SD n=3, p< 0.001 as determined by 
two-way ANOVA. Hcy (control) vs 3.125M (p<0.001), 6.25M (p<0.001), 12.5M (p<0.05) 
as determined by Bonferroni post hoc. 
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Figure 3.20: The effect of cobalamin pre-treatment on necrosis activity. Sk-hep1 cells 
were pre-incubated with 25M cobalamin for 2 hours and treated with a range of H2O2 
concentrations for 2 hours and control cells were treated with H2O2 alone. Necrosis measured 
at EX=535/EM=617. Data are means ± SD n=3, p< 0.001 as determined by two-way ANOVA. 
Hcy (control) vs 6.25M (p<0.05), 12.5M (p<0.001) 25M (p<0.001), 50M (p<0.001) as 
determined by Bonferroni post hoc. 
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Figure 3.21: The effect of cobalamin pre-treatment on necrosis activity. Sk-hep1 cells 
were pre-incubated with 25M cobalamin for 2 hours and treated with a range of Hcy 
concentrations for 2 hours and control cells were treated with Hcy alone. Necrosis measured 
at EX=535/EM=617. Data are means ± SD n=3, p< 0.001 as determined by two-way ANOVA. 
Hcy (control) vs 6.25M (p<0.05), 12.5M (p<0.001) 25M (p<0.001), 50M (p<0.001) as 
determined by Bonferroni post hoc. 
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3.3.2.3 ROS and cobalamin apoptosis protection: 
3.3.2.3.1 Measurement of mitochondrial membrane potential () (ROS 
generation). 
The measurement of intracellular ROS was achieved by the use of fluorescence 
redox active probe2’, 7’-dichlorfluorescein-diacetate (DCFH-DA). Intracellular levels 
of ROS generation were determined using the non-fluorescence probe2’, 7’-
dichlorfluorescein-diacetate group. The action of intracellular esterases results in the 
release of dichloroflurescine, which on exposure to ROS, is oxidised to fluorescence 
probe dichlorofluorescine, allowing for quantification.  The intensity of fluorescence 
was measured at Ex=485/Em=530nm using a 37C pre-warmed fluorescence 
microplate reader. 
 
The treatment with Cbl, Hcy and Cbl+Hcy had a significant effect on the fluorescence 
intensity of DCFH-AC (P0.001, as determined by on-way ANNOVA), (Figure 3.22). 
(P0.001, as determined by one-way ANNOVA), Post-hoc pairwise comparisons 
showed cells were subjected to Hcy had a significant increase in the ROS production 
(P0.001) compared to control (non-treated) and  when cells were pre-treated with 
cobalamin and then were further treated with Hcy, there was a significant reduction in 
the ROS production compared to Hcy alone (P0.001). Cobalamin alone had no 
significant effect on ROS production above control cells (P0.05)  
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Figure 3.22: Effect of cobalamin on generation of reactive oxygen species. Sk-hep1 cells 
were pre-incubated in black 96-well plate with10mM DCFH-diacetate, then 25MCbl for 2 
hours followed by 2hours treatments with 3.125M Hcy, control cells were non-treated and 
then all cells solubilised in 0.1N NaOH. DCFH-DA activity was measured at 
EX=485/EM=530nm following incubation Data are means ± SD n=3, p< 0.001 as determined 
by two-way ANOVA. Hcy vs Cbl+Hcy (p< 0.001) Tukey post hoc. 
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3.3.2.3.2 Measurement of superoxide under oxidative stress and anti oxidative 
stress conditions: 
Generation of O2
- production was demonstrated by measurement of the 
chemiluminescence of Lucigenin at 550nm using a 37C pre-warmed fluorescence 
microplate reader. The treatment with Cbl, Hcy and Cbl+Hcy had a significant effect 
on the O2
- generation (P0.001, as determined by one-way ANNOVA), (Figure 3.23).  
Further analysis with Tukey pairwise showed cells exposed to 3.125M Hcy had a 
significant increase of O2
- generation compared to control cells (P0.001). In contrast 
cells which were subjected to 25M cobalamin prior 3.1.25M Hcy showed a 
significant reduction in the O2
- generation compared to Hcy alone (P0.001), while 
there was no detectable difference in O2
- generation in cobalamin alone treatment 
compared to control cells (non-treated) (P0.05). 
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Figure 3.23: Effect of cobalamin on the superoxide generation. Sk-hep1 cells were pre-
treated in 96-well plate with Lucigenin (5M), and then treated with 25M cobalamin for 2 
hours followed by 2hours treatments with 3.125M Hcy. Lucigenin chemiluminescence was 
measured at 550nm following incubation. Data presented are ±SEM n=4. P>0.05, ***p< 
0.001, one-way ANOVA, Tukey post hoc. 
 
 
 
 
 70 
3.3.3 Induction apoptosis and necrosis in Jurkat cells via Hydrogen peroxide and 
Homocysteine. 
 
The mode of Jurkat cell death was investigated to determine if apoptosis or necrosis 
was being initiated by H2O2 or Hcy. In order to examine caspase-3 activity under 
oxidative stress, Jurkat cells were subjected to range of H2O2 and Hcy 
concentrations in a time-dependant study.  
 
In Figures 3.24 & 3.25, cells were exposed to a range of H2O2 concentrations 
for different times showed a significant effect on caspase-3 and necrosis 
activity (P0.001, as determined by two-way ANNOVA). The Bonferroni 
pairwise analysis showed control vs 2 hours incubation at 0-10mM H2O2 had no 
significant effect on caspase-3 activity (P0.05). While there was a significant 
increase of caspase-3 activity at low concentrations (0.001mM, P0.001) with 
4 hours incubation to peak at 0.01mM H2O2 (P0.001), after which activity 
declined such that at ≥1mM H2O2 showed no detectable caspase-3 activity (P0.05). 
However, after 6 hour caspase-3 activity was elevated significantly at low 
concentrations (0.001mM, P0.001) to peak at 0.01mM H2O2 (P0.001) 
compared to 2 hour and 4 hour treatments, after which activity decreased 
significantly. At 1mM H2O2 cells had no caspase-3 activity detected compared 
to control cells (P0.05).  Control cells had no significant caspase-3 activity 
(P0.05).  
 
On the other hand, the post-hoc comparison showed no significant necrosis 
activity after 2 hours incubation as compared to control (P0.05). However, 
after 4 hours, necrosis significantly increased at 0.1mM H2O2 (P0.001) and 
treatment with 10mM H2O2 showed significant increase of necrosis which reached 
100% (Figure 3.25). Furthermore, exposing cells to a range of H2O2 concentrations 
for 6 hours, resulted in a significant increase in necrosis activity at  0.1mM H2O2 
(P0.001) ,and there was a significant difference at 10mM H2O2 in necrosis 
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activity compared to 2 and 4 hours treatments (P0.001), although control cells 
showed no necrosis activity. 
 
Jurkat cells were then treated with a range of Hcy concentrations (0-100M) 
for 3 and 6 hours showed a significant effect on apoptosis and necrosis 
activity (P0.001, as determined by two-way ANNOVA) (Figure 3.26).  The 
Bonferroni pairwise analysis resulted in; Caspase-3 activity significantly peaked 
at 3.125M Hcy after 3 hours (P 0.001), then activity declined with no 
significant activity of caspase-3 at  12.5M Hcy (P0.05) However, after 6 
hours treatments caspase-3 peaked at 3.125M Hcy which were significantly 
different from the 3 hours treatments (P 0.001), then activity decreased at 
12.5M Hcy with no significant activity detected (P0.05).  
 
Moreover, the cells had significant necrosis activity at 12.5M Hcy after 3 
hours treatment (P 0.01) followed by increasing necrosis activity by 
increasing concentrations such at 100M Hcy 65% of the cells were necrotic. 
However, after 6 hours incubation, cells were significantly necrotic at  
12.5M Hcy (P 0.001) compared to 3 hours treatment and reached 100% 
necrosis at 100M Hcy (Figure 3.27).  
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Figure 3.24: Time course study effect of H2O2 on caspase-3 activity in Jurkat cells. Cells 
were exposed to increasing concentrations of H2O2 (0-10mM) for 2, 4, and 6 hours, control 
were non-treated cells, caspase-3 measured after at EX=496/Em=520. Data are means ± SD 
n=4, p< 0.001 as determined by two-way ANOVA. Baseline (control) vs 4h; 0.001mM 
(p<0.001), 4h; 0.01mM, 6h; 0.001mM (p<0.001), 6h; 0.01mM (p<0.001), and 6h; 0.1mM 
(p<0.001) as determined by Bonferroni post hoc. 
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Figure 3.25: Time course study the effect of H2O2 on necrosis level of Jurkat cells. Cells 
were exposed to increasing concentrations of H2O2 (0-10mM) for 3, and 6 hours, control cells 
were non-treated. Followed by staining with PI which measured at EX=535/EM=617. Data are 
means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline (control) vs 4h; 
0.1mM, (p<0.001), 4h; 1mM (p<0.001), 4h; 10mM (p<0.001), 6h; 0.1mM (p<0.001), 6h; 1mM 
(p<0.001), and 6h; 10mM (p<0.001) as determined by Bonferroni post hoc. 
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Figure 3.26: Time course study the effect of homocysteine on caspase-3 activity in 
Jurkat cells. Cells were exposed to increasing concentrations of Hcy (0-100M) for 3, and 6 
hours, control cells were non-treated. Caspase-3 measured at Ex=496/Em=520. Data are 
means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline (control) vs 3h; 
1.325M (p<0.001), 3h; 3.125M (p<0.001), 3h; 6.25M (p<0.001), 6h; 1.325M (p<0.001), 
6h; 3.125M (p<0.001), 6h; 6.25M (p<0.001) as determined by Bonferroni post hoc. 
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Figure 3.27: Time course study the effect of homocysteine on necrosis level of Jurkat 
cells. Cells were exposed to increasing concentrations of Hcy (0-100M) for 3, and 6 hours 
followed by PI staining measured at Ex=535/Em=617. Data are means ± SD n=4, p< 0.001 as 
determined by two-way ANOVA. Baseline (control) vs 3h; 6.25M (p<0.001), 3h; 12.5M 
(p<0.001), 3h; 25M (p<0.001), 50M (p<0.001), 100M (p<0.001), 6h; ; 6.25M (p<0.001), 
3h; 12.5M (p<0.001), 3h; 25M (p<0.001), 50M (p<0.001), 100M (p<0.001) as determined 
by Bonferroni post hoc. 
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In order to confirm that apoptosis is the main cell death in Jurkat at 0.01mM 
H2O2 or 3.125M Hcy and cells mainly died by necrosis at 10mM H2O2 or 
100M Hcy after 6 hours incubation, cells were double stained with Annexin-V 
and PI prior subjecting cells for 24 hours to 0.01mM H2O2 or 3.125M Hcy for 
apoptosis detection and 10mM H2O2 or 100M Hcy for necrosis in a time-
course study showed a significant effect on apoptosis activity and necrosis 
(P0.001, as determined by one-way ANNOVA) . Further analysis with Tukey 
pairwise showed PS  was significantly increased on the surface of the cells 
after 4 hours of H2O2 (P0.05) or Hcy (P0.001) treatments, the majority of 
cells were positive to Annexin-v with 6 hours treatment, and PS externalization 
declined such that after 24 hours there was no significant difference compared 
to control cells (P0.05), (Figures 3.28 & 3.29). PI detection showed 
significant increase in necrosis activity with  4hours treatment of H2O2 or Hcy 
(P0.001), followed by significant increase such that after 6 hours 90% of the 
cells were necrotic and100% of cells were necrotic after 24 hours (Figures 
3.30 & 3.31).   
 
The scatter plot illustrates the distribution of the cells depending on if they are 
Annexin-V positive or PI positive (x-axis -Annexin-v and y-axis - PI). Cells in C 
area are viable, cells were Annexin-V positive when they shifted to the D area, 
cells were late apoptotic/necrotic at B area, and cells became late necrotic at 
A area. As it shown in Figure 3.32, the majority of the cells were shifted to 
annexin-V positive area when they treated with 3.125M Hcy for 6 hours with 
no necrosis activity, while 100M Hcy result it in majority of the cells allocated 
in the late apoptotic/necrosis area.  
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Figure 3.28: Time course study the effect of H2O2 on the PS externalization in Jurkat 
cells. Cells were treated with 0.01mM H2O2 for (0-24hours), control cells were non-treated. 
Cells were double stained to Annexin-v FITC and PI as an early apoptosis marker and 
necrosis then analysed by flow cytometry and BD FACSDiva software. Data are means ± SD 
n=4, p< 0.001 as determined by one-way ANOVA. Baseline (control) vs 3h (p<0.001), 4h 
(p<0.001), 5h (p<0.001), 6h (p<0.001) and 8h (p<0.001) as determined Tukey post hoc. 
 
1 2 4 8 16 32
0
100
200
300
400
500 Hcy
hours
M
F
I
 
Figure 3.29: Time course study the effect of Hcy on the PS externalization in Jurkat 
cells. Cells were treated with 3.125M Hcy for (0-24hours), control cells were non-treated. 
Cells were double stained to Annexin-v FITC and PI as an early apoptosis marker and 
necrosis then analysed by flow cytometry and BD FACSDiva software. Data are means ± SD 
n=4, p< 0.001 as determined by one-way ANOVA. Baseline (control) vs 3h (p<0.001), 4h 
(p<0.001), 5h (p<0.001), 6h (p<0.001) and 8h (p<0.001) as determined Tukey post hoc. 
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Figure 3.30: Time course study the effect of H2O2 on the necrosis activity of Jurkat 
cells. Cells were treated with 10mM for (0-24hours), control cells were non-treated. Cells 
were stained with PI for necrosis detection then analysed by flow cytometry and BD 
FACSDiva software. Data are means ± SD n=4, p< 0.001 as determined by one-way ANOVA. 
Baseline (control) vs 3h (p<0.001), 4h (p<0.001), 5h (p<0.001), 6h (p<0.001) and 8h 
(p<0.001) as determined Tukey post hoc. 
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Figure 3.31: Time course study the effect of Hcy on the necrosis activity of Jurkat cells. 
Cells were treated with 50MHcy for (0-24hours), control cells were non-treated. Cells were 
stained with PI for necrosis detection. And then samples analysed by flow cytometry and BD 
FACSDiva software. Data are means ± SD n=4, p< 0.001 as determined by one-way ANOVA. 
Baseline (control) vs 3h (p<0.001), 4h (p<0.001), 5h (p<0.001), 6h (p<0.001) and 8h 
(p<0.001) as determined Tukey post hoc. 
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Figure 3.32: The effect of Hcy on the PS externalization in Jurkat cells. Cells 
were subjected to (3.125M Hcy for Annexin-v and 100M for necrosis detection) 
for 2 hours. Cells were stained to Annexin-v FITC and PI as an early apoptosis 
marker and necrosis then analysed by flow cytometry and BD FACSDiva software. 
A: late necrotic cells, B: late apoptotic and early necrosis, C: viable cells and D: 
apoptotic cells. 
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After determining the required time to induce apoptosis and necrosis, the 
concentrations needed to induce apoptosis or necrosis as a main cell death pathway 
were confirmed. In Jurkat cells treatment with H2O2 showed a significant effect on 
caspase-3 and necrosis activity (P0.001, as determined by one-way 
ANNOVA) (Figure 3.34). And the Tukey pairwise showed that after 6 hours, 
caspase-3 significantly increased at  0.01mM H2O2 (P0.001), and the cells were 
mostly apoptotic at 0.01mM H2O2 (P0.001) with no significant necrosis 
activity (P0.05). Followed by reduction in caspase-3 such at above 1mM 
there was no significant caspase-3 activity (P0.05).  
 
In contrast, Tukey pairwise analysis showed that necrosis was significantly 
induced at  0.1mM H2O2 (P0.001) when the caspase-3 activity declined, then 
cells reached 100% necrosis at 10mM H2O2 with no caspase-3 activity 
detected (Figure 3.33).  When the cells were treated with a range of Hcy 
concentrations for 6 hours resulted in the majority of the cells were apoptotic 
at 3.125M Hcy with no detection of necrosis activity, followed by decline in 
the casapse-3 activity such that at 12.5M Hcy necrosis induced significantly 
(P0.001) compared to control cells. Furthermore, necrosis reached 100% at 
100M Hcy (P0.001) with no caspase-3 activity detected (P0.05) (Figure 
3.34) 
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Figure 3.33: Mechanisms of cell of Jurkat cells death after exposure to H2O2. Cells were 
exposed to increasing concentrations of H2O2 (0-10mM) for 6 hours, caspase-3 measured at 
Ex=496/520 and PI staining was measured at EX=535/EM=617. Data are means ± SD n=4, 
p< 0.001 as determined by one-way ANOVA. Baseline (control) vs 0.001mM-caspase 
(p<0.001), 0.01mM-caspase, 0.1mM-caspase (p<0.001), 0.1mM-PI, (p<0.001), 1mM-PI 
(p<0.001), 10mM-PI (p<0.001) as determined by Tukey post hoc. 
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Figure 3.34: Mechanisms of cell of Jurkat cells death after exposure to Hcy. Cells were 
exposed to increasing concentrations of Hcy (0-100M) for 6 hours, caspase-3 measured at 
EX=496/EM=520 and PI staining was measured at EX=535/EM=617. Data are means ± SD 
n=4, p< 0.001 as determined by one-way ANOVA. Baseline (control) vs 3.125M-caspase 
(p<0.001), 6.25M-caspase (p<0.001), 12.5M-caspase (p<0.001), 12.5M (p<0.001)-PI, 
25M (p<0.001)-PI, 50M (p<0.001)-PI, 100M (p<0.001)-PI as determined by Tukey post 
hoc. 
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3.3.4 Folate protects cells from apoptosis and necrosis induced by oxidative 
stress: 
 
As previously demonstrated, majority of the cells died by apoptosis at 0.01mM H2O2 
and 3.125M Hcy after 6 hours of incubation. Also, majority of the cells died by 
necrosis at 10mM H2O2 and 100M Hcy with 6 hours treatments.  
 
In order to examine the protection role of folate, the effect of folate on caspase-3 and 
necrosis activity was determined. Folate had no significant effect on caspase-3 or 
necrosis activity, since addition up to 100M folate to the cells for 2 hours, resulted in 
no significant difference in caspase-3 activity and PI labelling comparing to control 
cells (P0.05, as determined by one-way ANNOVA), (Figures 3.35 & 3.36). 
 
Pre-incubation of cells with 30M folate has provided significant protection against 
apoptosis induced by H2O2 and Hcy (P0.001, as determined by two-way 
ANNOVA), (Figures 3.37 & 3.38). The post-hoc comparison showed that at 
0.01mM H2O2 and 3.125M Hcy 68% (P0.001) and 75% (P0.001) of the cells, 
respectively, were protected. Also, significant protection was provided at higher 
concentrations of H2O2 and Hcy such as 0.1mM H2O2 and 6.25M Hcy (P0.001) as 
compared to H2O2 and Hcy alone.  
 
Moreover, the same dose of folate protects Jurkat cells from necrosis induced by 
H2O2 and Hcy significantly (P0.001, as determined by two-way ANNOVA), 
(Figures 3.39 & 3.40). The Bonferroni pairwise comparison showed that pre-
incubation with 30M folate provided a significant protection at 0.1mMH2O2 or 
12.5M Hcy (P0.001). Additionally, at 10mM H2O2 or 100M Hcy protect 65% 
P0.001 and 70% (P0.001) of the cells from necrosis respectively compared to 
control cells, H2O2 or Hcy alone treated cells  
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Figure 3.35: Effect of folate on caspase-3 in Jurkat cells. Cells were pre-incubated with a 
range of folate concentrations (0-100M) for 2 hours, caspase-3 was measured at 
Ex=496/Em=617. The data presents are means ± SD n=3. p  0.05 as determined by one-
way ANOVA. 
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Figure 3.36: Effect of folate on necrosis of Jurkat cells. Cells were pre-incubated with a 
range of folate concentrations (0-100M) for 2 hours, necrosis activity was measured after at 
Ex=496/Em=520. The data presents are means ± SD n=3. p  0.05 as determined by one-
way ANOVA. 
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Figure 3.37: The effect of folate pre-treatment on the caspase-3 activity. Jurkat cells were 
pre-incubated with 30M folate for 2 hours then treated with a range of H2O2 concentrations 
for 6 hours and the control cells were treated with H2O2 only. Caspase-3 was measured after 
at EX=496/EM=520. Data are means ± SD n=4, p< 0.001 as determined by two-way ANOVA. 
H2O2 vs folate+ 0.001mM H2O2 (p<0.001), Folate+0.01mM, (p<0.001), as determined by 
Bonferroni post hoc. 
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Figure 3.38: The effect of folate pre-treatment on the caspase-3 activity. Jurkat cells were 
pre-incubated with 30M folate for 2 hours then treated with a range of Hcy concentrations for 
6 hours and the non-treated cells were the control cells, caspase-3 was measured after at 
EX=496/EM=520. Data are means ± SD n=4, p< 0.001 as determined by two-way ANOVA. 
Hcy vs Folate 3.125M (p<0.001), Folate+6.25M (p<0.001), folate+12.5M (p<0.001), as 
determined by Bonferroni post hoc. 
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Figure 3.39: Effect of folate pre-treatment on necrosis. Jurkat cells were pre-incubated 
with 30M folate for 2 hours then cells treated with a range of H2O2 concentrations for 6 hours 
and the control cells were treated with H2O2 alone, necrosis activity was measured at 
EX=535/EM=617.The Data are means ± SD n=4, p< 0.001 as determined by two-way 
ANOVA. H2O2 vs folate+0.1mM H2O2 (p<0.001), Folate+1mM, (p<0.001), Folate+10mM, 
(p<0.001), as determined by Bonferroni post hoc. 
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Figure 3.40: Effect of folate pre-treatment on necrosis. Jurkat cells were pre-incubated 
with 30M folate for 2 hours then cells were treated with a range of concentrations of Hcy for 
6 hours and the control cells were treated with Hcy alone. Necrosis activity was measured at 
EX=535/EM=617. The Data are means ± SD n=4, p< 0.001 as determined by two-way 
ANOVA. Hcy vs Folate 3.125M (p<0.001), Folate+6.25M (p<0.001), folate+12.5M 
(p<0.001), as determined by Bonferroni post hoc. 
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3.3.5 Induction of apoptosis and necrosis in normal blood cells via exposure to 
Hydrogen peroxide and Homocysteine. 
 
After investigating the effect of oxidative stress and death pattern in Sk-hep1 and 
Jurkat cells, we examined further the effect of oxidative stress on healthy peripheral 
blood cells. Whole blood was collected from healthy volunteers and peripheral blood 
cells were isolated and treated with a range of concentrations of H2O2 or Hcy to 
induce apoptosis and necrosis. Caspase-3 activity, Annexin-V and PI uptake were 
used to detect apoptosis and necrosis via flow cytometry.  
 
The treatments with H2O2 or Hcy have a significant effect on the PS externalisation 
and PI uptake (P0.001, as determined by two-way ANNOVA), (Figures 3.41& 
3.42).  Further analysis with Bonferroni pairwise showed that After 1 hour exposing 
neutrophil cells to a range of H2O2 concentrations (0-10mM) there was no significant 
effect on the PS externalisation on the cells compared to control cells (P0.05). 
However, with 2, 3, 4 hours treatment, PS externalisation peaked at 0.01mM H2O2 to 
reach 33%, 60% and 23% respectively, and then declined at 0.1mM with significant 
difference (P 0.001) while at 1mM H2O2  and above there was no significant 
difference (P0.05) compared to control cells (Figure 3.41).  Furthermore, subjecting 
neutrophil cells to a range of Hcy concentration for 1, 2, and 3 hours resulted in; PS 
externalisation significantly increased such that at 0.01mM Hcy  reach 73% (P 
0.001), 39% (P 0.001),  and 35% (P 0.001) after 1,2 and 3 hours respectively. 
This was followed by a reduction in the PS appearance on the surface of the cells at 
0.05mM Hcy with a significant difference compared to control cells (P 0.001), while 
above 0.1mM Hcy (P0.05) there was no significant effect on PS externalisation 
compared to control cells which have no significant activity of PS translocation 
(Figure 3.42).  
 
Caspase-3 activity was significantly affected by H2O2 and Hcy (P0.001, as 
determined by two-way ANNOVA), (Figures 3.43 & 3.44). Post-hoc 
comparison showed there is a significant increase at low concentration of 
H2O2 in neutrophil cells, hence at 0.01mM H2O2 caspase-3 reached 60% 93%, 
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and 25% after 2, 3 and 4 hours treatment (P 0.001), followed by decrease in 
caspase-3 activity such at above 1mM H2O2 there was no significant 
difference (P0.05)  compared to control cells (Figure 3.43). On the other 
hand, at low concentrations of Hcy there was a significant effect on caspase-3 
after 1, 2, and 3 hours incubation; such that at 0.01mM Hcy caspase-3 
reached 91%, 64% and 46% respectively as compared to control cells (P 
0.001). Although above 0.1mMHcy (P0.05) treatment have no detectable effect on 
caspase-3 activity (Figure 3.44). 
 
Moreover, the H2O2 and Hcy treatment induced a significant effect on necrosis 
activity of neutrophils (P0.001, as determined by two-way ANNOVA), 
(Figures 3.45 & 3.46).  The Bonferroni pairwise analysis showed that when 
neutrophils were exposed to range of H2O2 concentrations no significant effect 
on necrosis activity was observed after 1 hour (P0.05). However, at 0.1mM 
H2O2 a significant increase in necrosis activity was observed after 2, 3, and 4 
hours treatments, and at 10mM necrosis reached 79% (P 0.001), 91% (P 
0.001) and 97% (P 0.001) after 2, 3, and 4 hours exposing compared to 
control cells (Figure 3.45). Also Hcy has a significant effect on necrosis such 
that at above 0.05mM Hcy there was a significant elevation of necrosis 
detected with 1, 2 and 3 hours exposure (P 0.001), followed by a significant 
increase in necrosis activity with increasing Hcy concentrations and more than 
91%, 94%, 96% of the cells were dying neurotically at 1mM Hcy (P 0.001) 
after 1, 2 and 3 hours exposure (Figure 3.46). 
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Figure 3.41: Time course study the effect of H2O2 on PS translocation in neutrophil 
cells. Cells were incubated with a range of H2O2 concentrations (0-10mM) for 1, 2 and 3 
hours.  Control cells were non-treated. Then cells were stained Annexin-v FITC labelled and 
analysed using flowcytometry and BD FACSDiva software. The Data are means ± SD n=4, p< 
0.001 as determined by two-way ANOVA. Baseline (control) vs 2h; 0.01mM (p<0.001), 3h; 
0.01mM (p<0.001), 3h; 0.1mM (p<0.001), 4h; 0.01mM (p<0.001), as determined by Bonferroni 
post hoc. 
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Figure 3.42: Time course study the effect of Hcy on PS translocation in neutrophil cells. 
Cells were treated with a range of concentrations of Hcy (0-10mM) for 1, 2 and 3 hours.  
Control cells were non-treated. Then cells were stained Annexin-v FITC labelled and analysed 
using flowcytometry and BD FACSDiva software.  The Data are means ± SD n=4, p< 0.001 as 
determined by two-way ANOVA. Baseline (control) vs 1h; 0.01mM (p<0.001), 1h; 0.05mM 
(p<0.001), 2h; 0.01mM (p<0.001), 2h; 0.1mM (p<0.001), 2h; 0.01mM (p<0.001), as 
determined by Bonferroni post hoc. 
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Figure 3.43: Time course study the effect of H2O2 on caspase-3 level in neutrophil cells. 
Cells were treated with a range of H2O2 concentrations (0-10mM) for 1, 2 and 3 hours. Cells 
were then stained with monoclonal anti-rabbit caspase-3 FITC labelled antibody.  Control 
cells: Non-treated cells. The Data are means ± SD n=4, p< 0.001 as determined by two-way 
ANOVA. Baseline (control) vs 2h; 0.01mM (p<0.001), 3h; 0.01mM (p<0.001), 3h; 0.1mM 
(p<0.001), 4h; 0.01mM (p<0.001), 4h; 0.1mM (p<0.001), as determined by Bonferroni post 
hoc. 
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Figure 3.44: Time course study the effect of Hcy on caspase-3 level in neutrophil cells. 
Cells were treated with a range of concentrations Hcy (0-1mM) for 1, 2 and 3 hours. Cells 
were then stained with monoclonal anti-rabbit caspase-3 FITC labelled antibody. Control cells; 
non-treated cells. The data are means ± SD n=4, p< 0.001 as determined by two-way 
ANOVA. Baseline (control) vs 1h; 0.01mM (p<0.001), 1h; 0.05mM (p<0.001), 1h; 0.1mM 
(p<0.001), 2h; 0.01mM (p<0.001), 2h; 0.05mM (p<0.001), 3h; 0.01mM (p<0.001), 2h; 0.05mM 
(p<0.001), as determined by Bonferroni post hoc. 
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Figure 3.45: Time course study the effect of H2O2 on necrosis level of neutrophil cells. 
Cells were incubated with range of H2O2 concentrations (0-10mM) for 1, 2 and 3 hours. Then 
cells were stained with PI and analysed using flowcytometry and BD FACSDiva. Control cells 
were non-treated. The data are means ± SD n=4, p< 0.001 as determined by two-way 
ANOVA. Baseline (control) vs 2h; 0.1mM (p<0.001), 2h; 1mM (p<0.001), 2h; 10mM (p<0.001), 
3h; 0.1mM (p<0.001), 3h; 1mM (p<0.001), 3h; 10mM (p<0.001), 4h; 0.1mM (p<0.001),  4h; 
1mM (p<0.001),  4h; 10mM (p<0.001), as determined by Bonferroni post hoc. 
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Figure 3.46: Time course study the effect of Hcy on necrosis level of neutrophil cells. 
Cells were treated with a range of Hcy concentrations (0-1mM) for 1, 2 and 3 hours. Then 
cells were stained with PI and analysed using flowcytometry and BD FACSDiva. Control cells; 
non-treated cells. The data are means ± SD n=4, p< 0.001 as determined by two-way 
ANOVA. Baseline (control) vs 1h; 0.1mM (p<0.001), 1h; 1mM (p<0.001), 2h; 0.1mM 
(p<0.001), 2h; 1mM (p<0.001), 3h; 0.01mM (p<0.001), 3h; 0.1mM (p<0.001), 3h; 1mM 
(p<0.001) as determined by Bonferroni post hoc. 
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In Figure 3.47, the scatter plot demonstrated the distribution of the blood cells 
according to size neutrophils presented by blue colour. The histogram showed 
that the cells had significant increase of the fluorescence intensity after 
exposing the cells for 1 hour to 0.01mM Hcy, compared to control cells and 
most of the cells were shifted to the annexin-v positive area. Also the majority 
of the cells shifted to the necrotic/late apoptotic area after 1 hour exposure to 
1mM Hcy, in comparison to the control cells.  
 
The neutrophil cells that were subjected to a range of H2O2 concentrations for 
3 hours or Hcy for 1 hour showed significant effect in caspase-3 and necrosis 
activity (P 0.001, as determined by one-way ANNOVA), (Figure 3.48). The 
Tukey pairwise analysis showed that at 0.01mM most of the cells were 
caspase-3 positive (P 0.001), followed by a reduction in both of them such 
that at above 0.1mM H2O2 or 0.05mM Hcy showed no significant increase in 
casapse-3 activity as compared to control cells (P0.05). In contrast, necrosis 
was increased significantly at 0.1mM H2O2 or 0.05mM Hcy (P 0.001) when 
caspase-3 reduced, and at 10mM H2O2 or 1mMHcy resulted in cells were 
mostly necrotic with no caspase-3 activity (Figure 3.48).  
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Figure 3.47: Induction of apoptosis and necrosis in neutrophil cells. Cells were 
treated for 1 hour with 0.01mM Hcy for apoptosis induction and 1mM Hcy for necrosis 
induction. Then cells were stained with monoclonal anti-rabbit caspase-3 FITC labelled 
antibody for caspase activity measurement and doubled stain with Annexin-v and PI for 
early apoptosis and necrosis measurements using flowcytometry and BD FACSDiva 
software to analyse. A. distribution of the cells according cell size, B. Caspase-3 control 
(non-treated), C. Cells treated with 0.01mM Hcy, D. control cells for Annexin-v and PI 
(non-treated), E. Cells treated with 0.01mM Hcy and F. cells treated with1mM Hcy. 
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Figure 3.48: Mechanisms of neutrophil cells death subjected to H2O2 or Hcy. Cells were 
exposed to increasing concentrations of A. H2O2 (0-10mM) for 3 hours or B. Hcy (0-1mM) for 
1 hour. Then cells were stained with monoclonal anti-rabbit caspase-3 FITC labelled antibody 
for caspase activity measurement using flowcytometry and BD FACSDiva software to 
analyse. The present data are means ± SD n=4, p< 0.001 as determined by two-way ANOVA.  
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The H2O2 and Hcy had a significant effect on the PS exposure in monocyte cells (P 
0.001, as determined by two-way ANNOVA), (Figure 3.49 & 3.50). The analysis with 
Bonferroni pairwise resulted in PS externalisation increased significantly in monocyte 
cells at 0.01mM H2O2 after 1, 2 and 3 hours incubation (P 0.001). There were further 
increases in PS translocation at 0.1mM H2O2 which reached 31% (P 0.001), 72% (P 
0.001) and 53% (P 0.001) after 1, 2 and 3 hours treatment. This was followed by a 
reduction in the PS appearances such that at 10mM there was no significant increase in 
the PS externalisation (P0.05) compared to control cells (Figure 3.49). However, at 
0.01mM Hcy PS externalisation reached 82%, 67% and 33% after 1, 2, and 3 hours 
treatment respectively (P 0.001), followed by reduction such at 0.1mM Hcy showed 
no significant increase in the PS externalisation after 1, 2, and 3 hours incubation 
(P0.05), (Figure 3.50).  
 
Caspase-3 activities were significantly affected in monocyte by H2O2 and Hcy treatment 
(P 0.001, as determined by two-way ANNOVA), (Figures 3.51 & 3.52). The post-
hoc comparison showed that when monocyte cells were exposed to a range of H2O2 
concentrations (0-10mM) for 1 hour incubation, there was no significant increase of 
caspase-3 activity (P>0.05) as compared to control cells (non-treated). However, 
exposing cells to a range of H2O2 concentrations for up 2 and 3 hours resulted in a 
significant increase in the caspase-3 at 0.01mM H2O2 (p<0.001). And at higher 
concentrations such at 0.1mM H2O2 caspase-3 activity reached 50% and 91% after 2, 
and 3 hours respectively (P 0.001), followed by decreases such that at 10mM H2O2  
there was no significant effect on caspase-3 activity (P0.05) compared to control cells 
(Figure 3.51). Exposing cells to a range of Hcy concentrations for 1 hour showed 
significant effect at 0.01mMHcy (p<0.001). However, higher concentrations such 
as 0.1mM and 1mM showed no significant effect on caspase-3 activity as 
compared to control cells (non-treated) (P0.05). While after 2 and 3 hours of 
exposing cells to a range of Hcy resulted in a significant increase of caspase-3 to 
reach 94% and 76% at 0.01mM Hcy respectively (P 0.001), after which 
caspase-3 reduced and there was no significant difference at 0.1mM Hcy(P0.05)  
compared to control cells (Figure 3.52).  
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Also H2O2 and Hcy had a significant effect on necrosis activity in monocyte (P 0.001, 
as determined by two-way ANNOVA), (Figure 3.53 & Figure 3.54).  However, 
further analysis with Bonferroni pairwise indicated no significant effect on necrosis 
when monocyte were exposed to a range of H2O2 concentrations after 1 hour 
(P0.05). While at 0.1mMH2O2 there was a significant increase in necrosis 
activity observed after 2, and 3 hours treatments, and at 10mM necrosis reached 
74% (P 0.001) and 92% (P 0.001) after 2, and 3 hours of treatments compared 
to control cells (Figure 3.53). Moreover, 1 hour treatment of Hcy showed no 
significant effect on necrosis (P0.05). However, Hcy has a significant effect on 
necrosis such at above 0.05mM Hcy there was significant necrosis detected with 
2 and 3 hours exposure (P 0.001), followed by a significant increase in necrosis 
activity with increasing Hcy concentrations and more than 92% (P 0.00) and 
98%(P 0.001) of the cells were dying neurotically at 1mM Hcy after 2 and 3 
hours exposure (Figure 3.54).   
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Figure 3.49: Time course study the effect of H2O2 on PS translocation in monocyte 
cells. Cells were incubated with a range of H2O2 concentrations (0-10mM) for 1, 2 and 3 
hours.  Control cells were non-treated. Then cells were stained by Annexin-v FITC, labelled 
and analysed using flowcytometry and BD FACSDiva software. The Data are means ± SD 
n=4, p< 0.001 as determined by two-way ANOVA. Baseline (control) vs 1h; 0.01mM 
(p<0.001), 1h; 0.1mM (p<0.001), 1h; 1mM (p<0.001), 2h; 0.01mM (p<0.001), 2h; 0.1mM 
(p<0.001), 2h; 1mM (p<0.001), 3h; 0.01mM (p<0.001), 3h; 0.1mM (p<0.001), 3h; 1mM 
(p<0.001),  as determined by Bonferroni post hoc. 
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Figure 3.50: Time course study the effect of Hcy on PS translocation in monocyte cells. 
Cells were incubated with a range of Hcy concentrations (0-1mM) for 1, 2 and 3 hours.  
Control cells were non-treated. Then cells were stained with Annexin-v FITC, labelled and 
analysed using flowcytometry and BD FACSDiva software. The Data are means ± SD n=4, p< 
0.001 as determined by two-way ANOVA. Baseline (control) vs 1h; 0.01mM (p<0.001), 1h; 
0.05mM (p<0.001), 1h; 0.1mM (p<0.001), 2h; 0.01mM (p<0.001), 2h; 0.05mM (p<0.001), 2h; 
0.1mM (p<0.001), 3h; 0.01mM (p<0.001), 3h; 0.05mM (p<0.001) as determined by Bonferroni 
post hoc. 
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Figure 3.51: Time course study the effect of H2O2 on caspase-3 level in Monocyte cells. 
Cells were treated with a range of H2O2 concentrations (0-10mM) for 1, 2 and 3 hours. Cells 
were then stained with monoclonal anti-rabbit caspase-3 FITC labelled antibody.  Control 
cells: Non-treated cells. The Data are means ± SD n=4, p< 0.001 as determined by two-way 
ANOVA. Baseline (control) vs 2h; 0.01mM (p<0.001), 2h; 0.1mM (p<0.001), 2h; 1mM 
(p<0.001), 3h; 0.01mM (p<0.001), 3h; 0.1mM (p<0.001), 3h; 1mM (p<0.001), as determined 
by Bonferroni post hoc. 
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Figure 3.52: Time course study the effect of Hcy on caspase-3 level in Monocyte cells. 
Cells were treated with a range of Hcy concentrations (0-10mM) for 1, 2 and 3 hours. Cells 
were then stained with monoclonal anti-rabbit caspase-3 FITC labelled antibody.  Control 
cells: Non-treated cells. The Data are means ± SD n=4, p< 0.001 as determined by two-way 
ANOVA. Baseline (control) vs 1h; 0.01mM (p<0.001), 1h; 0.05mM (p<0.001), 2h; 0.01mM 
(p<0.001), 2h; 0.05mM (p<0.001), 3h; 0.01mM (p<0.001), 3h; 0.05mM (p<0.001), 3h; 0.1mM 
(p<0.001), as determined by Bonferroni post hoc. 
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Figure 3.53: Time course study the effect of H2O2 on necrosis level of monocyte cells. 
Cells were incubated with a range of H2O2 concentrations (0-10mM) for 1, 2 and 3 hours. 
Then cells were stained with PI and analysed using flowcytometry and BD FACSDiva. Control 
cells; non-treated cells. The Data are means ± SD n=4, p< 0.001 as determined by two-way 
ANOVA. Baseline (control) vs 2h; 1mM (p<0.001), 2h; 10mM (p<0.001), 3h; 0.1mM (p<0.001), 
3h; 1mM (p<0.001), 3h; 10mM (p<0.001), as determined by Bonferroni post hoc. 
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Figure 3.54: Time course study the effect of Hcy on necrosis level of monocyte cells. 
Cells were incubated with a range of Hcy concentrations (0-10mM) for 1, 2 and 3 hours. Then 
cells were stained with PI and analysed using flowcytometry and BD FACSDiva. Control cells 
were non-treated.  The Data are means ± SD n=4, p< 0.001 as determined by two-way 
ANOVA. Baseline (control) vs 2h; 0.05mM (p<0.001), 2h; 0.1mM (p<0.001), 2h; 1mM 
(p<0.001), 3h; 0.05mM (p<0.001), 3h; 0.1mM (p<0.001), 3h; 1mM (p<0.001) as determined by 
Bonferroni post hoc. 
 
In Figure 3.55, the scatter plot demonstrated the distribution of the blood cells 
according to size, and the monocyte cells were presented in green. The 
histogram showed a significant increase of the fluorescence intensity after 2 
hours of exposing the cells to 0.01mM Hcy, in comparison to the control cells 
and most of the cells were shifted to the annexin-v positive area. Also, the 
majority of the cells were shifted to the necrotic/late apoptotic area after 1 hour 
of exposing the cells to 1mM Hcy (in comparison to the control cells). When 
monocyte cells were subjected to range of H2O2 concentrations for 3 hours or 
Hcy for 2 hours, it resulted in a significant effect on caspase-3 and necrosis 
activity (P 0.001, as determined by one-way ANNOVA), (Figure 3.56). The 
Tukey pairwise analysis showed that when cells were exposed to a range of 
concentrations of H2O2 for 3 hours or Hcy for 2 hours, they showed significant 
increase in caspase-3 activity which peaked at 0.1mM (P 0.001), followed by 
a reduction in caspase-3 activity with both treatments and at higher 
concentrations of H2O2 or Hcy (10mM H2O2 and 1mM Hcy) there was no 
significant increase in casapse-3 activity as compared to control cells (P0.05). 
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In contrast, necrosis has increased significantly at 0.1mM H2O2 or 0.05mM 
Hcy when caspase-3 activity reduced (P 0.001), and at 10mM H2O2 or 
1mMHcy  resulted in 100% necrosis with no caspase-3 activity (Figure 3.56).  
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Figure 3.55: Induction of apoptosis and necrosis in monocyte cells. Cells were treated 
for 2 hours with 0.01mM Hcy for apoptosis induction and 1mM Hcy for necrosis induction. 
Then cells were stained with monoclonal anti-rabbit caspase-3 FITC labelled antibody for 
caspase activity measurement and doubled stain with Annexin-v and PI for early apoptosis 
and necrosis measurements using flowcytometry and BD FACSDiva software to analyse.: 
A. distribution of cells according cell size, B. Caspase-3 control (non-treated), C. Cells 
treated with 0.01mM Hcy, D. control cells for Annexin-v and PI (non-treated), E. Cells 
treated with 0.01mM Hcy and F. cells treated with1mM Hcy. 
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Figure 3.56: Mechanisms of monocyte cells death subjected to H2O2 or Hcy. Cells were 
exposed to increasing concentrations of A. H2O2 (0-10mM) for 3 hours or B. Hcy (0-1mM) for 
2 hours. Then cells were stained with monoclonal anti-rabbit caspase-3 FITC labelled 
antibody for caspase activity, and for PI detection cells were stained with PI and measured 
using flowcytometry and BD FACSDiva software to analyse. The present data are means ± 
SD n=4, p< 0.001 as determined by two-way ANOVA.  
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Lymphocyte cells also showed a significant activity of PS after treatment with a range 
of H2O2 and Hcy concentrations (P 0.001, as determined by two-way ANNOVA), 
(Figures 3.57 & 3.58). The comparison with post-hoc showed that when 
lymphocyte cells exposed to a range of H2O2 concentrations (0-10mM), they showed a 
significant effect on the PS externalisation into the surface of the cells, to reach 74%, 
64% and 53% at 0.01mM after 1, 2 and 3 hours respectively, in comparison to the 
control cells (P 0.001), and then declined at 0.1mM (P0.001), while above 1mM 
H2O2, there was no significant difference in the PS (P0.05) compared to control cells 
(non-treated) (Figure 3.57). Furthermore, subjecting lymphocyte cells to a range of Hcy 
concentration for 1, 2, and 3 hours resulted in increased PS externalisation such that at 
0.01mM Hcy  reach 84% , 76% and 48% after 1, 2 and 3 hours respectively. Followed 
by a reduction in the PS appearance on the surface of the cells at 0.05mM Hcy with a 
significant difference, when compared to control cells (P 0.001), while above 0.1mM 
Hcy had no significant effect on the PS externalisation (P0.05) compared to control 
cells (non-treated) (Figure 3.58).  
 
In the same time caspase-3 and necrosis activity were significantly affected by 
the H2O2 and Hcy exposure (P 0.001, as determined by two-way ANNOVA), 
(Figures 3.59, 3.60, 3.61 & 3.62). Further analysis with Bonferroni pairwise 
indicated that caspase-3 significantly increased at low concentrations of H2O2, 
hence at 0.01mM H2O2 caspase-3 reached 62% 95%, and 75% after 1, 2 and 3 
hours treatment respectively (P<0.001), followed by a decrease in caspase-3 
activity such that at above 1mM H2O2 there was no significant difference 
(P0.05) compared to control cells (Figure 3.59). At low concentrations of Hcy 
there was a significant effect on caspase-3 activity after 1, 2, and 3 hours 
incubation such that at 0.01mM Hcy caspase-3 reached 50%, 97% and 72% 
respectively as compared to control cells (P 0.001). Although above 0.1mM Hcy 
had no detectable effect on caspase-3 (P0.05) compared to control cells (Figure 
3.60). 
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Also the Post-hoc comparison showed that when lymphocyte were exposed to a 
range of H2O2 concentrations, they showed a significant effect on necrosis 
activity observed after 1 hour at 0.1mM H2O2 (P 0.001), while 2 and 3 hours 
treatment induced necrosis at 0.1mM H2O2 significantly (P 0.001). However, 
necrosis activity was increased with increasing concentrations which reached 
58%(P 0.001), 92% (P 0.001) and 95% (P 0.001) at 10mMH2O2 after 1, 2, 
and 3 hours treatment when compared to control cells (Figure 3.61). Also, Hcy 
has a significant effect on necrosis that at above 0.1mM Hcy there was a 
significant increase of necrosis detected after 1 hour exposing (P 0.001), 
whereas after 2 and 3 hours treatments it showed a significant increase in 
necrosis activity at 0.05mM Hcy, and then necrosis activity increased with 
higher concentration such at 1mM Hcy reached 34%(P 0.001), 90% (P 0.001) 
and 96%(P 0.001) necrosis after 1, 2 and 3 hours (Figure 3.62).   
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Figure 3.57: Time course study the effect of H2O2 on PS translocation in lymphocyte 
cells. Cells were incubated with a range of H2O2 concentrations (0-10mM) for 1, 2 and 3 
hours.  Control cells were non-treated. Then cells were stained Annexin-v FITC labelled and 
analysed using flowcytometry and BD FACSDiva software. The Data are means ± SD n=4, p< 
0.001 as determined by two-way ANOVA. Baseline (control) vs 1h; 0.01mM (p<0.001), 1h; 
0.1mM (p<0.001), 2h; 0.01mM (p<0.001), 2h; 0.1mM (p<0.001), 2h; 1mM (p<0.001), 3h; 
0.01mM (p<0.001), 3h; 0.1mM (p<0.001), as determined by Bonferroni post hoc. 
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Figure 3.58: Time course study the effect of Hcy on PS translocation in lymphocyte 
cells. Cells were incubated with a range of Hcy concentrations (0-1mM) for 1, 2 and 3 hours.  
Control cells werenon-treated. Cells were then stained by Annexin-v FITC labelled and 
analysed using flowcytometry and BD FACSDiva software. The Data are means ± SD n=4, p< 
0.001 as determined by two-way ANOVA. Baseline (control) vs 1h; 0.01mM (p<0.001), 1h; 
0.05mM (p<0.001), 1h; 0.1mM (p<0.001), 2h; 0.01mM (p<0.001), 2h; 0.05mM (p<0.001), 3h; 
0.01mM (p<0.001), 3h; 0.05mM (p<0.001) as determined by Bonferroni post hoc. 
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Figure 3.59: Time course study the effect of H2O2 on caspase-3 level in lymphocyte 
cells. Cells were treated with a range of H2O2 concentrations (0-10mM) for 1, 2 and 3 hours. 
Cells were then stained with monoclonal anti-rabbit caspase-3 FITC labelled antibody.  
Control cells were non-treated. The Data are means ± SD n=4, p< 0.001 as determined by 
two-way ANOVA. Baseline (control) vs 1h; 0.01mM (p<0.001), 1h; 0.1mM (p<0.001), 2h; 
0.01mM (p<0.001), 2h; 0.1mM (p<0.001), 2h; 1mM (p<0.05), 3h; 0.01mM (p<0.001), 3h; 
0.1mM (p<0.001), as determined by Bonferroni post hoc. 
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Figure 3.60: Time course study the effect of Hcy on caspase-3 level in lymphocyte 
cells. Cells were treated with a range of Hcy concentrations (0-1mM) for 1, 2 and 3 hours. 
Cells were then stained with monoclonal anti-rabbit caspase-3 FITC labelled antibody.  
Control cells were non-treated. The Data are means ± SD n=4, p< 0.001 as determined by 
two-way ANOVA. Baseline (control) vs 1h; 0.01mM (p<0.001), 1h; 0.05mM (p<0.001), 1h; 
0.1mM (p<0.01), 2h; 0.01mM (p<0.001), 2h; 0.05mM (p<0.001), 2h; 0.1mM (p<0.001), 3h; 
0.01mM (p<0.001), 3h; 0.05mM (p<0.001),  3h; 0.1mM (p<0.01) as determined by Bonferroni 
post hoc. 
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Figure 3.61: Time course study the effect of H2O2 on necrosis level of lymphocyte cells. 
Cells were incubated with a range of H2O2 concentrations (0-10mM) for 1, 2 and 3 hours. 
Then cells were stained with PI and analysed using flowcytometry and BD FACSDiva. Control 
cells were non-treated. The Data are means ± SD n=4, p< 0.001 as determined by two-way 
ANOVA. Baseline (control) vs 1h; 1mM (p<0.001), 1h; 10mM (p<0.001), 2h; 0.1mM (p<0.001), 
2h; 1mM (p<0.001), 2h; 10mM (p<0.001), 3h; 0.1mM (p<0.001), 3h; 1mM (p<0.001), 3h; 
10mM (p<0.001)as determined by Bonferroni post hoc. 
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Figure 3.62: Time course study the effect of Hcy on necrosis level of lymphocyte cells. 
Cells were incubated with a range of Hcy concentrations (0-1mM) for 1, 2 and 3 hours. Then 
cells were stained with PI and analysed using flowcytometry and BD FACSDiva. Control cells 
were non-treated. The Data are means ± SD n=4, p< 0.001 as determined by two-way 
ANOVA. Baseline (control) vs 1h; 0.1mM (p<0.001), 1h; 1mM (p<0.001), 2h; 0.05mM 
(p<0.01), 2h; 0.1mM (p<0.001), 2h; 1mM (p<0.001), 3h; 0.05mM (p<0.001), 3h; 0.1mM 
(p<0.001), 3h; 1mM (p<0.001) as determined by Bonferroni post hoc. 
 
The scatter plots in Figure 3.63, illustrates the distribution of the blood cells 
according to size and lymphocyte cells presented with red colour. The 
histogram present a significant increase of the fluorescence intensity of 
caspase-3 after 2 hours of exposing cells to 0.01mM Hcy, compared to control 
cells, and majority of cells were shifted to the annexin-v positive scatter. Also, 
majority of the cells were shifted to the necrotic/late apoptotic scatter after 2 
hour exposing cells to 1mM Hcy compared to control cells. In order to induce 
mainly apoptosis once or necrosis once again, cells were exposed to a range 
of concentrations of H2O2 for 2 hours or Hcy for 2 hours and resulted in a 
significant effect in caspase-3 and necrosis activity (P 0.001, as determined 
by one-way ANNOVA), (Figure 3.64). The Tukey pairwise analysis showed 
that a significant increase in caspase-3 activity which peaked at 0.01mM (P 
0.001), followed by a reduction in both of them with high concentrations of 
H2O2 or Hcy resulted in no significant increase in casapse-3 activity as 
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compared to control cells (P0.05). In contrast, necrosis has increased 
significantly at 0.1mM H2O2 or 0.05mM  
Hcy (P 0.001), which then reached 93% necrosis at 10mM H2O2 or 1mM Hcy  
with no caspase-3 activity (Figure 3.64). 
 
A. Distribution of the 
cells  
according cell size 
 
 
B. Caspase-3 control 
 
 
C. Cells treated with 
0.01mM Hcy 
 
D. Control cells for 
Annexin-v and PI 
 
E. Cells treated with 
0.01mM  
Hcy 
 
F. Cells treated with1mM 
Hcy 
 
Figure 3.63: Induction of apoptosis and necrosis in lymphocyte cells. Cells were 
treated for 2 hours with 0.01mM Hcy for apoptosis induction and 1mM Hcy for necrosis 
induction. Then cells were stained with monoclonal anti-rabbit caspase-3 FITC labelled 
antibody for caspase activity measurement and doubled stain with Annexin-v and PI for 
early apoptosis and necrosis measurements using flowcytometry and BD FACSDiva 
software to analyse: A. distribution of the cells according cell size, B. Caspase-3 control, 
C. Cells treated with 0.01mM Hcy, D. control cells for Annexin-v and PI, E. Cells treated 
with 0.01mM Hcy and F. cells treated with1mM Hcy. 
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Figure 3.64: Mechanisms of lymphocyte cells death subjected to H2O2 or Hcy Cells were 
exposed to increasing concentrations of A. H2O2 (0-10mM) for 2 hours or B. of Hcy (0-1mM) 
for 2 hours. Then cells were stained with monoclonal anti-rabbit caspase-3 FITC labelled 
antibody for caspase activity measurement using flowcytometry and BD FACSDiva software 
to analyse. The present data are means ± SD n=4, p< 0.001 as determined by two-way 
ANOVA.  
. 
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3.4 Discussion: 
The aims of this chapter were to investigate mechanisms of cells death under 
oxidative stress, and the protection role of folate and cobalamin that they can be 
provided against oxidative stress. 
 
The results in this chapter present clearly the mechanisms of cell death under 
oxidative stress is dose-dependent hence, at 3.125M Hcy or H2O2  Sk-Hep-1 cells 
were mostly apoptotic with high activity of caspase-3, and this activity reduced when 
cell death switched to the necrosis pathway. The PI assay showed significant 
increase in necrosis activity and cells were dying neurotically with 50M Hcy or H2O2.  
Additionally, the same pattern of cell death pathways under oxidative stress observed 
in other cells types such as Jurkat cells, were mainly dying through apoptosis 
pathway with a significant increase in caspase-3 and translocation of PS to the 
surface of the cells at 0.01mM H2O2 or at 3.125M Hcy after 6 hours. While the 
activity of apoptosis was reduced with higher concentrations when necrosis was 
induced and cell were dying through necrosis such at 10mM H2O2 or 100M Hcy 
reached 100% necrosis.  Furthermore, the normal peripheral blood (Neutrophil, 
Monocyte and lymphocyte) cells had a specific point where cells undergo apoptosis 
and another different point where cells undergo necrosis under oxidative stress. 
 
These results indicate that cell death mechanisms under oxidative stress are 
apoptosis or necrosis depending on the dose and time. This data strengthen the 
previous results obtained by others studies, that low concentrations of oxidative 
stressor induce apoptosis and high concentrations induce necrosis in Jurkat cells 
(Hampton & Orrenius, 1997), endothelium cells (Liu et al., 2005; Obeid & Herrmann, 
2006), smooth muscle cells (Buemi et al., 2001), primary human bone marrow 
stromal cells and the HS-5 cell line (Kim, et al., 2006) It has been reported that when 
cells undergo apoptosis intracellular ATP increased while necrotic cells have no such 
ATP activity. However, when the loss of the intracellular ATP inhibited in the necrotic 
cell, cell death type switched to apoptosis (Saito et al., 2006; Nicotera & Melino, 
2004). This might suggest that cells undergo necrosis at higher concentration due to 
the loss of intracellular ATP.  
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The results presented in this chapter suggest that endothelial cells are more sensitive 
to oxidative stress than blood cells with 2 hours incubation of 3.125M Hcy or H2O2 
induce apoptosis in sk-hep1 cells, whereas 6 hours are required for inducing 
apoptosis in Jurkat cells by 3.125M Hcy or 0.01mM H2O2. This sensitivity might be 
due to the fact that endothelial cells interface between the vessel wall and circulating 
bloods, so they act as a sensor and transducer of signals, and therefore they are 
sensitive to oxidative stress (Ryter et al., 2007). On this basis Sk-hep1 was used as a 
suitable model the further studies. 
 
As it is known that peripheral blood cells function differently, interestingly their 
resistance against oxidative stress were also different. Previous researchers have 
shown that neutrophils are resistance to H2O2 (Pietarinen-Runtti et al., 2000), also 
there was another study demonstrated the resistance of peripheral blood cells to 
H2O2 but this study was limited to investigating the PS exposure only (Nishioka et al., 
2003). However, there is no such study that showed the effect of the homocysteine. 
The result in this chapter demonstrates the resistance of peripheral blood cells 
against oxidative stress as such, monocyte cells were more resistance to hydrogen 
peroxide than neutrophils and lymphocyte cells since they required higher 
concentration and time to induce apoptosis and necrosis.  The resistance of the 
monocyte cells to the oxidative agents might be due to the level of glutathione 
peroxidase (GPx) and glutathione activity, which were high in the monocyte cells GPx 
containing a selenocysteine moiety in its catalytic centre, which is  an antioxidant 
enzymes that reduce lipid and hydrogen peroxide to their respective alcohols 
(Pietarinen-Runtti et al., 2000).  Moreover, peripheral blood cells were more sensitive 
to homocysteine compared to hydrogen peroxide as less incubation time and 
concentrations of Hcy were required to induce cell death either by apoptosis or 
necrosis and the same observation detected in other cell lines such as Jurkat. This 
sensitivity of cells to Hcy might be due to generating intracellular H2O2 by Hcy when 
Hcy-induced cell death (Malinow, 1990; Harker et al., 1976).  
 
After determining the mechanisms of cells death under oxidative stress in different 
cells type, the hypothesis of antioxidant and cobalamin provide protection from 
apoptosis or necrosis induced by oxidative stressor was examined. Since in the 
literature it has been reported that folate and cobalamin supplementations reduce 
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Hcy level in the plasma of hyperhomocysteimia patient and protect cells form 
oxidative stress injury (Rosenberg,2007; Kazerooni et al., 2008; Nagaraja et al., 
2008).  Folic acid supplementation could be a useful approach for reducing the risk 
and treatment of cardiovascular diseases associated with hyperhomocysteimia (Woo 
et al., 1999; Chambers et al., 2000). The results in this chapter clearly demonstrated 
that folate provides protection to the cells from apoptosis and necrosis induced by 
oxidative stress. Moreover, cobalamin has a significant protection impact on 
apoptosis and necrosis induced by Hcy and H2O2; hence 70% of cells were 
protected from apoptosis and necrosis which correlated with reduction in caspase-3 
in the apoptosis condition or reduction in free penetration of PI in the necrosis 
condition, which indicates a novel role of cobalamin as antioxidant activity despite 
being a cofactor enzyme as recent studies confirm this finding (Birch et al., 2009). 
The protection was not limited to the sk-hep1 cells but it was also found in Jurkat 
cells. At the same time, there was no toxicity effect on the cells observed from 
cobalamin and folate on sk-hep1 and Jurkat cells.   This study showed clearly the 
protective role of folate and cobalamin which support other studies that suggested 
folate and cobalamin administration improve the severity of coronary heart disease 
and prevents endothelial dysfunction (Chamber et al., 2000) Also, it has examined 
the protective effect of folate on U937 cells against apoptosis induced by 7-
ketocholestrol (Huang et al., 2004).  
 
Furthermore, the result showed that cobalamin and folate have the ability to reduce 
ROS and superoxide activity. This finding agreed with pervious research which 
suggested that folate have the ability to reduce ROS (Huang et al., 2004).  
 
To conclude, the result in this chapter clearly demonstrates that under oxidative 
stress apoptosis and necrosis occurred in a dose dependent manner in different cells 
types. Folate and cobalamin provide significant protection against apoptosis and 
necrosis. Also, the result indicates that cobalamin function is not only as a cofactor 
enzyme but it plays a vital role in anti-oxidative activity. The folate and cobalamin 
protection was associated with reduction in the ROS and super oxide which indicate 
that folate and cobalamin had a significant effect on the apoptosis signalling.  
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The mechanisms of cobalamin protection is still not clearly understood, and possibly 
the Hsps plays a vital role in this protection. This hypothesis will be investigated in the 
next chapter. 
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Chapter 4 
 
Heat Shock Proteins Induction By Cobalamin 
 
4.1 Introduction: 
Heat shock proteins are up-regulated to protect against various physiological and 
environmental stress conditions (Binder et al., 2004). It has been demonstrated in 
vitro and in vivo that over-expression of Hsps can prevent apoptosis induced by 
chemicals or non-lethal thermal stress (Musch et al., 1996; Otani et al., 1997; Ren et 
al., 2001; Ropeleski et al., 2003; Kojima et al., 2003). Over-expression of Hsp27 
protects hippocampal progenitor cells (Son et al., 2005), HeLa cells (Tsuchiya et al., 
2005) and breast cancer cells (Casado et al., 2007) from apoptosis.  
 
Furthermore, Hsp27 over-expression protects cells from necrosis induced by 
oxidative stress (Mehlen et al., 1995). The chaperone activity of Hsp27 reduces the 
toxic effect of oxidised proteins, and Hsp27 has the ability to induce glutathione 
thereby increasing the antioxidant defence of the cells (Arrigo et al., 2005).  
 
Several studies have shown previously that induction of HO-1 by different stimuli 
provides an important cellular defence mechanism against tissue injury (Motterlini. et 
al; 1996, Tian. et al, 2001; Amersi. et al, 1999; Clark. et al; 2000, Yet. et al; 2001, 
Foresti. et al; 1999). While, over-expression of HO-1 inhibits apoptosis in vascular 
smooth muscle cells (Liu. et al; 2005).  
 
Over-expression of Hsp72 provides protection against cell death induced by oxidative 
stress (Huot et al., 1991; Mehlen et al., 1993), hyperthermia (Landry, 1989), and 
anticancer drugs (Huot et al., 1991; Garrido et al., 1997). It has been reported that 
Hsp72 has the ability to protect cells from both apoptosis and necrosis induced by 
oxidative stress (Samali et al., 1996; Lindquist, 1986; Creagh & Cotter, 1999; Creagh, 
2000; Ohkawara et al., 2006; Batelli et al., 2008). Hsp90 is likely to play a role in the 
oxidative stress as it is induced in vascular smooth muscle cells during oxidative 
stress (Liao et al., 2000).  
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The aim of this chapter is to investigate whether cobalamin and folate induce Hsps, 
and if Hsps are involved in the protection mechanism of cobalamin. 
 
 
4.2 Methods 
All preparations and cell culture experiments were carried out within a class II tissue 
culture hood.  
 
4.2.1 Sk-hep1 cells preparation. 
Cells were passage every 3 days as described in (section 2.4.1). 
 
4.2.2 Jurkat cells preparation 
Cells were passage every 3 days as described in (section 2.4.2) 
 
4.2.3 Cells count and viability test by trypan blue exclusion: 
For the flow cytometry assays, following treatment cells were re-suspend in to the 
media by pipetting. Cells were then counted and assessed by trypan blue exclusion 
(section 2.4.6) 
 
4.2.4 Measurement of intracellular Hsps 
Following test conditions, cells were processed for staining and analysis as described 
in (section 2.4.13) 
 
The antibodies used were: Anti-Hsp27 mouse monoclonal FITC conjugated antibody, 
Anti-HO-1 mouse monoclonal FITC conjugated antibody, Anti-Hsp72 mouse 
monoclonal FITC conjugated antibody and Anti-Hsp90 mouse monoclonal R-
Phycoerythrin conjugated antibody. The dilution was 1:100. 
 
4.2.5 Inhibition of HO-1 and Hsp72 
For inhibition of HO-1, cells were pre-treated with 12.5M SN (IV) Protoporphyrin IX 
dichloride for 4 hours then subjected to the test compounds. 
 For inhibition of the Hsp72, cells were pre-treated with 200M KNK437 for 1 hour, 
and then cells subjected to the test compounds.  
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4.2.6 Induction of HO-1 and Hsp72 
In order to induce HO-1 prior to treatment with test compound, cells were subjected 
to 12M Hemin for 2 hours.  
 
For the induction of the Hsp72 prior treatment, cells were heat shocked at 42C for 1 
hour and then incubated at 37C for 2 hours. 
 
4.2.7 Determination of apoptosis 
Cells were plated on to a black 96 well cell plate, treated under test conditions and 
then analysed for apoptosis by determination of caspase-3/7 activity (section 2.4.9). 
 
4.2.8 Determination of necrosis: 
Cells were plated on to a black 96 well cell plate, treated under test condition then 
analysed for necrosis by PI incorporation (section 2.4.11). 
 
The treatment with Hcy+cobalamin or folate will be referred to as cobalamin-
apoptosis protection or folate-apoptosis protection. 
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4.3 Result 
 
4.3.1 Induction of intracellular Hsps under apoptosis induced by oxidative 
stress and under apoptosis protection conditions: 
 
4.3.1.1 Impact of cobalamin on intracellular Hsps: 
In order to investigate the impact of cobalamin on intracellular Hsps, sk-hep1 cells 
were treated with a range of cobalamin concentrations (0-50M) for 2 hours, which 
resulted in a significant effect (P0.001, as determined by one-way ANNOVA), 
(Figures 4.1& 4.2). The Post-hoc comparison showed that at ≥12M of cobalamin 
there was a significant induction of iHsp27 (P0.05), iHO-1 (P0.05), iHsp72 (P0.05) 
and iHsp90 (P0.01) compared to control cells. The induction of the iHsps peaked at 
25M cobalamin (P0.001) followed by a significant reduction in iHsp27 (P0.001), 
iHO-1 (P0.05), iHsp72 (P0.01) and iHsp90 (P<0.01) at higher concentrations 
(50M) as compared to 25M cobalamin treatment.  
 
The histograms demonstrate the induction of iHsps when sk-hep1 exposed to 25M 
cobalamin. The significant increase in the intensity fluoresces of iHsp27, iHO-1, 
iHsp72 and iHsp90 compared to control cells can be visualised clearly in the 
histograms (Figure 4.3). 
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Figure 4.1: Effect of cobalamin on the iHsp27 and iHO-1 level. Sk-hep1 cells were treated 
with a range of cobalamin concentrations (0-50M) for 2 hours, control cells were not treated. 
Cells were then stained with monoclonal mouse A. Anti-Hsp27 or B. Anti-HO-1 FITC labelled 
antibodies and analyzed using Flow cytometry and BD FACSDiva software. The Data are 
means ± SD n=4, p< 0.001 as determined by one-way ANOVA. Baseline (control) vs 12M 
(p<0.05), 25M (p<0.001), 50M (p<0.01) as determined by Tukey post hoc. 
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Figure 4.2: Effect of cobalamin on iHsp72 and iHsp90. Sk-hep1 cells were treated with a 
range of cobalamin concentrations (0-50M) for 2 hours, control cells were non-treated. Cells 
were then stained with monoclonal mouse A. Anti-Hsp72 FITC labelled or B. Anti-Hsp90 PE 
labelled antibodies and analyzed using Flow cytometry and BD FACSDiva software. The Data 
are means ± SD n=4, p< 0.001 as determined by one-way ANOVA. Baseline (control) vs 
12M (p<0.05), 25M (p<0.001), 50M (p<0.01) as determined by Tukey post hoc. 
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Figure 4.3: Effect of cobalamin on intracellular Hsps level. Sk-hep1 cells were treated 
with 25M cobalamin for 2 hours then cells were stained with specific antibodies and 
analyzed using Flow cytometry BD FACSDiva. A. non treated cells PE control, B. non 
treated cells FITC control, C. iHsp27 D. iHO-1, E. iHsp72, and F. iHsp90. 
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In the previous chapter it had been demonstrated that 25M cobalamin protects cells 
from apoptosis induced by 3.125M Hcy. In this chapter, the intracellular Hsps under 
apoptosis and protection conditions were examined. There were significant effect on 
iHsps under apoptosis and protection condition (p<0.001, as determined by one-way 
ANNOVA), (Figures 4.4& 4.5). Further analysis with Tukey pairwise showed that 
iHsp27 were increased significantly at 3.125M Hcy and reached 97% (p<0.001) as 
compared to control cells. However, pre-incubation with 25M cobalamin for 2 hours 
followed by 2 hours incubation with 3.125M Hcy, decreased iHsp27 by 20% in 
comparison to Hcy treatment only. On the other hand, at 3.125M Hcy iHO-1, 
iHsp72, and iHsp90 elevated up to 70%, 53%, and 58% respectively (p<0.001), while 
incubating cells with 25M cobalamin prior to exposure to 3.125M Hcy, the iHO-1, 
iHsp72 and iHsp90 reached 98% induction (p<0.001). 
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Figure 4.4: Intracellular Hsp27 and HO-1 during cobalamin apoptosis-protection. Sk-
hep1 cells were pre-treated with 25M cobalamin for 2 hours followed by 2hours treatments 
with 3.125M Hcy, then cells were stained with monoclonal mouse A. Anti-Hsp27 or B. Anti-
HO-1 FITC labelled and analyzed using Flow cytometry, Control cells were non-treated. The 
Data are means ± SD n=4, p< 0.001 as determined by one-way ANOVA. Baseline (control) vs 
Cbl (p<0.05), Hcy (p<0.001), Cbl+Hcy (p<0.001) as determined by Tukey post hoc. 
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Figure 4.5: Intracellular Hsp72 and Hsp90 during cobalamin apoptosis-protection. Sk-
hep1 cells were pre-treated with 25M cobalamin for 2 hours followed by 2hours treatments 
with 3.125M Hcy, then cells were stained with monoclonal mouse A. Anti-Hsp72 FITC 
labelled or B. Anti-Hsp90 PE labelled antibodies and analyzed using Flow cytometry, control 
cells were non-treated. The Data are means ± SD n=4, p< 0.001 as determined by one-way 
ANOVA. Baseline (control) vs Cbl (p<0.05), Hcy (p<0.01), Cbl+Hcy (p<0.001) as determined 
by Tukey post hoc. 
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4.3.1.2 Induction of intracellular Hsps under oxidative stress and under 
protection from apoptosis via folate in sk-hep1: 
 
As previously demonstrated that cobalamin has a significant effect on intracellular 
Hsps under apoptosis protection conditions, so the aim is to investigate intracellular 
Hsps under folate-apoptosis protection conditions.  
 
Folate treatment had a significant effect on iHsps (P0.001, as determined by one-
way ANNOVA), (Figures 4.6 & 4.7). The Tukey comparison showed that exposing 
cells to 30M folate had no significant effect on iHsp27 (P0.05) but it had induced 
iHO-1 significantly (P0.05). However, iHsp27 reached 98% at 3.125M Hcy, while 
pre-incubation with folate reduced iHsp27 by 25%. In the same time 75% of HO-1 
was induced by Hcy and reached 100% when cells were pre-incubated with folate 
(Figure 4.6). Additionally, folate treatment alone induced iHsp72 (P0.05) and iHsp90 
(P0.05) significantly compared to control cells (non-treated). Moreover 51% of 
iHsp72 and 46% of iHsp90 increased at 3.125M Hcy (P0.001) to reach 100% 
induction of iHsp72 and iHsp90 when cells were exposed to folate prior to treatment 
with Hcy (Figure 4.7). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 121 
 
A. 
B.
Control Folate Hcy Folate+Hcy
0
1000
2000
3000
4000
iHsp27
M
F
I
  
 
Figure 4.6: Effect of folate on iHsp27 and iHO-1 induction. Sk-hep1 cells were pre-treated 
with 30M folate for 2 hours followed by 2hours treatments with 3.125M Hcy, or 30M folate 
alone or 3.125M Hcy.  Cells were then stained with monoclonal mouse A. Anti-Hsp27 or B. 
Anti-HO-1 FITC labelled antibodies and analyzed by flow cytometry, control cells were non-
treated. The Data are means ± SD n=4, p< 0.001 as determined by one-way ANOVA. 
Baseline (control) vs folate (p<0.05)-HO-1, Hcy (p<0.001), folate+Hcy (p<0.001) as 
determined by Tukey post hoc. 
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Figure 4.7: Effect of folate on iHsp72 and iHsp90 induction. Sk-hep1 cells were pre-
treated with 30M folate for 2 hours followed by 2hours treatments with 3.125M Hcy 30M 
folate alone or 3.125M Hcy, Cells were then stained with monoclonal mouse A. Anti-Hsp72 
FITC or B. Anti-Hsp90 PE labelled antibodies and analyzed by flow cytometry, control cells 
were non-treated. The Data are means ± SD n=4, p< 0.001 as determined by one-way 
ANOVA. Baseline (control) vs Folate (p<0.05)-HO-1, Hcy (p<0.001), folate+Hcy (p<0.001) as 
determined by Tukey post hoc. 
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4.3.2 The impact of overexpression and inhibition of Hsp72 on apoptosis 
induced by oxidative stress and protected by cobalamin: 
 
4.3.2.1 Induction of Hsp72 and oxidative stress. 
 
Previously it had been demonstrated that iHsps were induced by cobalamin. So the 
potential involvement of these proteins in the cobalamin-apoptosis protection was 
investigated. 
 
Sk-hep1 cells were heat shocked at 42C for 1 hour followed by 2 hours recovery at 
37C which resulted in a significant effect on the iHsp27 and iHsp72 (P0.001, as 
determined by one-way ANNOVA), (Figure 4.8). The post-hoc comparison showed 
significant increase in iHsp27 and iHsp72 after 1 hour (P0.001) and 2 hours 
recovery (P0.001) compared to control cells (non-treated). Although there was a 
significant reduction in both iHsp27 and iHsp72 after 2 hours recovery compared to 1 
hour recovery (P0.001), (Figure 4.8). 
 
Interestingly, the overexpression of iHsp27 and iHsp72 had significant effect on 
caspase-3 (P0.001, as determined by two-way ANNOVA), (Figures 4.9, 4.10 & 
4.11). The post-hoc comparison showed that induction of iHsp27 and iHsp72 prior to 
treatment with 3.125M Hcy or H2O2 for 2 hours (these concentrations previously 
proved to induce apoptosis), showed a significant reduction in caspase-3 after 1 and 
2 hours recovery prior to treatment with Hcy (P0.001) or H2O2 (P0.001) compared 
to Hcy or H2O2 treatment alone (Figure 4.9). However, 1 hour recovery partially 
protected the cells from apoptosis induced by Hcy (P0.05) or H2O2 (P0.001) 
compared to control,  whereas 2 hours recovery provided complete protection against 
apoptosis induced by Hcy (P0.05) or H2O2 (P0.05), (Figure 4.10). At the same time 
there was no significant detection of necrosis activity in the heat shocked and cells 
recovered for 1 hour or 2 hours as compared to non-treated cells (P0.05), also cells 
recovered for 1 or 2 hours+Hcy showed no significant necrosis activity as compared 
to non-treated cells (P0.05), (Figure 4.11). 
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Figure 4.8: Induction of iHsp27 and iHsp72 in sk-hep1. Cells were heat shocked for 1hour 
at 42C followed by 1hour and 2 hours recovery at 37C prior treatments with 3.125M Hcy 
for 2 hours. Cells were then stained with monoclonal mouse A. Anti-Hsp27 or B. Anti-Hsp72 
FITC labelled antibodies and analyzed by flow cytometry, control cells were non-treated. The 
Data are means ± SD n=4, p< 0.001 as determined by one-way ANOVA. Baseline (control) vs 
1h recovery (p<0.001), 2h recovery (p<0.001) as determined by Tukey post hoc. 
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Figure 4.9: Effect induction of Hsp72 on caspase-3 activity induced by Hcy or H2O2. Sk-
hep1 cells were heat shocked for 1hours at 42C and followed by 1hour and 2 hours recovery 
at 37C prior treatments with 3.125M A. Hcy or B.H2O2 for 2 hours. Caspase-3 was 
measured after by staining the cells with monoclonal anti-caspase-3 FITC congregated 
antibodies and analyzed by flow cytometry, control cells were heat shocked for 2 hours at 
42C. The Data are means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline 
(control) vs 1h recovery+ H2O2 or Hcy (p<0.01), H2O2 or Hcy (p<0.001) as determined by 
Bonferroni post hoc. 
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Figure 4.10: Effect of induction of the Hsp72 on necrosis activity under oxidative 
stress. Sk-hep1 cells were heat shocked for 1 hour at 42C followed by 1hour and 2 hours 
recovery at 37C prior treatments with 3.125MHcy for 2 hours. Necrosis measured at 
EX=535/EM=617. , control cells were non-treated. The Data are means ± SD n=4, p>0.05 as 
determined by two-way ANOVA.  
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The heat shock and recovery had significant effect on iHsps (P0.001, as determined 
by two-way ANNOVA), (Figures 4.11, 4.12, 4.13 & 4.14). Further analysis with 
Bonferroni pairwise showed that exposing cells for 1 hour at 42C followed by 1 hour 
or 2 hours incubation at 37C (when apoptosis reduced), showed a significant 
increase in iHsp27 (P0.001), iHsp72 (P0.001) and iHsp90 (P0.001) with no effect 
on iHO-1 (P0.05) as compared to control cells. Moreover, after 2 hours of recovery 
the iHsp27 showed significant induction under oxidative stress+ recovery  more than 
under recovery only (P<0.001). However, after 1 hour of recovery showed a 
significant induction of iHsp27 more than under 1 hour of recovery+oxidative recovery 
only (P<0.001). During the same time, iHsp27 significantly increased at 3.125M Hcy 
or H2O2 (under apoptosis condition) more than non-treated cells (P<0.001) (Figure 
4.11). Whereas after 1 or 2 hours recovered + oxidative stress treated cells, iHO-1 
was significantly more than those in 1 or 2 hours recovered cells only (P0.001), 
(Figure 4.12). Additionally, cells subjected to 3.125M Hcy or H2O2 (apoptosis 
condition) induced iHsp72 significantly when compared to control cells (P0.001).  
After 1 hour of recovery it showed a significant increase of iHsp72 more than 1 hour 
recovered+oxidative treated cells (P0.001), however, 2 hours recovered cells 
showed significant reduction of iHsp72 compared to 2 hours recovered+oxidative 
treated cells (P0.001) (Figure 4.13). Furthermore, iHsp90 induced at 3.125M Hcy 
or H2O2 above control cells (P0.001). While 1 hour recovered cells resulted in 
significant increase in the iHsp90 more than 1 hour recovered+oxidative (P0.001), 
but there was no significant difference in the iHsp90 after 2 hours recovered cells 
compared  to 2 hours recovered+ recovered+oxidative treated cells (P0.05), (Figure 
4.13). 
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Figure 4.11: The intracellular Hsp27 after heat shock and apoptosis induction by 
oxidative stress. Sk-hep1 cells were  incubated for 1 hour at 42C followed by 1hour and 2 
hours recovery at 37C prior treatments with A. 3.125M Hcy or B. 3.125M H2O2 for 2 hour. 
Cells were then stained with monoclonal mouse anti-Hsp27 FITC labelled antibodies and 
analyzed by flow cytometry and BD FACSDiva, control cells were heat shocked for 1 hour at 
42C. The Data are means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline 
(control) vs H2O2 or Hcy (p<0.01), 1h recovery+H2O2 or Hcy (p<0.001) 2h recovery+H2O2 or 
Hcy (p<0.01) as determined by Bonferroni post hoc. 
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Figure 4.12: The intracellular HO-1 after heat shock and apoptosis induction by 
oxidative stress. Sk-hep1 cells were incubated for 1 hour at 42C followed by 1hour and 2 
hours recovery at 37C prior treatments with A. 3.125M Hcy or B. 3.125M H2O2 for 2 hour. 
Cells then were stained with monoclonal mouse anti-HO-1 FITC labelled antibodies and 
analyzed by flow cytometry and BD FACSDiva, control cells were heat shocked for 1 hour at 
42C. The Data are means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline 
(control) vs H2O2 or Hcy (p<0.001), 1h recovery+H2O2 or Hcy (p<0.01) 2h recovery+H2O2 or 
Hcy (p<0.01) as determined by Bonferroni post hoc. 
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Figure 4.13: The intracellular Hsp72 after heat shock and apoptosis induction by 
oxidative stress. Sk-hep1 cells were incubated for 1 hour at 42C followed by 1hour and 2 
hours recovery at 37C prior treatments with A. 3.125M Hcy or B.3.125M H2O2 for 2 hours. 
Cells then stained with monoclonal mouse anti-Hsp72 FITC labelled antibodies and analyzed 
by flow cytometry and BD FACSDiva, control cells were heat shocked for 1 hour at 42C. The 
Data are means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline (control) vs 
H2O2 or Hcy (p<0.001), 1h recovery+H2O2 or Hcy (p<0.001) 2h recovery+H2O2 or Hcy 
(p<0.001) as determined by Bonferroni post hoc.  
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Figure 4.14: The intracellular Hsp90 after heat shock and apoptosis induction by 
oxidative stress. Sk-hep1 cells were incubated for 1 hour at 42C followed by 1hour and 2 
hours recovery at 37C prior treatments with A. 3.125M Hcy or B. H2O2 for 2 hours. Cells 
then were stained with monoclonal mouse anti-Hsp90 PE labelled antibodies and analyzed by 
flow cytometry and BD FACSDiva. Control cells were heat shocked for 1 hour at 42C. The 
Data are means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline (control) vs 
H2O2 or Hcy (p<0.001), 1h recovery+H2O2 or Hcy (p<0.001) 2h recovery+H2O2 or Hcy 
(p<0.001) as determined by Bonferroni post hoc.  
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4.3.2.2 Effect of Hsp72 inhibition by KNK437 on cobalamin protection. 
 
In order to inhibit iHsp72, cells subjected to 200M KNK437 for 1 hour prior heat 
shock at 42C for 1 hour and recovered for 1 hour at 37C, resulted in significant 
inhibition of iHsps72 (P0.001, as determined by one-way ANNOVA), (Figure 4.15). 
Moreover Tukey pairwise showed there was significant reduction of iHsp72 as 
compared to heat shocked and recovered cells (P0.001). Also the inhibition of 
Hsp72 has no significant effect on necrosis activity in the cells treated with Hcy as 
compared to control cells (P0.05, as determined by two-way ANNOVA), (Figure 
4.16). 
 
The inhibition of iHsp72 prevented cobalamin protecting cells from apoptosis induced 
by oxidative stress significantly (P0.001, as determined by two-way ANNOVA), 
(Figures 4.17 & 4.18). The post-hoc comparison showed that when cells were treated 
with 200M KNK437 for 1 hour, followed by 25M cobalamin and 3.125M Hcy or 
H2O2, the protection against Hcy or H2O2 induced apoptosis was lost (P0.001), 
(Figure 4.17). Caspase activity was not significantly different from Hcy treated cells 
(P>0.05), (Figure 4.17). Similarly folate protection against Hcy or H2O2 induced 
apoptosis was lost following treatment with 200M KNK437 for 1 hour (P0.001), 
(Figure 4.18).  
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Figure 4.15: inhibition of Hsp72 by KNK437 in sk-hep1 cells. Sk-hep1 cells were pre-
treated with 200M KNK437 for 1hours followed by 1 hour exposure to 42C and 1 hour at 
37C, control cells were non-treated cells. Cells were then stained with monoclonal anti-hsp72 
FITC congegated and analyzed by flow cytometry and BD FACSDiva. The Data are means ± 
SD n=4, p< 0.001 as determined by one-way ANOVA.  1h 42C+1h at 37C vs 1h 42C+1h at 
37C+KNK437 (p<0.001), as determined by Tukey post hoc.  
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Figure 4.16: Effect of Hsp72 inhibition on necrosis activity under oxidative stress. Sk-
hep1 cells were pre-treated with 200M KNK437 for 1 hours followed by 2 hours treatment 
with 3.125M Hcy. Control cells were non-treated with inhibitor. Necrosis activity measured at 
EX=535/EM=617. The Data are means ± SD n=4, p>0.05 as determined by two-way ANOVA. 
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Figure 4.17: Effect of Hsp72 inhibition on cobalamin apoptosis-protection. Sk-hep1 cells 
were pre-treated with 200M KNK437 for 1 hour followed by 2 hours treatment with 25M 
cobalamin and 2 hours treatment with A. 3.125M Hcy or B. H2O2. Cells were stained with 
monoclonal anti-caspase-3 FITC congegated antibodies and analyzed by flow cytometry, 
control cells were non-treated with the inhibitor. The Data are means ± SD n=4, p< 0.001 as 
determined by two-way ANOVA.  H2O2 or Hcy+cbl vs H2O2 or Hcy+Cbl+KNK437 (p<0.001), 
as determined by Bonferroni post hoc. 
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Figure 4.18: Effect of Hsp72 inhibition on folate apoptosis-protection. Sk-hep1 cells were 
pre-treated with KNK437 for 1 hour followed by 2 hours treatment with 25M cobalamin or 
30M folate and 2 hours treatment with A. 3.125M Hcy or B. 3.125M H2O2. Cells stained 
with monoclonal anti-caspase-3 FITC congegated antibodies and analyzed by flow cytometry, 
control cells were non-treated with the inhibitor. The Data are means ± SD n=4, p< 0.001 as 
determined by two-way ANOVA. H2O2 or Hcy+Folate vs H2O2 or Hcy+Folate+KNK437 
(p<0.001), as determined by Bonferroni post hoc. 
. 
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4.3.3 Impact of inhibition and induction of HO-1 on cobalamin and folate 
apoptosis-protection: 
 
4.3.3.1 The effect of iHO-1 induction by hemin on apoptosis induced by 
oxidative stress: 
In order to induce iHO-1, Sk-hep1 cells which were subjected to 12M Hemin for 2 
hours had a significant effect on Ho-1 induction and caspase-3 level under apoptosis 
condition (P0.001, as determined by two-way ANNOVA), (Figures 4.19 & 4.20). 
Further post-hoc comparison showed that hemin treatment had a significant increase 
of iHO-1 when compared to control cells (P0.001), (Figure 4.19) and a reduction in 
Hcy induced caspase-3 activation (P0.001), (Figure 4.20).  Also, there was no 
significant necrosis activity detected in cells treated with hemin prior Hcy as 
compared to control cells (P0.05, as determined by two way ANNOVA), (Figure 
4.21).  
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Figure 4.19: The induction of iHO-1 by Hemin. Sk-hep1 cells were pre-treated with 12M 
Hemin for 2 hours followed by 2 hours treatment with of 3.125M Hcy. Control cells were non-
treated cells. Cells were then stained with specific monoclonal HO-1 FITC labelled antibody 
and analyses by flow cytometry and BD FACSDiva software. The Data are means ± SD n=4, 
p< 0.001 as determined by one-way ANOVA. Baseline (control) vs Hemin (p<0.001), as 
determined by Tukey post hoc. 
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Figure 4.20: Effect of iHO-1 induction on caspase-3 under oxidative stress. Sk-hep1 
cells were pre-treated with 12M Hemin for 2 hours and followed by 2 hours treatment with 
3.125M Hcy. Csapase-3 was measured after at EX=496/EM=520. Control cells were non-
treated with hemin cells. The Data are means ± SD n=4, p< 0.001 as determined by two-way 
ANOVA. Baseline (control) vs Hcy+Hemin (p<0.001), as determined by Bonferroni post hoc. 
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Figure 4.21: Effect of HO-1 induction on necrosis activity under oxidative stress 
induces. Sk-hep1 cells were pre-treated with 12M Hemin for 2 hours followed by 2hours 
treatment with 3.125M Hcy. Necrosis was measured after at EX=535/EM=617. Control cells 
were non-treated with hemin. The Data are means ± SD n=4, p> 0.05 as determined by two-
way ANOVA. 
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4.3.3.2 The impact of iHO-1 inhibition by Sn(IV) Protoporphyrin IX dichloride 
on cobalamin-apoptosis protection:  
 
Treatment cells were induced with 12.5M Sn(IV) Protoporphyrin IX dichloride for 4 
hours prior to exposure to 3.125M Hcy for another 2 hours , which resulted in 
significant inhibition of iHO-1 compared to Hcy alone (P0.001, as determined by 
one-way ANNOVA), (Figure 4.22). Also inhibition of HO-1 had a significant effect on 
caspase-3 activity under protection (P0.001, as determined by two-way ANNOVA), 
(Figures 4.23 & 4.24). Further analysis with Bonferroni pairwise showed that when 
the Sn(IV) Protoporphyrin IX dichloride was applied prior to incubation with 25M 
cobalamin followed by 3.125M Hcy or H2O2 there was a significant increase in the 
caspase-3 activity by 54% or 43%, respectively, more than cells treated with 
cobalamin+Hcy or H2O2 alone (P0.001), (Figure 4.23). There was no significant 
effect of HO-1 inhibition on caspase-3 induced by Hcy or H2O2 alone (P0.05), 
(Figure 4.23). Similarly, inhibition of HO-1 with Sn(IV) Protoporphyrin IX dichloride 
had a significant effect on caspase-3 activity in cells treated with folate+Hcy or H2O2 
such caspase-3 increased by 35% or 30% above cells treated with folate+Hcy or 
H2O2 alone (P0.001), (Figure 4.24). However, there was no significant activity of 
necrosis detected in the cells treated with Hcy after inhibition of HO-1 (P0.05, as 
determined by two-way ANNOVA), (Figure 4.25). 
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Figure 4.22: Inhibition of iHO-1 with SN (IV) Protoporphyrin IX dichloride in sk-hep1. 
Cells were treated with 12.5M SN (IV) Protoporphyrin IX dichloride for 4 hours. iHO-1 
measured after using Flow cytometry and BD FACSDiva software. Control cells were treated 
with 3.125M Hcy for 2hours. The Data are means ± SD n=4, P<0.001 as determined by one-
way ANOVA. Baseline (Hcy) vs Hcy+SN(IV) (p<0.001) as determined by tukey post hoc 
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Figure 4.23: Effect of iHO-1 inhibition on Cobalamin–apoptosis protection in sk-hep1 
cells. Cells were treated with 12.5M SN (IV) Protoporphyrin IX dichloride for 4 hours 
followed by 2 hours treatment with 25M of cobalamin and 2 hours of A. 3.125M Hcy or B. 
3.125M H2O2. Caspase-3 was measured at EX=496/EM=520. Control cells were treated with 
3.125M Hcy for 2hours. The Data are means ± SD n=4, p< 0.001 as determined by two-way 
ANOVA. Baseline (H2O2 or Hcy+Cbl) vs H2O2+Hcy+Cbl+SN(IV) (p<0.001), as determined by 
Bonferroni post hoc. 
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Figure 4.24: Effect of iHO-1 inhibition on folate–apoptosis protection in sk-hep1 cells. 
Cells were treated with 12.5M SN (IV) Protoporphyrin IX dichloride for 4 hours followed by 2 
hours treatment with 30M of folate and 2 hours of 3.125M A. Hcy or B. H2O2. Caspase-3 
was measured after at EX=496/EM=520. Control cells were treated with 3.125M Hcy for 
2hours. The Data are means ± SD n=4, p< 0.001 as determined by two-way ANOVA. 
Baseline (H2O2 or Hcy+folate) vs H2O2+Hcy+folate+SN(IV) (p<0.001), as determined by 
Bonferroni post hoc. 
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Figure 4.25: Effect of iHO-1 inhibition on necrosis activity under oxidative stress. Sk-
hep1 cells were treated with 12.5M SN (IV) Protoporphyrin IX dichloride for 4 hour followed 
by 2 hours treatment and 2 hours of 3.125M Hcy. Necrosis was measured after at 
ex=535/em=617. Control cells were treated with 3.125M Hcy for 2 hours. The Data are 
means ± SD n=4, p>0.05 as determined by two-way ANOVA.  
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4.3.4 Intracellular Hsps under antioxidant protection in Jurkat: 
 
In Jurkat cells, folate had a significant effect on the iHsps (P0.001, as determined by 
one-way ANNOVA), (Figures 4.25 & 4.26). However, Post-hoc comparison showed 
folate did not have significant effect on iHsp27 or iHO-1 induction more than in control 
cells (P0.05). However, pre-incubation cells with folate, followed by treatment with 
Hcy showed a significant increase of iHsp27 and iHO-1 by 24% and 27% respectively 
(P0.001), (Figure 4.25). Furthermore, folate has a significant effect on iHsp72 
(P0.001) and iHsp90 (P0.05) induction in comparison to control cells. Also, 
exposing cells to folate prior to Hcy treatment resulted in significant induction of 
iHsp72 and iHsp90, by 58% and 49% more than Hcy treatment alone (P0.001), 
(Figure 4.26). 
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Figure 4.26: Effect of folate on iHsp27 and iHO-1 level in Jurkat cells. Cells were pre-
treated with 30M Folate for 2 hours followed by 6 hours treatments with 3.125M Hcy then 
cells were stained with monoclonal mouse A. Anti-Hsp27 B. Anti-HO-1 FITC labelled 
antibodies and analyzed using Flow cytometry and BD FACSDiva software. Control cells were 
non-treated. The Data are means ± SD n=4, p< 0.001 as determined by two-way ANOVA. 
Baseline (control) vs Hcy (p<0.001), folate+Hcy (p<0.001), as determined by Bonferroni post 
hoc. 
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Figure 4.27: Effect of folate on iHsp72 and iHsp90 level in Jurkat cells. Cells were pre-
treated with 30M Folate for 2 hours followed by 6 hours treatments with 3.125M Hcy then 
cells were stained with monoclonal mouse A. Anti-Hsp72 FITC B.Anti-Hsp90 PE labelled 
antibodies and analyzed using Flow cytometry and BD FACSDiva software. Control cells were 
non-treated. The Data are means ± SD n=4, p< 0.001 as determined by two-way ANOVA. 
Baseline (control) vs Folate (p<0.05), Hcy (p<0.001), folate+Hcy (p<0.001), as determined by 
Bonferroni post hoc. 
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4.4 Discussion: 
The aim of this chapter was to investigate the impact of cobalamin on iHsps and the 
involvement of the Hsps in the apoptosis protection mechanism.  
 
Previous work has shown that oxidative stress  induces the production of Hsp27, HO-
1, Hsp72 and Hsp90 (Liu et al., 2007; Musch et al., 1996, Musch et al., 1999; Liao et 
al., 2000). HSP production is known to be induced by a wide range of treatments 
(Landry et al., 1989; Huot et al., 1991; Mehlen et al., 1993; Garrido et al., 1996; 
Garrido et al., 1997). Interestingly, the results in this chapter demonstrated that 
cobalamin to be a novel inducer of HSP production. Subjecting cells to cobalamin 
resulted in significant increase of iHps27, iHO-1, iHsp72 and iHsp90. This result was 
not expected and the mechanisms by which cobalamin have antiapoptotic effects will 
be explored further in the next chapter.  
 
Moreover, when cobalamin is protecting cells from apoptosis, iHO-1, iHsp72 and 
iHsp90 were higher than their level with Hcy alone. The same was observed with 
folate-apoptosis protection. Folate treatment alone induced iHsp72 and iHsp90 and 
under folate apoptosis protection there was a further induction of iHsp27, iHO-1, 
iHsp72 and iHsp90 in both Sk-hep1 and Jurkat cells. This suggests that one of the 
properties of protective molecules such as cobalamin and folate is to prime the cells 
to produce HSPs. When challenged with Hcy, the cells then responded with a more 
rapid response in terms of HSP production. 
 
HSPs are known to have antiapoptotic properties (Mosser et al., 1997; Samali et al., 
2001). In the literature it has been reported that overexpression of Hsps protects cells 
from oxidative injury and other stressors (Huot et al., 1991; Mehlen et al., 1993; 
Ohkawara et al., 2006). More over, it has been reported that overexpression of 
Hsp72 through heat shock in prostate cancer cells prevents apoptosis induction by 
chemical and radiation (Gibbson et al., 2000). Also, increased expressions of Hsp72 
in breast cancer cells by heat shock provided protection against chemotherapy 
(Fuqua et al., 1994), and the inhibition of Hsp72 resulted in losing the protection 
(Gibbson et al., 2000). The results of this chapter were in agreement with the 
previous investigations of cytoprotective role of Hsps, hence over-expression of 
 146 
Hsp72 or HO-1 by heat shock or hemin, have protected cells from apoptosis induced 
by oxidative stress.  
 
In order to investigate the role of Hsps in the cobalamin protection mechanism, 
Hsp72 inhibited by KNK437 and HO-1 by Sn (VI) Protoporphyrin IX dichloride 
respectively as they are known as Hsp72 and HO-1 inhibitors (Brich, PhD 2007).  
Inhibition of Hsp72 prevented the protection provided by cobalamin and folate against 
apoptosis induced by oxidative stress. Also inhibition of HO-1 partially prevents 
protection of cobalamin and folate. This was not a general inhibition of apoptosis or 
necrosis because neither inhibitor had any effect on caspase 3 activity or PI 
incorporation in control cells.  
 
Several studies have demonstrated the antiapoptotic effect of Hsps through their 
ability to regulate pro-caspases and release of cytochrome c. The protection of 
cobalamin was associated with induction of Hsps, and this was essential for the 
protection from apoptosis induced by oxidative stress. It has been reported that the 
induction of Hsp27 blocks cytochrome c release and reduces ROS generation under 
oxidative stress. (Garrido et al., 1999; Bruey et al., 2000; Pandey et al.,2000; 
Concannon et al., 2001; Samali et al., 2001; Liu et al., 2007)  At the same time Hsp72 
prevents formation of apoptosomal and prevent caspases activation which leads to 
protect cells from apoptosis (Samali et al., 2001; Beere et al., 2000; Saleh et al., 
2000).  
 
Furthermore overexpression of HO-1 induces antioxidant and antiapoptotic proteins 
(Brouard et al., 2000; Lee et al., 2002; Choi et al., 2002). HO-1 also produces 
bilirubin, which is an antioxidant molecule that has the ability to protect cells from 
oxidative stress (Stocker et al., 1990). It is obvious that the induction of Hsps is 
essential for the cobalamin protection mechanism.  
 
To conclude, the results in this chapter clearly demonstrated a novel impact of 
cobalamin and folate on iHsps. Moreover, the induction of Hsps that is associated 
with cobalamin or folate protection was essential in the protection mechanism. This 
conclusion leads to the next questions: how does cobalamin turn on the Hsp genes? 
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And which signal transduction pathway does lead to cobalamin induced HSP 
production? These questions shall be investigated further in the next chapter. 
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Chapter 5  
Cobalamin Protection Mechanism 
 
5.1 Introduction 
Signal transduction pathways regulate survival and death signalling of the cells under 
different stimuli (Xia et al., 1995; Matsuzaki et al., 1999; Uchiyama et al., 2004; Wang 
et al., 1998; Qin & Chock., 2003). The signalling pathways regulate essential 
processes of the cells such as gene transcription, protein translation, cytoskeletal 
remodelling, endocytosis, cell metabolism, cell proliferation and survival.  Recently, it 
has been reported that oxidative stress activates the JNK and P38 pathways, and 
they act as death signalling pathways (Xia et al., 1995; Harper & LoGrasso, 2001; 
Crossthwaite et al., 2002). Inhibition of these pathways by specific inhibitors 
suppressed apoptosis induced by oxidative stress. On the other hand, oxidative 
stress also activated the NfkB, ERK1/2 and PI3/AKT pathways and these act as 
antiapoptotic pathways (Junttila et al., 2008; Kurland et al., 2003; Johnson & Lapadat, 
2002).  
 
NfkB plays a vital role in cell protection from apoptosis by regulating antiapoptotic 
protein induction (Lin & Karin., 2003; Wang et al., 1998). It has been reported that 
activation of NfkB leads to reduce ROS and protects cells from apoptosis induced by 
oxidative stress (Kim et al., 2008; Kiningham et al., 2008; Nakano et al., 2006; Pham 
et al., 2004; Zanotto-Filho et al., 2009) and the inhibition of NfkB by Bay-117082, 
increased the induction of ROS and cells became apoptotic (Zanotto-Filho et al., 
2009). Also it is known that NfkB regulates iNOS, which is an important anti-
inflammatory factor (Guoping et al., 2001; Zeng et al., 2005). 
 
At the same time, The MAPK family is activated under oxidative stress (wang et al., 
1998; Qin & chock, 2003). ERK1/2 has been suggested to be a survival signal 
(Junttila et al., 2008) and this role has been demonstrated in several cell line under 
oxidative stress for example; in neuroblastoma cells (Ruffel et al.,2004) and 
osteoblastic cells (Yung et al.,2007), PC12 cells and primary cortical neurons (Guyton 
et al., 1996; Crossthwaite et al., 2002) in which the  activation of ERK1/2 protects 
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cells from apoptosis induced by oxidative stress. Moreover, the inhibition of ERK1/2 
by U0126 enhanced apoptosis (Seo et al., 2005).  
 
In contrast, other members of the MAPK family JNK and P38 act as cell death signals 
(Xia et al., 1995; Matsuzaki et al., 1999; Uchiyama et al., 2004) and the inhibition of 
theses pathways suppressed cell death induced by oxidative stress.  
 
Furthermore, the third main signal transduction pathway is the AKT/PI3 pathway, 
which is known to be activated under oxidative stress and is believed to act as 
antiapoptotic pathway (Crossthwaite et al., 2002). Also it is known that the activation 
of AKT/PI3 pathway leads to upregulation of Nrf2. Recent studies have showed that 
Nrf2 is involved in the oxidative stress protection via binding and activating the ARE 
(Nguyen et al., 2003). Many genes important to the response to oxidative stress 
include ARE in their promoter, such as HO-1, glutathione transferases and SOD-1 
(Lee et al., 2003). Furthermore, several studies have demonstrated ERK1/2 
involvement in the activation of Nrf2; when cells were protected from apoptosis 
induced by oxidative stress Nrf2 is upregulated through AKT/ERK1/2 signals 
transduction pathways and leads to induction of the HO-1 (Kim et al, 2008; Chen et 
al, 2004; Kong et al, 2001; Nakaso et al, 2003; Zhang et al, 2006). Inhibition of 
AKT/ERK1/2 prevents the protection of oxidative stress and prevents HO-1 induction.  
 
From this context it is obvious that NfkB, ERK1/2 and AKT/PI3 pathways are 
antiapoptotic pathways while JNK and P38 enhanced cell death. In the previous 
chapters it has been demonstrated that cobalamin provided protection against 
oxidative stress induced apoptosis. And this protection correlated with induction of 
the Hsps which is essential in the protection mechanism. 
 
The aim of this chapter is to investigate the mechanism of cobalamin apoptosis 
protection via the possible involvement of the signal transduction pathways. 
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5.2 Methods 
 
All preparations and cell culture experiments were carried out within a class II tissue 
culture hood and the Sk-hep1 cell was the main cell line.  
 
5.2.1 The inhibitory study: 
Cells were plated on to a black 96 well cell plate over night. Cells then were pre-
incubated with the inhibitors for 2 hours followed by treatment with 25M cobalamin 
for 2 hours and 3.125M Hcy for another 2 hours, different analysis was carried out 
after.  
 
Actinomycin was used as gene transcription inhibitor. A stock of 2mg/ml actinomycin 
was prepared by dissolving it in acetonitrile and stored at 2-5C. On the day of the 
experiment, the required concentration was prepared by diluting the stock in media. 
 
Bay11-7082 was used to inhibit the NfkB activation. A stock of 10mM Bay11-7082 
was prepared by dissolving it in dimethyl sulfoxide and stored at 2-5C. On the day of 
the experiment, the required concentration was prepared by diluteing the stock in 
media. 
 
U0126 was used to inhibit the ERK1/2 activation. A stock of 1mM U0126 was 
prepared by dissolving in dimethyl sulfoxide and stored at 2-5C. On the day of the 
experiment, the required concentration was prepared by diluting the stock in media. 
 
LY-294 was used to inhibit the AKT/PI3 activation. A stock of 1mM LY-294 was 
prepared by dissolving it in ethanol acetate and stored at 2-5C. On the day of the 
experiment, the required concentration was prepared by diluting the stock in media. 
 
Wortmanin was used to inhibit the Nrf2 activation. A stock of 1mM wortmanin was 
prepared by dissolving it in ethanol acetate and stored at 2-5C. On the day of the 
experiment, the required concentration was prepared by diluting the stock in media. 
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SP600125 was used to inhibit the JNK activation. A stock of 1mM SP600125 was 
prepared by dissolving it in dimethyl sulfoxide and stored at 2-5C. On the day of the 
experiment, the required concentration was prepared by diluting the stock in media. 
 
SB202190 was used to inhibit the P38 activation. A stock of 1mM U0126 was 
prepared by dissolving it in dimethyl sulfoxide and stored at 2-5C. On the day of the 
experiment, the required concentration was prepared by diluting the stock in media. 
 
5.2.2 Cells count and viability test by trypan blue exclusion: 
For the flow cytometry assays, the following treatment cells were re-suspend into the 
media by pipetting. Cells were then counted and assessed by trypan blue exclusion 
as described in (section 2.4.6) 
 
5.2.3 Measurement of intracellular Hsps 
The antibodies used were: Anti-Hsp27 mouse monoclonal FITC conjugated antibody, 
Anti-HO-1 mouse monoclonal FITC conjugated antibody, Anti-Hsp72 mouse 
monoclonal FITC conjugated antibody and Anti-Hsp90 mouse monoclonal R-
PHycoerythrin conjugated antibody. The dilution was 1:100. 
 
Cells were treated under test condition. , Once incubation time was over, cells were 
processed for staining and analysis as described in (section 2.4.13) 
 
5.2.4 Measurement of pNfkB induction: 
Cells were treated under test condition and then processed as in (section 2.4.13). 
Polyclonal anti-pNfkB Rabbit IgG antibody was diluted to 1:100 and used as first 
antibody and anti- rabbit IgG-FITC conjugated antibody was diluted to 1:100 and 
used as second antibody. 
 
 
5.2.5 Measurement of pERK1/2 induction: 
Cells were treated under test condition and then processed as in (section 2.4.13). 
Polyclonal anti-pERK1/2 Rabbit IgG antibody was diluted to 1:100 and used as first 
antibody and anti- rabbit IgG-FITC conjugated antibody was diluted to 1:100 and 
used as second antibody. 
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5.2.6 Measurement of pAKT induction: 
Cells were treated under test condition and then processed as in (section 2.4.13). 
Polyclonal anti-pAKT Rabbit IgG antibody was diluted to 1:100 and used as first 
antibody and anti- rabbit IgG-FITC conjugated antibody was diluted to 1:100 and 
used as second antibody. 
 
5.2.7 Measurement of Nrf2 induction: 
Cells were treated under test condition and then processed as in (section 2.4.13). 
Polyclonal anti-NRf2 goat IgG antibody was diluted to 1:100 and used as first 
antibody and anti- goat IgG-FITC conjugated antibody was diluted to 1:100 and used 
as second antibody. 
 
5.2.8 Measurement iNOS induction: 
Cells were treated under test condition and then processed as in (section 2.4.13). 
Polyclonal anti-iNOS Rabbit IgG antibody was diluted to 1:100 and used as first 
antibody and anti-rabbit IgG-FITC conjugated antibody was diluted to 1:100 and used 
as second antibody. 
 
5.2.9 Measurement of super oxide generation 
Cells were plated onto a black 96 well cell plate and treated under test condition then 
analysed for generation of super oxide by Lucigenin assay as described in (section 
2.4.15). 
 
5.2.10 Measurement of ROS generation 
Cells were plated onto a black 96 well cell plate and treated under test condition then 
analysed for generation of reactive oxygen species by the fluorescence redox active 
probe2’, 7’-dichlorfluorescein-diacetate detection as described in (section 2.4.16). 
 
5.2.11 Determination of apoptosis 
Cells were plated on to a black 96 well cell plate and treated under test condition then 
analyzed for apoptosis by caspase-3/7detection as described in (section 2.4.9). 
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5.3 Result 
 
5.3.1 Impact of signal transduction pathways on cobalamin apoptosis-
protection: 
 
To investigate the mechanisms of the cobalamin protection, the effect of gene 
transcription on the cobalamin’s protection was first determined. Cells were pre-
treated with 1 and 5g/ml of actinomycin for 2 hours, prior to incubation with 25M 
cobalamin for 2 hours followed by 2 hours exposure to 3.125M Hcy showed 
significant effect on caspase-3 (P0.001, as determined by two-way ANNOVA), 
(Figure 5.1). Further analysis with Bonferroni pairwise has resulted in a significant 
increase of caspase-3 at 1 and 5g/ml actinomycin compared to control cells treated 
with cobalamin and Hcy only (P0.001). At the same time actinomycin had no 
significant effect on caspase-3 under apoptosis induction (P0.05) and there was no 
significant induction of caspase-3 with actinomycin treatment only (P0.05) as 
compared to control cells (non-treated) (Figure 5.1). 
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Figure 5.1:  Effect of gene transcription inhibitor on cobalamin apoptosis protection. 
Sk-hep1 cells were pre-treated with 1 and 5 g/ml of actinomycin for 2 hours followed by 2 
hours treatment with 25M cobalamin and 2 hours of 3.125M Hcy. Control cells were 
nottreated with actinomycin. Caspase-3 was measured after at EX=496/EM=520. The Data 
are means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline (Hcy+Cbl) vs 
Cbl+Hcy+ACt (p<0.001), as determined by Bonferroni post hoc. 
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Following determining the regulation level of the cobalamin-apoptosis protection, we 
investigated the effect of signal transduction pathways on the apoptosis protection 
provided by cobalamin. Cells were subjected to 5M Bay-117082 for 2 hours prior to 
treatments with 25M cobalamin for 2 hours followed by 3.125M Hcy for another 2 
hours.  This treatment had significant effect on caspase-3 (P0.001, as determined 
by two-way ANNOVA), (Figure 5.2). The post-hoc comparison resulted in a significant 
increase in caspase-3 level up to 62% more than cells treated with 25M cobalamin 
for 2 hours and Hcy for 2 hours more (P0.001). Inhibition of pNfkB by Bay-117082 
had no significant effect on caspase-3 induced by Hcy compared to cells treated with 
Hcy only (P0.05) and the Bay-117082 alone had no significant activity of caspase-3 
as compared to control cells (Figure 5.2). 
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Figure 5.2: Effect of Bay-117082 on cobalamin apoptosis-protection. Sk-hep1 cells were 
pre-treated with 5M Bay-117082 for 2 hours followed by 2 hours treatment with 25M 
cobalamin and 2 hours of 3.125M Hcy. Control cells were not treated with Bay-117082. 
Caspase-3 was measured after at EX=496/EM=520. The Data are means ± SD n=4, p< 0.001 
as determined by two-way ANOVA. Baseline (Hcy+Cbl) vs Cbl+Hcy+Bay-117082 (p<0.001), 
as determined by Bonferroni post hoc. 
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Inhibition of pERK1/2 had a significant effect on the protection of apoptosis by 
cobalamin (P0.001, as determined by two-way ANNOVA), (Figure 5.3). The 
Bonferroni pairwise showed that when cells were subjected to 1M U0126 for 1 hour 
followed by incubation for 2 hours with 25M cobalamin and 2 hours incubation with 
3.125M Hcy, they showed a significant increase of caspase-3 up to 60% above 
cobalamin+Hcy treatment (P0.001).  Inhibition of pERK1/2 had no significant effect 
on caspase-3 level at 3.125M Hcy as compared to Hcy treatment alone (P0.05). 
The U0126 had no significant activity of caspase-3 (P0.05) as compared to control 
cells (non-treated) (Figure 5.3). 
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Figure 5.3: Effect of U0126 on cobalamin apoptosis-protection. Sk-hep1 cells were pre-
treated with 1M U0126 for 1 hour followed by 2 hours treatment with 25M cobalamin and 2 
hours of 3.125M Hcy. Control cells were not treated with U0126. Caspase-3 was measured 
at EX=496/EM=520. The Data are means ± SD n=4, p< 0.001 as determined by two-way 
ANOVA. Baseline (Hcy+Cbl) vs Cbl+Hcy+U0126 (p<0.001), as determined by Bonferroni post 
hoc. 
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Inhibition of PI3/AKT with 10M of LY294002 inhibitor for 1 hour prior to treatment 
with 25M cobalamin for 2 hours and 3.125M Hcy for 2 hours had a significant 
effect on caspase-3 (P0.001, as determined by two-way ANNOVA), (Figure 5.4). 
Moreover, analysis with Bonferroni pairwise resulted in a significant increase of 
caspase-3 up to 61% above cobalamin+ Hcy treatment only (P0.001). The 
LY294002 inhibitor had no significant effect on the caspase-3 level at 3.125M Hcy 
as compared to Hcy treatment only (P0.05). Also the inhibition of PI3/AKT didn’t 
induce caspase-3 (P0.05) as compared to control cells (non-treated) (Figure 5.4). 
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Figure 5.4: Effect of LY294002 cobalamin apoptosis-protection. Sk-hep1 cells were pre-
treated with 10M LY294002 for 1 hour followed by 2 hours treatment with 25M cobalamin 
and 2 hours of 3.125M Hcy. Control cells were not treated with LY294002. Caspase-3 was 
measured after at EX=496/EM=520. The Data are means ± SD n=4, p< 0.001 as determined 
by two-way ANOVA. Baseline (Hcy+Cbl) vs Cbl+Hcy+ LY294002 (p<0.001), as determined by 
Bonferroni post hoc. 
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Nrf2 was also inhibited with 1M Wortmanin for 1 hour prior to treatment with 25M 
cobalamin for 2 hours followed by 3.125M Hcy for 2 hours of incubation. This 
inhibition had significant effect on caspase-3 activity (P0.001, two-way ANNOVA), 
(Figure 5.5). Also post-hoc comparison showed a significant increase in caspase-3 
up to 61% above 25M cobalamin+Hcy treatment without the inhibitor (P0.001). 
While there was no significant effect on caspase-3 in cells treated with1M 
Wortmanin for 1 hour prior treatment with 3.125M Hcy for 2 hours as compared to 
cells treated with Hcy only (P0.05). Also cells were subjected to 1M Wortmanin had 
no caspase-3 activity (P0.05) as compared to control cells (non-treated) (Figure 
5.5). 
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Figure 5.5: Effect of wortmanin cobalamin apoptosis-protection. Sk-hep1 cells were pre-
treated with 1M wortmanin for 1 hour followed by 2 hours treatment with 25M cobalamin 
and 2 hours of 3.125M Hcy. Control cells were not treated with wortmanin. Caspase-3 was 
measured at EX=496/EM=520. The Data are means ± SD n=4, p< 0.001 as determined by 
two-way ANOVA. Baseline (Hcy+Cbl) vs Cbl+Hcy+ wortmanin (p<0.001), as determined by 
Bonferroni post hoc. 
 
 
 
 
 
 158 
In order to determine effect of P38 pathway on the cobalamin apoptosis protection, 
cells were treated with 12M SB202190 for 1 hour prior to exposing the cells to 25M 
cobalamin for 2 hours and another 2 hours for 3.125M Hcy, resulted in  significant 
effect on caspase-3 activity (P0.001, as determined by two-way ANNOVA), (Figure 
5.6). The Bonferroni pairwise analysis showed there was a significant increase in 
caspase-3 by 10% above cobalamin+Hcy treatment alone (P0.001). Although the 
inhibition of P38 showed a significant reduction in the caspase-3 level up to 25% less 
than Hcy treatment alone (P0.001). There was no significant activity of caspase-3 at 
12M SB202190 treatment alone (P0.05) as compared to control cells (non-treated) 
(Figure 5.6). 
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Figure 5.6: Effect of SB202190 cobalamin apoptosis-protection. Sk-hep1 cells were pre-
treated with 12M SB202190 for 1 hour followed by 2 hours treatment with 25M cobalamin 
and 2 hours of 3.125M Hcy. Control cells were not treated with SB202190. Caspase-3 was 
measured at EX=496/EM=520. The Data are means ± SD n=4, p< 0.001 as determined by 
two-way ANOVA. Baseline (Hcy) vs Hcy+ SB202190 (p<0.001), Baseline (Hcy+Cbl) vs 
Cbl+Hcy+ SB202190 (p<0.001), as determined by Bonferroni post hoc. 
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JNK was inhibited by treating cells with 5M SP600125 for 2 hours followed by 2 
hours treatment with 25M cobalamin and 2 hours of 3.125M Hcy. This inhibition 
had significant effect on caspase-3 (P0.001, as determined by two-way ANNOVA), 
(Figure 5.7). However, the post-hoc comparison showed no significant difference in 
caspase-3 as compared to cells treated with  cobalamin+Hcy alone (P0.05). 
However, the SP600125 had a significant effect on the caspase-3 level of such at 
3.125M Hcy showed a significant reduction of caspase-3 by 38% less than Hcy 
alone (P0.001) The JNK inhibitor treatment alone had no significant caspase-3 
activity (P0.05) as compared to control cells (non-treated(Figure 5.7). 
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Figure 5.7: Effect of SP600125 on cobalamin apoptosis-protection. Sk-hep1 cells were 
pre-treated with 5M SP600125 for 2 hours followed by 2 hours treatment with 25M 
cobalamin and 2 hours of 3.125M Hcy. Control cells were not -treated with SP600125. 
Caspase-3 was measured at EX=496/EM=520. The Data are means ± SD n=4, p< 0.001 as 
determined by two-way ANOVA. Baseline (Hcy) vs Hcy+ SP600125 (p<0.001), as determined 
by Bonferroni post hoc. 
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5.3.2 Impact of cobalamin on phosphorelated level of signal transduction 
pathways: 
 
In order to determine the impact of signal transduction pathways on cobalamin 
protection mechanism, we investigated the effect of cobalamin on phosphorelated 
NfkB (pNfkB), phosphorelated ERK1/2 (pERK1/2) and phosphorelated (pAKT) which 
identified by flowcytometry. Resulted in cobalamin had significant effect on pNfkB 
(P0.001, as determined by one-way ANNOVA), (Figure 5.8A). Further analysis with 
Tukey pairwise showed there was a significant increase in pNfkB induction at 
3.125M Hcy as compared to control cells (non-treated) (P0.001). Although there 
was a significant increase in the intracellular level of pNfkB at 25M cobalamin as 
compared to the apoptotic cells (P0.01). Furthermore, co-treatments of 25M 
cobalamin and 3.125M Hcy, induced pNfkB significantly more than Hcy or cobalamin 
treatments alone (P0.001).  
 
The histogram (Figure 5.8 B&C) illustrates the significant increase in the fluorescent 
intensity of pNfkB at 25M cobalamin as compared to control cells (non-treated).  
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A. Intracellular level of pNfkB via flowcytometry 
 
    
 
B. Control cells 
 
C. Cells treated with 25MCbl 
 
Figure 5.8: induction of pNfkB by cobalamin. A) sk-hep1 cells were pre-treated with 
25MCbl for 2 hours followed by 2 hour treatment with 3.125M Hcy, then cells were stained 
with a specific antibody and analysed by Flowcytometry FACSDiva. Control cells were not 
traeted. The Data are means ± SD n=4, p< 0.001 as determined by one-way ANOVA. 
Baseline (control) vs Hcy (p<0.001), Cbl (p<0.001), Cbl+Hcy (p<0.001), as determined by 
Tukey t post hoc. B) Control cells (non-treated). C) Cells treated with 25MCbl. 
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Furthermore, cobalamin had significant effect on the pERK1/2 (P0.001, as 
determined by one-way ANNOVA), (Figure 5.9A). Also the post-hoc comparison 
showed that there was a significant induction of pERK1/2 at 3.125M Hcy (P0.05) 
as compared to control cells (non-treated), while cobalamin treatment alone resulted 
in significant induction of pERK1/2 more than Hcy treatment alone (P0.001). And 
cells subjected to 25M cobalamin for 2 hours prior treatment with 3.125M Hcy for 
another 2 hours had a significant induction of pERK1/2, higher than cobalamin or Hcy 
treatment alone (P0.001), (Figure 5.9A).  
 
The histogram in Figure 5.9 B & C, illustrated the induction of pERK1/2 by cobalamin, 
since there was a significant increase in the fluorescent intensity of pERK1/2 at 25M 
cobalamin as compared to control cells (non-treated).  
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A. Intracellular level of pERK1/2 by flowcytometry. 
 
 
 
B. Control cells C. Cells treated with 25MCbl 
 
Figure 5.9: Induction of pERK1/2 by cobalamin. A) Cells were pre-treated with 25MCbl for 2 
hours followed by 2 hour treatment with 3.125M Hcy. Cells were then stained with a specific 
antibody and analysed by Flowcytometry FACSDiva. Control cells were not treated. The Data are 
means ± SD n=4, p< 0.001 as determined by one-way ANOVA. Baseline (control) vs Hcy (p<0.05), 
Cbl (p<0.001), Cbl+Hcy (p<0.001), as determined by Tukey test post hoc. B) Control cells (non-
treated). C) Cells treated with 25MCbl. 
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The cobalamin also had a significant effect on the pAKT level (P0.001, as 
determined by one-way ANNOVA), (Figure 5.10A).  Additionally, Tukey pairwise 
showed that cells treated with 3.125M Hcy showed a significant induction of pAKT 
as compared to control cells (non-treated) (P0.01). The pAKT induction was 
increased significantly more at 25M cobalamin than Hcy alone (P0.01). Also cells 
subjected to 25M cobalamin prior treatment with Hcy showed a significant induction 
of pAKT(P0.001)  as compared to cobalamin treatment or Hcy treatment alone 
(Figure 5.10A).  
 
The histogram demonstrated the induction of pAKT since there was a significant 
increase in the fluorescent intensity at 25M cobalamin as compared to control cells 
(non-treated) (Figure 5.10 B & C). 
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A. Intracellular level of pAKT via flowcytometry. 
 
 
 
 
B. Control cells 
 
 
 
C. Cells treated with 25MCbl 
 
Figure 5.10: induction of pAKT by cobalamin. A) Cells were pre-treated with 25MCbl 
for 2 hours followed by 2 hour treatment with 3.125M Hcy, then cells were stained with a 
specific antibody and analyzed by Flowcytometry FACSDiva. Control cells were not treated. 
The Data are means ± SD n=4, p< 0.001 as determined by one-way ANOVA. Baseline 
(control) vs Hcy (p<0.001), Cbl (p<0.001), Cbl+Hcy (p<0.001), as determined by Tukey test 
post hoc. A) Intracellular pNfkB by flowcytometry. B) Control cells (non-treated). C) Cells 
treated with 25MCbl. 
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5.3.3 Effect of cobalamin protection on Nrf2  
 
Cobalamin and folate had significant effect on the Nrf2 level in sk-hep1 cells 
(P<0.001, as determined by one-way ANNOVA), (Figures 5.11&5.12). The post-hoc 
comparison showed that at ≥25M cobalamin induce Nrf2 significantly and peaked at 
50M cobalamin as compared to control cells (non-treated) (P0.001), and Nrf2 
induction decreased at higher concentration (100M) of cobalamin (Figure 5.11). 
Moreover, cells subjected to 3.125M Hcy showed a significant increase in the Nrf2 
induction as compared to control cells (non-treated)  (P<0.001). And there was a 
further induction of Nrf2 when cells were subjected to 25M cobalamin prior Hcy 
treatment as compared to Hcy alone (P0.001). Furthermore, cells were pre-treated 
with folate showed a significant induction of Nrf2 as compared to Hcy treatment alone 
(P0.001), (Figure 5.12).  
 
The histograms in Figure 5.13, present the induction of Nrf2, such at 3.125M Hcy 
showed a significant increase in the fluorescent intensity. Also when cells were per-
incubated with folate or cobalamin, it resulted in a significant shift in the fluorescent 
intensity.  
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Figure 5.11: Effect of cobalamin on Nrf2 induction. Sk-hep1 cells were treated with a 
range of cobalamin concentrations (0-100M) for 2 hours, control cells were not treated. Cells 
then were stained with Nrf2 specific antibody and analyzed using flow cytometry FACSDiva. 
The Data are means ± SD n=4, p< 0.001 as determined by one-way ANOVA. Baseline 
(control) vs 25M (p<0.001), 50M (p<0.001), 100M (p<0.001), as determined by Tukey post 
hoc.   
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Figure 5.12: Induction of Nrf2 under cobalamin apoptosis protection. Sk-hep1 cells were 
pre-treated with 25M cobalamin for 2 hours followed by treatment with 3.125M Hcy for 
another 2 hours, control cells were not treated .cells then were stained with specific antibody 
and analyzed using flowcytometry and BD FACSDiva software. The Data are means ± SD 
n=4, p< 0.001 as determined by one-way ANOVA. Baseline (control) vs Hcy (p<0.001), 
Folate+Hcy (p<0.001), Cbl+Hcy (p<0.001), as determined by Tukey post hoc.          
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A. Control cells 
 
B.  3.125M Hcy 
 
C. 30M folate 2hours + 3.125M Hcy 
 
D. 25MCbl + 3.125M Hcy 
 
Figure 5.13: Induction of Nrf2 under oxidative stress and apoptosis protection 
conditions. After the indicated treatments and incubation time Sk-hep1cells were stained 
with Nrf2 antibody and analyzed using flow cytometry. The Histograms are; A. control cells 
(non-treated), B. 3.125M Hcy for 2 hours, C. 30M folate 2hours followed by 3.125M Hcy 
for 2 hours, D. 25MCbl for 2 hours and 3.125M Hcy for 2 hours. 
                                               
 
 
 
 
 
 
 
 
 
 
 169 
5.3.4 Effect of signals transduction inhibitors on intracellular Hsps: 
 
5.3.4.1 Effect of NfkB inhibition on intracellular Hsps: 
As previously demonstrated, signals transduction pathways had a significant effect on 
cobalamin apoptosis protection; we further investigated the effect of these pathways 
on the intracellular Hsps under cobalamin apoptosis protection. Cells were 
sequentially treated with 5M Bay-117082 for 2 hours, 25M cobalamin for 2 hours 
and 3.125M Hcy for another 2 hours. The result showed a significant effect on the 
intracellular Hsps under cobalamin protection condition (P0.001, as determined by 
two-way ANNOVA), (Figures 5.14 & 5.15). Further analysis with Bonferroni pairwise 
showed that there were significant reductions in iHsp27, iHO-1 and iHsp72 by 20%, 
40% and 75% respectively (P0.001), while Bay-117082 had no significant effect on 
iHsp90. Moreover, when cells were treated with Bay-117082 and Hcy showed no 
significant effect iHsp27, iHO-1, iHsp72 and iHsp90 compared to control cells (Hcy 
alone) (P0.05), (Figures 5.14 & 5.15), and treatment with Bay-117082 alone had no 
significant effect on iHsps induction as compared to control cells (non-treated) 
(P0.05) .  
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Figure 5.14: Effect of Bay-117082 on intracellular Hsp27 and HO-1 under cobalamin 
apoptosis-protection. Sk-hep-1 cells were pre-treated with 5M Bay-117082 for 2 hour 
followed by 2 hours treatment with 25M cobalamin and 2 hours of 3.125M Hcy, control cells 
were not treated with bay-117082. Cells were then stained with monoclonal A. anti-Hsp27 or 
B. anti-HO-1 FITC was labelled and analyzed useing flowcytometry FACSDiva. The Data are 
means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline (Cbl+Hcy) vs 
Cbl+Hcy+Bay-117082 (p<0.001), as determined by Bonferroni post hoc.          
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Figure 5.15: Effect of Bay-117082 on intracellular Hsp72 and Hsp90 under cobalamin 
apoptosis-protection. Sk-hep1 cells were pre-treated with 5M Bay-117082 for 2 hours 
followed by 2 hours treatment with 25M cobalamin and 2 hours of 3.125M Hcy, control cells 
were not treated with bay-117082. Cells were then stained with monoclonal A. anti-Hsp72 
FITC labelled or B. anti-Hsp90 PE was labelled and analyzed using flowcytometry FACSDiva. 
The Data are means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline 
(Cbl+Hcy) vs Cbl+Hcy+Bay-117082 (p<0.001)-Hsp72, as determined by Bonferroni post hoc.          
 
               
 
 
 
 
 172 
5.3.4.2 Effect of ERK1/2 inhibition on intracellular Hsps: 
 
Cells were subjected to 1M U0126 for 1 hour prior exposure to 25M cobalamin for 
2 hours and 3.125M Hcy for another 2 hours resulted in;a significant effect on the 
iHsps (p0.001, as determined by two-way ANNOVA), (Figures 5.16 & 5.17). further 
analysis with Bonferroni pairwise showed significant reduction in the iHsp27 (P0.01), 
iHO-1 (P0.001), iHsp72 (P0.001) and iHsp90 (P0.05), by 25%, %61, %64 and 
%17 respectively less than cobalamin+Hcy treatment alone. However, U0126 had no 
significant effect on iHsps at Hcy treatment compared to Hcy treatment alone 
(P0.05). Also the iHsps had not been affected by treatment with U0126 alone as 
compared to control cells (non-treated) (P0.05), (Figures 5.16 & 5.17). 
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Figure 5.16: Effect of U0126 on intracellular Hsp27 and HO-1 under cobalamin 
apoptosis-protection. Sk-hep1 cells were pre-treated with 1M U0126 for 2 hour followed by 
2 hours treatment with 25M cobalamin and 2 hours of 3.125M Hcy. Control cells were non-
treated with U0126. Cells were then stained with monoclonal A. anti-Hsp27 or B. anti-HO-1 
FITC was labelled and analyzed using flowcytometry FACSDiva. The Data are means ± SD 
n=4, p< 0.001 as determined by two-way ANOVA. Baseline (Cbl+Hcy) vs Cbl+Hcy+U0126 
(p<0.001), as determined by Bonferroni post hoc.          
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Figure 5.17: Effect of U0126 on intracellular Hsp72 and Hsp90 under cobalamin 
apoptosis-protection. Sk-hep1 cells were pre-treated with 1M U0126 for 2 hour followed by 
2 hours treatment with 25M cobalamin and 2 hours of 3.125M Hcy, control cells were not 
treated with U0126. Cells were then stained with monoclonal A. anti-Hsp72 FITC labelled or 
B. anti-Hsp90 PE was labelled and analyzed using flowcytometry FACSDiva. The Data are 
means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline (Cbl+Hcy) vs 
Cbl+Hcy+ U0126 (p<0.001), as determined by Bonferroni post hoc.          
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5.3.4.3 Effect of P38 inhibition on intracellular Hsps: 
 
Cell were subjected to 12M SB202190 for 2 hours prior 25M cobalamin for 2 hours 
and Hcy treatment resulted in no significant  difference in the iHsp27 as compared to 
cobalamin+Hcy treatment alone (P>0.05, as determined by two-way ANNOVA). 
However, inhibition of P38 had a significant effect on iHO-1, iHsp72 and iHsp90 
(P<0.001, as determined by two-way ANNOVA), (Figures 5.18 &5.19). Also the post-
hoc comparison showed that there was a significant reduction in the iHO-1 
(P<0.001), iHsp72 (P<0.001), iHsp90 (P<0.001) by 20%, 22% and 23% respectively 
less than cobalamin+Hcy treatment alone. Moreover, the inhibition of P38 had no 
significant effect of iHsps at 3.125M Hcy, compared to Hcy treatment alone 
(P>0.05). In the same time, SB202190 treatment alone had no significant effect on 
the intracellular Hsps as compared to control cells (non-treated) (P>0.05), (Figures 
5.18 &5.19). 
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Figure 5.18: Effect of SB202190 on intracellular Hsp27 and HO-1 under cobalamin 
apoptosis-protection. Sk-hep1 cells were pre-treated with 12M SB202190 for 2 hours 
followed by 2 hours treatment with 25M cobalamin and 2 hours of 3.125M Hcy, control cells 
were not treated with SB202190. Cells were then stained with monoclonal A. anti-Hsp27 or B. 
anti-HO-1 FITC was labelled and analyzed using flowcytometry FACSDiva. The Data are 
means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline (Cbl+Hcy) vs 
Cbl+Hcy+ SB202190 (p<0.001)-HO-1, as determined by Bonferroni post hoc.          
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Figure 5.19: Effect of SB202190 on intracellular Hsp72 and Hsp90 under cobalamin 
apoptosis-protection. Sk-hep1 cells were pre-treated with 12M SB202190 for 2 hours 
followed by 2 hours treatment with 25M cobalamin and 2 hours of 3.125M Hcy. Control 
cells were not treated with SB202190. Cells were then stained with monoclonal A. anti-Hsp72 
FITC labelled or B. anti-Hsp90 PE was labelled and analyzed using flowcytometry FACSDiva. 
The Data are means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline 
(Cbl+Hcy) vs Cbl+Hcy+ SB202190 (p<0.001), as determined by Bonferroni post hoc.          
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5.3.4.4 Effect of (PI3 /AKT) inhibition on intracellular Hsps: 
 
As previously showed PI3/AKT had a significant effect on cobalamin protection, also 
it seems had a significant effect on intracellular Hsps (P<0.001, as determined by 
two-way ANNOVA), (Figures 5.20& 5.21). Further analysis with Bonferroni pairwise 
showed that when cells were treated with 10M LY294002 for 1 hour followed by 2 
hours treatment with 25M cobalamin and 2 hours of 3.125M Hcy, they showed a 
significant reduction in the iHsp27, iHO-1, iHsp72 and iHsp90 by 43%, 88%, 51% and 
40% respectively less than cobalamin+Hcy alone (P<0.001). However, cells exposed 
to LY294002 and Hcy showed no significant difference in iHsp27, iHO-1, iHsp72 and 
iHsp90 as compared to Hcy alone (P>0.05).  The LY294002 treatment only showed 
no significant difference in the intracellular Hsps compared to control cells (non-
treated) (P>0.05), (Figures 5.20& 5.21). 
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Figure 5.20: Effect of LY294002 on intracellular Hsp27 and HO-1 under cobalamin 
apoptosis-protection. Sk-hep1 cells were pre-treated with 10M LY294002 for 2 hours 
followed by 2 hours treatment with 25M cobalamin and 2 hours of 3.125M Hcy. Control 
cells were non-treated with LY294002. Cells were then stained with monoclonal A. anti-Hsp27 
or B. anti-HO-1 FITC was labelled and analyzed using flowcytometry FACSDiva. The Data 
are means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline (Cbl+Hcy) vs 
Cbl+Hcy+ LY294002 (p<0.001), as determined by Bonferroni post hoc.          
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Figure 5.21: Effect of LY294002 on intracellular Hsp72 and Hsp90 under cobalamin 
apoptosis-protection. Sk-hep1 cells were pre-treated with 10M LY294002 for 2 hours 
followed by 2 hours treatment with 25M cobalamin and 2 hours of 3.125M Hcy. Control 
cells were not treated with LY294002. Cells were then stained with monoclonal A. anti-Hsp72 
FITC labelled or B. anti-Hsp90 PE was labelled and analyzed using flowcytometry FACSDiva. 
The Data are means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline 
(Cbl+Hcy) vs Cbl+Hcy+ LY294002 (p<0.001), as determined by Bonferroni post hoc.          
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5.3.4.5 Effect of Nrf2 inhibitor (Wortmanin) on intracellular Hsps under 
cobalamin apoptosis protection: 
 
Nrf2 was involved in the protection mechanism of cobalamin as had been showed 
previously. Following this, cells were treated with 1M Wortmanin for 1 hour prior 
treatments with 25M cobalamin for 2hours and 3.125M Hcy for another 2 hours, 
showed a significant effect on the iHsps (P<0.001, as determined by two-way 
ANNOVA), (Figures 5.22& 5.23). moreover, the post-hoc comparison showed 
significant differences in the iHsp27, iHO-1, iHsp72 and iHsp90 by 30%, 76%, 42% 
and 61% respectively less than cobalamin+Hcy alone (P<0.001). On the other hand, 
cells subjected to wortmanin prior Hcy treatment had no significant effect on iHsps as 
compared to Hcy alone (P>0.05). In the same time, the inhibition of Nrf2 didn’t effect 
the intracellular Hsps significantly as compared to control cells (non-treated) 
(P>0.05), (Figures 5.22& 5.23). 
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Figure 5.22: Effect of wortmanin on intracellular Hsp27 and HO-1 after cobalamin 
apoptosis-protection. Sk-hep1 cells were pre-treated with 1M wortmanin for 2 hour 
followed by 2 hours treatment with 25M cobalamin and 2 hours of 3.125M Hcy. Control 
cells were not treated with wortmanin. Cells were then stained with monoclonal A. anti-Hsp27 
or B. anti-HO-1 FITC was labelled and analyzed using flowcytometry FACSDiva. The Data 
are means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline (Cbl+Hcy) vs 
Cbl+Hcy+ wortmanin (p<0.001), as determined by Bonferroni post hoc.          
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Figure 5.23: Effect of wortmanin on intracellular Hsp72 and Hsp90 under cobalamin 
apoptosis-protection. Sk-hep1 cells were pre-treated with 1M wortmanin for 2 hours 
followed by 2 hours treatment with 25M cobalamin and 2 hours of 3.125M Hcy. Control 
cells were not treated with wortmanin. Cells were then stained with monoclonal A. anti-Hsp72 
FITC labelled or B. anti-Hsp90 PE was labelled, and analyzed using flowcytometry 
FACSDiva. The Data are means ± SD n=4, p< 0.001 as determined by two-way ANOVA. 
Baseline (Cbl+Hcy) vs Cbl+Hcy+ wortmanin (p<0.001), as determined by Bonferroni post hoc.  
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5.3.5 Impact of signal transduction pathways on Nrf2 induction: 
 
In order to investigate if the NfkB, ERK1/2, AKT/PI3, P38 and JNK regulate the Nrf2 
induction, cells were subjected to 5M Bay-117082 or 1M U0126 or 10M 
LY294002 for 2 hours prior to exposure to 25M cobalamin for 2 hours and 3.125M 
Hcy for another 2 hours. Resulted in; Nrf2 significantly effected by this treatments 
(P<0.001, as determined by two-way ANNOVA), (Figures 5.23, 5.24, 5.24 & 5.25). 
Further more Bonferroni pairwise showed significant differences, by 60%, 70% and 
94% at Bay-117082, U0126 and LY294002 prior cobalamin+Hcy respectively as 
compared to cobalamin+Hcy alone (P<0.001) (Figures 5.23 & 5.24). In the same time 
Bay-117082 and U0126 had no significant effect on Nrf2 induction at 3.125M Hcy as 
compared to Hcy alone (P>0.05), except pre-treatment of LY294002 reduced Nrf2 by 
50% at 3.125M Hcy as compared to Hcy alone (P<0.01). Bay-117082, U0126 and 
LY294002 alone had no effect on Nrf2 induction significantly as compared to control 
cells (non-treated) (P>0.05) (Figures 5.24 & 5.25). 
 
On the other hand, cells were treated with 12M SB202190 or 5M SP600125 for 2 
hours prior to exposure to 25M cobalamin for 2 hours and 3.125M Hcy for another 
2 hours showed, no significant difference in the Nrf2 induction as compared to control 
cells (Hcy+Cbl) (P>0.05, as determined by two-way ANNOVA), (Figure 5.26). 
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Figure 5.24: effect of Bay-117082 and U0126 on Nrf2 induction under cobalamin-
apoptosis protection. Sk-hep1 cells were pre-treated with A. 5M Bay-117082 or B. 1M 
U0126 for 2 hours followed by treatments with 25M cobalamin 2 hours and with 3.125M 
Hcy. Control cells were not treated with U0126 or bay-117082. Then cells were stained with 
Nrf2 antibody and analyzed using flow cytometry FACSDiva. The Data are means ± SD n=4, 
p< 0.001 as determined by two-way ANOVA. Baseline (Cbl+Hcy) vs Cbl+Hcy+ Bay-117082 
(p<0.001), Cbl+Hcy+ U0126 (p<0.001), as determined by Bonferroni post hoc.          
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Figure 5.25: Effect of LY294002 on Nrf2 induction under cobalamin-apoptosis 
protection. Sk-hep1 cells were pre-treated with 10M LY294002 for 2 hours followed by 
treatments with 25M cobalamin 2 hours and with 3.125M Hcy for another 2 hours. Control 
cells were not treated with LY294002. Then cells were stained with Nrf2 antibody and 
analyzed using flow cytometry FACSDiva. The Data are means ± SD n=4, p< 0.001 as 
determined by two-way ANOVA. Baseline (Cbl+Hcy) vs Cbl+Hcy+ LY294002 (p<0.001), 
Baseline (Hcy) vs Hcy+ LY294002 (p<0.001), as determined by Bonferroni post hoc.          
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Figure 5.26: Effect of SB202190 or SP600125 on Nrf2 induction under cobalamin-
apoptosis protection. Cells were pre-treated with A. 12M SB202190 or B. 5M SP600125 
for 2 hours followed by treatments with 25M cobalamin for 2 hours and with 3.125M Hcy for 
another 2 hours. Control cells were not treated with SB202190 or SP600125. Cells then were 
stained with Nrf2 antibody and analyzed using flow cytometry FACSDiva. The Data are 
means ± SD n=4, p> 0.05 as determined by two-way ANOVA.  
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5.3.6 Effect of signal transduction pathways on ROS reduction by cobalamin.  
 
In order to study the effect of signal transduction pathways on ROS generation, cells 
were pre-treated with 5M Actinomycin, 5M Bay-117082, 1M ERK1/2, 10M 
LY294002, 12M SB202190 or 5M SP600125 for 2 hours followed by treatment with 
25M cobalamin and 3.125M Hcy. The result showed that there was a significant 
effect on the ROS generation (P<0.001, as determined by two-way ANNOVA), 
(Figures 5.27, 5.28, 5.29 & 5.30). The post-hoc comparison showed significant 
increase in the fluorescence intensity of DCFH-AC reached 45%, 56%, 60% and 66% 
respectively (P<0.001). However, pre-treatment with Actinomycin, Bay-117082, 
ERK1/2 and LY294002 had no significant effect on Hcy fluorescence intensity of 
DCFH-AC as compared to Hcy alone (P>0.05). The treatment of Actinomycin, Bay-
117082, ERK1/2 or LY294002 alone didn’t effect ROS generation as compared to 
control cells (P>0.05), (Figures 5.27& 5.28). On the other hand, the treatment of 
SB202190 or SP600125 had no significant effect on the fluorescence intensity of 
DCFH-AC above cobalamin+Hcy alone (P>0.05). Whereas cells exposed to 
SB202190 or SP600125 prior to Hcy showed a significant reduction of the 
fluorescence intensity of DCFH-AC by 42% and 40% respectively as compared to 
Hcy alone (P<0.001). However, the fluorescence intensity of DCFH-AC doesn’t had 
effect by the SB202190 or SP600125 treatment alone as compared to control cells 
(P0.05), (Figures 5.29 & 5.30). 
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Figure 5.27: Effect of Actinomycin and Bay-110782 on generation of ROS. Sk-hep1 cells 
were pre-incubated in black 96-well plate with10mM DCFH-diacetate, and then cells were 
treated with A. 5M Actinomycin for 1 hour or B. 5M Bay-117082 for 2 hours  and with 25M 
cobalamin for 2 hours followed by 2 hours treatments with 3.125M Hcy. Control cells were 
not treated with Actinomycine or Bay-110782. Cells then were solubilised in 0.1N NaOH. 
DCFH-DA activity was measured at Ex485/530nm following incubation. The Data are 
means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline (Cbl+Hcy) vs 
Cbl+Hcy+ actinomycine (p<0.001), Cbl+Hcy+ Bay-110782 (p<0.001), as determined by 
Bonferroni post hoc.          
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Figure 5.28: Effect of U0126 and LY294002 on generation of ROS. Sk-hep1 cells were 
pre-incubated in black 96-well plate with 10mM DCFH-diacetate, and then cells treated with 
A. 1M U0126 for 1 hour or B. 10M LY294002 for 2 hours  and with 25M cobalamin for 2 
hours followed by 2 hours treatments with 3.125M Hcy. Control cells were not treated with 
LY294002 or U0126. Then cells were solubilised in 0.1N NaOH. DCFH-DA activity was 
measured at EX=485/EM=530nm following incubation. The Data are means ± SD n=4, p< 
0.001 as determined by two-way ANOVA. Baseline (Cbl+Hcy) vs Cbl+Hcy+ LY294002 
(p<0.001), Cbl+Hcy+ U0126 (p<0.001), as determined by Bonferroni post hoc.          
 
 
 
 
 191 
A. 
control Hcy Cbl+Hcy
0
1000
2000
without SB202190
SB202190
R
e
la
ti
v
e
 f
lu
e
re
s
c
e
n
t 
u
n
it
s
 
B. 
control Hcy Cbl+Hcy
0
1000
2000
without SP600125
SP600125
R
e
la
ti
v
e
 f
lu
o
re
s
c
e
n
t 
u
n
it
s
 
Figure 5.29: Effect of SB202190 and SP600125 on generation of ROS. Sk-hep1 cells were 
pre-incubated in black 96-well plate with10mM DCFH-diacetate, and then cells were treated 
with A. 12M SB202190 for 1 hour or B. 5M SP600125 for 2 hours and with 25M 
cobalamin for 2 hours followed by 2 hours treatments with 3.125M Hcy. Control cells were 
not treated with SB202190 or SP600125. Cells were then solubilised in 0.1N NaOH. DCFH-
DA activity was measured at EX=485/EM=530nm following incubation. The Data are means ± 
SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline (Hcy) vs Hcy+ SB202190 
(p<0.001), Hcy+ SP600125 (p<0.001), as determined by Bonferroni post hoc.          
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5.3.7 Effect of signal transduction pathways on super oxide reduction by 
cobalamin 
 
The inhibitors of signal transduction had a significant effect on the superoxide 
generation (P0.001, as determined by two-way ANNOVA), (Figures 5.30, 5.31 & 
5.32). The post-hoc comparison showed that when cells were exposed to 
Actinomycin, Bay-117082, U0126 and LY294002 alone, they had no significant effect 
on the super oxide generation more than control cells (P0.05). However, When cells 
were exposed to the inhibitors (Actinomycin, Bay-117082, U0126 and LY294002 
before 25M cobalamin and 3.125M Hcy treatment, that resulted insignificant 
increase in O2
- generation which reached 45%, 64%, 63% and 68% above 
cobalamin+ Hcy treatment alone (P0.001). On the other hand, inhibitors had no 
significant effect on O2
- generation at 3.125M Hcy as compared to Hcy alone 
(P0.05), (Figures 5.30 & 5.31). Also, treatment with SB202190 and SP600125 prior 
to cobalamin and Hcy showed no significant difference on the O2
- generation above 
cobalamin+Hcy alone (P>0.05). However, inhibition of P38 and JNK reduced 
generation of O2
- significantly at 3.125M Hcy by 44% and 48% respectively less 
than Hcy alone (P<0.001). The SB202190 and SP600125 alone had no significant 
effect on O2
- generation as compared to control cells (P>0.05), (Figure 5.32). 
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Figure 5.30: Effect of Actinomycin or Bay-11 on the superoxide generation. Sk-hep1 
cells were pre-treated in 96-well plate with Lucigenin (5M), and then cells were treated with 
A. 5M actinomycin for 1 hour or B. 5M Bay-117082 for 2 hours prior to treatment with 25M 
cobalamin for 2 hours followed by 2 hours with 3.125M Hcy. Control cells were not treated 
with actinomycin or Bay-11 Lucigenin chemiluminescence was measured at 550nm following 
incubation. The Data are means ± SD n=4, p< 0.001 as determined by two-way ANOVA. 
Baseline (Cbl+Hcy) vs Cbl+Hcy+actinomycin (p<0.001), Cbl+Hcy+Bay-117082 (p<0.001), as 
determined by Bonferroni post hoc.          
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Figure 5.31: Effect of U0126 or LY294002 on the superoxide generation. Sk-hep1 cells 
were pre-treated in 96-well plate with Lucigenin (5M), and then cells were treated with A. 
1M U0126 for 1 hour or B. 10M LY294002 for 2 hours prior to treatment with 25M 
cobalamin for 2 hours followed by 2 hours with 3.125M Hcy. Control cells were not treated 
with U0126 or LY294002. Lucigenin chemiluminescence was measured at 550nm following 
incubation. The Data are means ± SD n=4, p< 0.001 as determined by two-way ANOVA. 
Baseline (Cbl+Hcy) vs Cbl+Hcy+U0126 (p<0.001), Cbl+Hcy+LY294002 (p<0.001), as 
determined by Bonferroni post hoc.          
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Figure 5.32: Effect of SB202190 or SP600125 on the superoxide generation. Sk-hep1 
cells were pre-treated in 96-well plate with Lucigenin (5M), and then cells were treated with 
A. 12M SB202190 for 1 hour or B. 5M SP600125 for 2 hours prior to treatment with 25M 
cobalamin for 2 hours followed by 2 hours with 3.125M Hcy. Control cells were not treated 
with SB202190 or SP600125. Lucigenin chemiluminescence was measured at 550nm 
following incubation. The Data are means ± SD n=4, p< 0.001 as determined by two-way 
ANOVA. Baseline (Hcy) vs Hcy+ SB202190 (p<0.001), Hcy+ SP600125 (p<0.001), as 
determined by Bonferroni post hoc.          
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5.3.8 Impact cobalamin on iNOS induction: 
 
To investigate the effect cobalamin on iNOS induction, cells which were exposed to 
25M cobalamin for 2 hours showed a significant increase in the fluorescent intensity 
of the iNOS as shown in Figure 5.33A-B.  
 
Also cobalamin had a significant effect on the iNOS induction (P<0.001, as 
determined by one-way ANNOVA), (Figure 5.34). The post-hoc comparison showed 
that under cobalamin, apoptosis protection condition iNOS has significantly increased 
as compared to control cells (P<0.001), while Hcy treatment showed no significant 
effect on the iNOS induction (P>0.05), however cobalamin treatment alone showed a 
significant increase in the iNOS fluorescent intensity (p>0.001), (Figure 5.34).  
 
 
A. Control cells 
 
B. 25M cobalamin 
 
Figure 5.33: Effect of cobalamin on iNOS induction. Sk-hep1 cells were subjected to 
25M cobalamin for 2 hours. Following incubation, cells were stained with specific 
monoclonal iNOS antibody and analyzed by flowcytometry using FACSDiva software; A. 
non-treated cells, B. cells treated with 25M cobalamin.  
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Figure 5.34: Effect cobalamin apoptosis protection on iNOS induction. Sk-hep1 cells 
were subjected to 25M cobalamin for 2 hours. Following incubation, cells were stained with 
specific monoclonal iNOS antibody and analyzed by flowcytometry using FACSDiva software. 
Control cells were not treated. The Data are means ± SD n=4, p< 0.001 as determined by 
one-way ANOVA. Baseline (control) vs Cbl+Hcy (p<0.001), Cbl (p<0.001), as determined by 
Tukey post hoc.          
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5.3.9 Impact of signals transduction pathways on iNOS induction: 
 
In order to investigate the effect of signal transduction inhibitors, cells were pre-
incubated with 5M Bay-117082 or 1M U0126 or 10M LY294002 for 2 hours 
followed by 2 hours incubation with 25M cobalamin and another 2 hours with 
3.125M Hcy. This treatment had a significant effect on the iNOS induction (P<0.001, 
as determined by one-way ANNOVA), (Figures 5.35, 5.36 & 5.37). The tukey 
pairwise showed there was a significant reduction of iNOS induction by 85%, 65% 
and 52%  at 5M Bay-117082, 1M U0126,10M LY294002 respectively less than 
cobalamin+Hcy Hcy alone (P<0.001). 
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Figure 5.35: Effect of Bay-117082 on iNOS induction. Sk-hep1 cells were subjected to 5M 
Bay-117082 for 2 hours prior to treatment with 25M cobalamin for 2 hours followed by 2 
hours with 3.125M Hcy. Following incubation, cells were stained with specific monoclonal 
iNOS antibody and analyzed by flowcytometry using FACSDiva software. Control cells were 
not treated with Bay-11082. The Data are means ± SD n=4, p< 0.001 as determined by one-
way ANOVA. Baseline (cbl+hcy) vs Cbl+Hcy+Bay-117082 (p<0.001), as determined by Tukey 
post hoc.          
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Figure 5.36: Effect of U0126 on iNOS induction. Sk-hep1 cells were subjected to 1M 
U0126 for 2 hours prior to treatment with 25M cobalamin for 2 hours followed by 2 hours with 
3.125M Hcy. Following incubation, cells were stained with specific monoclonal iNOS 
antibody and analyzed by flowcytometry using FACSDiva software. Control cells were not 
treated with U0126. The Data are means ± SD n=4, p< 0.001 as determined by one-way 
ANOVA. Baseline (cbl+Hcy) vs Cbl+Hcy+U0126 (p<0.001), as determined by Tukey post hoc.          
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Figure 5.37: Effect of LY294002 on iNOS induction. Sk-hep1 cells were subjected to 10M 
LY294002 for 2 hours prior to treatment with 25M cobalamin for 2 hours followed by 2 hours 
with 3.125M Hcy. Following incubation cells were stained with specific monoclonal iNOS 
antibody and analyzed by flowcytometry using FACSDiva software. Control cells were not 
treated with LY294002. The Data are means ± SD n=4, p< 0.001 as determined by one-way 
ANOVA. Baseline (cbl+Hcy) vs Cbl+Hcy+ LY294002 (p<0.001), as determined by Tukey post 
hoc.        
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5.4 Discussion: 
 
The aim of this chapter is to investigate the mechanism of cobalamin-apoptosis 
protection and the involvement of the signal transduction pathways in this 
mechanism.  
 
We first determined that cobalamin-apoptosis protection involves gene activation, 
regulated at gene transcription level, since the protection of cobalamin was prevented 
by pre-incubation with actinomycin which is known to inhibit gene transcription activity 
(Kvale & Holme, 1996).   
 
Cobalamin is not known to directly affect signal transduction pathways, but it is 
known to influence TNFα production (Veber et al., 2008). NfkB, ERK1/2 and AKT are 
induced by oxidative stress and act as a survival signals (Luo et al., 2005; Xia et al., 
1995; brunet et al., 2001; Harper & LoGrasso, 2001). The result in this chapter 
demonstrated a novel impact of cobalamin on the signal transduction pathways; 
hence there was a significant induction of pNfkB, pERK1/2 and pAKT at 25M 
cobalamin alone, although there was a further increase of pNfkB, pERK1/2 and pAKT 
during cobalamin apoptosis protection, more than their level under apoptosis and 
cobalamin alone.  
 
Moreover, Nrf2 was significantly induced by 25M cobalamin and higher 
concentrations. Also, under cobalamin apoptosis protection Nrf2 induction increased 
more than their level under apoptosis. We can say that cobalamin induced the 
survival signals of transduction pathways and activities the Nrf2 which in turn regulate 
the activity of the antioxidant proteins.  
 
We investigated further if these pathways are essential for the cobalamin-apoptosis 
protection. The result in this chapter showed that cobalamin protection was prevented 
when the pNfkB inhibited by Bay-117082 or pERK1/2 inhibited by U01267 or 
pAKT/PI3 inhibited by LY294002 or Nrf2 inhibited by wortmanin. The inhibition of 
these proteins had no significant effect on the apoptosis induced by Hcy. Also the 
inhibition of these pathways increased superoxide and reactive oxygen species 
generation under cobalamin apoptosis protection. At the same time inhibition of pNfkB 
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or pERK1/2 or pAKT had no significant effect on superoxide and reactive oxygen 
species generation under apoptosis induction. So we can confirm that NfkB, ERK1/2 
and AKT are antiapoptosis signals and they are essential for cobalamin apoptosis 
protection. 
 
On the other hand, the JNK and P38 are known as death signal pathways (Xia et al., 
1995; Brunet et al., 2001; Harper & LoGrasso, 2001; Luo et al., 2005), this statement 
supports the results of this chapter, which showed that the inhibition of these 
pathways had no significant effect on the cobalamin apoptosis protection. However, 
there was a significant reduction on apoptosis induction when JNK or P38 were 
inhibited, and this did not result in any increase in necrosis. At the same time the 
inhibition of JNK by SP600125 or P38 by SB202190 had no significant effect on 
superoxide and reactive oxygen species generation under cobalamin apoptosis 
protection, whereas there was a significant reduction in the superoxide and reactive 
oxygen species generation under apoptosis induction. It therefore has been 
demonstrated that JNK and P38 pathways are not essential in the cobalamin 
apoptosis protection.  
 
The possible explanation of the antiapoptotic effect of the ERK1/2 might be due to 
their ability to suppress the expression of apoptotic genes and reduce ROS 
generation which leads to prevention of apoptotic cell death (Kurland et al, 2003; 
Monick et al; 2008). And moreover it has been suggested to regulate the induction of 
Nrf2 as the results in this chapter confirm (Chen et al., 2004; Balogun et al., 2003; 
Gong et al., 2004). Furthermore, it has been demonstrated that AKT/PI3 regulate 
Nrf2 induction which controls ARE transcription that as a result regulates HO-1 and 
other antioxidant enzyme (Zhang & Gordon, 2004). Our result confirms that Nrf2 is 
mainly regulated by AKT/PI3, also by ERK1/2 and NfkB since there was a significant 
reduction of Nrf2 induction under cobalamin-apoptosis protection when ERK1/2 and 
NfkB inhibited. However, JNK and p38 had no significant effect on the Nrf2 activation 
as they are not essential for the protection.  
 
Moreover, as it is shown in this chapter that NfkB plays a vital role in the cobalamin-
apoptosis protection which might be due to NfkB ability to regulate the antiapoptotic 
proteins (Lin & Karin, 2003; Luo et al., 2005). And also it confirmed that NfkB 
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regulates iNOS induction (Guoping et al., 2001; Zeng et al., 2005; Li et al., 2006). 
Adding to the previous finding, the result showed that cobalamin had a novel impact 
on iNOS activity, since iNOS was induced by cobalamin and there was a further 
increase under cobalamin apoptosis protection as been hypothesised by Wheatley in 
2007.  
 
Recently it has been reported that NfkB/iNOS is regulated through ERK1/2 (Chun-
Han, 2009). This statement supports our results and suggests the NfkB/iNOS 
signalling pathways is regulated through ERK1/2 and AKT pathways cobalamin-
apoptosis protection system. As the inhibition of NfkB reduced iNOS induction by 
85%, while ERK1/2 or AKT decreased iNOS induction by 65% and 52% respectively. 
So the iNOS mainly regulated by NfkB through ERK1/2 and AKT pathways. 
 
In the previous chapter, we showed that cobalamin induced iHsps and also that HO-1 
and Hsp72 are essential for cobalamin apoptosis protection. The results in this 
chapter showed that under cobalamin apoptosis protection; NfkB had a significant 
impact on Hsp72 induction, also the ERK1/2 regulates the HO-1 and Hsp72, and the 
AKT regulate HO-1 induction. These findings are consistent with other studies 
demonstrating the regulation of HO-1 through AKT-ERK1/2/Nrf2 (Balogum et al., 
2003; Zipper & Mulcuhy, 2003; Chen et al., 2004; Gong et al., 2004; Shen et al., 
2004) and the induction of Hsp72 through ERK1/2 pathway (Chen et al., 2001).  
Hsp72 has been proposed to be regulated through ERK1/2, due to the ability of the 
ERK1/2 to phosphorelate Hsf1 which is a transcription factor of Hsp72 (Hung et al., 
1998). The inhibition of ERK1/2 leading to reduce Hsp72 expression as been 
demonstrated in this chapter confirm data from other laboratories (Chen et al., 2001; 
Yang et al., 2004; Seo et al., 2005; Taylor et al., 2007). 
 
So the mechanism of cobalamin apoptosis protection involves three signal 
transduction pathways: NfkB, ERK/12 and AKT, These signals regulate Nrf2 and 
iNOS induction which leads to activation of HO-1 and Hsp72 and other antioxidant 
proteins to provide cell protection from apoptosis.  
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Chapter 6 
 
Novel Cobalamin Protection Mechanism 
 
6.1  Introduction 
There are several forms of cobalamin, such as methylcobalamin, hydroxylcobalamin, 
cyanocobalamin and adenosylcobalamin, GSCbl is one of the cobalamin derivatives 
which, is synthesised in the presence of glutathione, methylcobalamin and 
adenosylcobalamin. The GSCbl synthesis reaction required cobalamin dependent 
enzymes; MS and methylmalonyl-CoA mutase (MCM) (Pezacka 1993). GSCbl is 
proposed to be more effective than other cobalamin derivatives, due to its superior 
ability to promote methionine synthase activity (Pezacka et al., 1990). Therefore, 
GSCbl might play a central role in the treatment of oxidative stress related diseases 
such as Alzheimer’s disease.  
Although GSCbl is a natural product and suggested to provide a protection against 
oxidative stress, also NACCbl proposed to provide a significant protection against 
oxidative stress (Birch et al 2009).  
 
In the previous chapter it had been demonstrated that cobalamin has the ability to 
protect cells from oxidative stress. Also it had been proposed a mechanism of this 
protection that includes signals transduction and Hsps induction.  
 
The aim of this chapter is to examine the protective role of the GSCbl and NACCbl 
and suggest a mechanism of their protection.   
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6.2 Methods  
 
All preparations and cell culture experiments were carried out within a class II tissue 
culture hood.  
 
6.2.1 The inhibitory study: 
Cells were plated onto a black 96 well cell plate over night. Cells then were pre-
incubated with the inhibitors for 2 hours followed by treatment with 25M cobalamin 
for 2 hours and 3.125M Hcy for another 2 hours, different analysis carried out after.  
 
Actinomycin used as gene transcription inhibitor. A stock of 2mg/ml actinomycin was 
prepared by dissolving with acetonitrile and stored at 2-5C. On the day of the 
experiment, the required concentration was prepared by diluting the stock with media. 
 
Bay11-7082 was used to inhibit the NfkB activation. A stock of 10mM Bay11-7082 
was prepared by dissolving with dimethyl sulfoxide and stored at 2-5C. On the day 
of the experiment, the required concentration was prepared by diluting the stock with 
media. 
 
U0126 was used to inhibit the ERK1/2 activation. A stock of 1mM U0126 was 
prepared by dissolving with dimethyl sulfoxide and stored at 2-5C. On the day of the 
experiment, the required concentration was prepared by diluting the stock with media. 
 
LY-294 was used to inhibit the AKT/PI3 activation. A stock of 1mM LY-294 was 
prepared by dissolving with ethanol acetate and stored at 2-5C. On the day of the 
experiment, the required concentration was prepared by diluting the stock with media. 
 
Wortmanin was used to inhibit the Nrf2 activation. A stock of 1mM wortmanin was 
prepared by dissolving with ethanol acetate and stored at 2-5C. On the day of the 
experiment, the required concentration was prepared by diluting the stock with media. 
 
SP600125 was used to inhibit the JNK activation. A stock of 1mM SP600125 was 
prepared by dissolving with dimethyl sulfoxide and stored at 2-5C. On the day of the 
experiment, the required concentration was prepared by diluting the stock with media. 
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SB202190 was used to inhibit the P38 activation. A stock of 1mM U0126 was 
prepared by dissolving with dimethyl sulfoxide and stored at 2-5C. On the day of the 
experiment, the required concentration was prepared by diluting the stock with media. 
 
6.2.2 Cells count and viability test by trypan blue exclusion: 
For the flow cytometry assays, following treatment, cells were re-suspended into the 
media by pipetting. Cells were then counted and assessed by trypan blue exclusion 
as described in (section 2.4.6) 
 
6.2.3 Measurement of intracellular Hsps 
The antibodies used were Anti-Hsp27 mouse monoclonal FITC conjugated antibody, 
Anti-HO-1 mouse monoclonal FITC conjugated antibody, Anti-Hsp72 mouse 
monoclonal FITC conjugated antibody and Anti-Hsp90 mouse monoclonal R-
PHycoerythrin conjugated antibody. The dilution was 1:100. 
 
Cells were treated under test conditions, once incubation time was over, cells were 
processed for staining and analysis as described in (section 2.4.13) 
 
6.2.4 Measurement of pNfkB induction: 
Cells were treated under test condition and then processed as in (section 2.4.13). 
Polyclonal anti-pNfkB Rabbit IgG antibody were diluted to 1:100 and used as first 
antibody and anti- rabbit IgG-FITC conjugated antibody were diluted to 1:100 and 
used as second antibody. 
 
6.2.5 Measurement of pERK1/2 induction: 
Cells were treated under test condition and then processed as in (section 2.4.13). 
Polyclonal anti-pERK1/2 Rabbit IgG antibody were diluted to 1:100 and used as first 
antibody and anti- rabbit IgG-FITC conjugated antibody were diluted to 1:100 and 
used as second antibody. 
 
6.2.6 Measurement of pAKT induction: 
Cells were treated under test condition and then processed as in (section 2.4.13). 
Polyclonal anti-pAKT Rabbit IgG antibody were diluted to 1:100 and used as first 
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antibody and anti- rabbit IgG-FITC conjugated antibody were diluted to 1:100 and 
used as second antibody. 
 
6.2.7 Measurement of Nrf2 induction: 
Cells were treated under test condition and then processed as in (section 2.4.13). 
Polyclonal anti-NRf2 goat IgG antibody were diluted to 1:100 and used as first 
antibody and anti- goat IgG-FITC conjugated antibody were diluted to 1:100 and used 
as second antibody. 
 
6.2.8 Measurement iNOS induction: 
Cells were treated under test condition and then processed as in (section 2.4.13). 
Polyclonal anti-iNOS Rabbit IgG antibody were diluted to 1:100 and used as first 
antibody and anti-rabbit IgG-FITC conjugated antibody were diluted to 1:100 and 
used as second antibody. 
 
6.2.9 Measurement of super oxide generation 
Cells were plated on to a black 96 well cell plate and treated under test condition then 
analysed for generation of super oxide by Lucigenin assay as described in (section 
2.4.15). 
 
6.2.10 Measurement of ROS generation 
Cells were plated on to a black 96 well cell plate and treated under test condition then 
analysed for generation of reactive oxygen species by the fluorescence redox active 
probe2’, 7’-dichlorfluorescein-diacetate detection as described in (section 2.4.16). 
 
6.2.11 Determination of apoptosis 
Cells were plated on to a black 96 well cell plate and treated under test condition then 
analyzed for apoptosis by caspase-3/7detection as described in (section 2.4.9). 
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6.3 Results 
 
6.3.1 Effect of GSCbl and NACCbl on the apoptosis, necrosis induced by 
oxidative stress: 
 
In chapter 3, it was demonstrated that folate and cobalamin provided a significant 
protection against apoptosis and necrosis induced by oxidative stress. However, in 
this chapter, NACCbl and GSCbl were more effective in terms of protection from 
apoptosis and necrosis induced by Hcy (P0.001, as determined by two-way 
ANNOVA), (Figures 6.3& 6.4). Further analysis with Bonferroni pairwise showed that 
pre-treatment of cells for 2 hours with 30M NACCbl and GSCbl followed by 2 hours 
exposing to range of Hcy concentrations (0-50M), resulted in a significant protection 
provided at low concentration(1.325M) of Hcy (P0.001). Protection increased up to 
80% and 82% at 3.125M Hcy with pre-treatment with NACCbl and GSCbl 
respectively compared to control cells (P0.001), followed by a significant protection 
with increasing concentration, compared to control cells (P0.001), (Figures 6.1 & 
6.2). More over, NACCbl and GSCbl both provided significant protection against 
necrosis at 12.5M Hcy (P0.001). Necrosis activity reached less than 25% or 20% 
with pre-incubation of NACCbl and GSCbl respectively compared to control cells 
(non-treated) (P0.001), (Figures 6.3& 6.4). 
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Figure 6.1: The effect of GSCbl pre-treatment on the caspase-3 activity. Sk-hep1 cells 
were pre-incubated with 30M GSCbl for 2 hours and treated with range of Hcy 
concentrations for 2 hours and control cells were treated with range of Hcy concentrations for 
2 hours; Caspase-3 measured at EX=496nm/EM=520nm. The Data are means ± SD n=4, p< 
0.001 as determined by two-way ANOVA. Baseline (Hcy) vs GSCbl +1.325MHcy (p<0.001), 
GSCbl+3.125MHcy (p<0.001), GSCbl+6.25MHcy (p<0.001), GSCbl+12.5MHcy (p<0.01), 
as determined by Bonferroni post hoc. 
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Figure 6.2: The effect of NACCbl pre-treatment on the caspase-3 activity. Sk-hep1 cells 
were pre-incubated with 30M NACCbl for 2 hours and treated with a range of concentrations 
of Hcy for 2 hours and the control cells were treated with a range of Hcy concentrations for 2 
hours; Caspase-3 measured at EX=496nm/EM=520nm. The Data are means ± SD n=4, p< 
0.001 as determined by two-way ANOVA. Baseline (Hcy) vs NACCbl 1.325MHcy (p<0.001), 
NACCbl+3.125MHcy (p<0.001), NACCbl +6.25MHcy (p<0.001), NACCbl+12.5MHcy 
(p<0.01), as determined by Bonferroni post hoc.  
 
 
 
 
 
 
 
 
 210 
         
1 2 4 8 16 32 640
0
25
50
75
100 Control
GSCbl
Hcy, M
R
e
la
ti
v
e
 f
lu
o
re
s
c
e
n
t 
u
n
it
s
 
Figure 6.3: The effect of GSCbl pre-treatment on necrosis. Sk-hep1 cells were pre-
incubated with 30M GSCbl for 2 hours and treated with a range of Hcy concentrations for 2 
hours and the control cells were treated with a range of Hcy concentrations for 2 hours; PI 
penetration assay was measured after at EX=535/EM=617. The Data are means ± SD n=4, 
p< 0.001 as determined by two-way ANOVA. Baseline (Hcy) vs GSCbl +12.5MHcy 
(p<0.001), GSCbl+25MHcy (p<0.001), GSCbl+50MHcy (p<0.001), GSCbl+12.5MHcy 
(p<0.01), as determined by Bonferroni post hoc.     
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Figure 6.4: The effect of NACCbl pre-treatment on necrosis .Sk-hep1 cells were pre-
incubated with 30M NACCbl for 2 hours and treated with a range of Hcy concentrations for 2 
hours while control cells were treated with a range of Hcy concentrations for 2 hours; PI 
penetration was measured after at EX=535/EM=617. The Data are means ± SD n=4, p< 
0.001 as determined by two-way ANOVA. Baseline (Hcy) vs NACCbl 12.5MHcy (p<0.001), 
NACCbl+25MHcy (p<0.001), NACCbl+50MHcy (p<0.001), as determined by Bonferroni 
post hoc.           
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6.3.2 The impact of GSCbl and NACCbl on ROS and super oxide generation: 
 
In chapter 3, it had been showed that cobalamin reduce superoxide and ROS 
significantly, so in order to determine the effect of GSCbl and NACCbl on ROS and 
O2
- generation and compare it to cobalamin, cells were subjected to 30M GSCbl, 
30M NACCbl and 25M cobalamin for 2 hours prior 3.125M Hcy for another 2 
hours. This resulted in a significant effect on the ROS and super oxide generation 
(P<0.001, as determined by one-way ANNOVA), (Figures 6.5& 6.6). The post hoc 
comparison showed that the DCFH-AC fluorescence intensity decreased significantly 
at 30M GSCbl (P<0.001), 30M NACCbl (P<0.01) as compared to cobalamin+Hcy, 
in the same time GSCbl, NACCbl and cobalamin treatment alone had no significant 
effect on the DCFH-AC fluorescence intensity as compared to control cells (P>0.05), 
(Figure 6.5). Additionally, there was a significant decrease in the O2
- generation at 
30M GSCbl (P<0.001), 30M NACCbl (P<0.001) as compared to cobalamin+Hcy. 
Also there was no detectable difference in O2
- generation in GSCbl and NACCbl 
treatment alone compared to control cells (P0.05), (Figure 6.6). 
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Figure 6.5: Effect of GSCbl and NACCbl on generation of reactive oxygen species. Sk-
hep1 cells were pre-incubated in black 96-well plate with10mM DCFH-diacetate, then 25M 
cobalamin for 2 hours followed by 2 hours treatments with 3.125M Hcy, control cells were 
not treated and then all cells were solubilised in 0.1N NaOH. DCFH-DA activity was measured 
at EX=485/EM=530nm following incubation. The Data are means ± SD n=4, p< 0.001 as 
determined by one-way ANOVA. Baseline (Hcy) vs Cbl+Hcy (p<0.001), GSCbl+Hcy 
(p<0.001), NACCbl+Hcy (p<0.001), as determined by Tukey post hoc.    
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Figure 6.6: Effect of GSCbl and NACCbl on the superoxide generation. Sk-hep1 cells 
were pre-treated in 96-well plate with Lucigenin (5M), and then treated with 30M GSCbl, 
30M NACCbl or 25M cobalamin for 2 hours followed by 2 hours treatments with 3.125M 
Hcy, control cells were not treated. Lucigenin chemiluminescence was measured at 550nm 
following incubation. The Data are means ± SD n=4, p< 0.001 as determined by one-way 
ANOVA. Baseline (Hcy) vs Cbl+Hcy (p<0.001), GSCbl+Hcy (p<0.001), NACCbl+Hcy 
(p<0.001), as determined by Tukey post hoc.    
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6.3.3 Induction of Hsps by novel cobalamin NACCbl and GSCbl 
 
Previously it had been demonstrated in chapter 4, that treatment with 25M 
cobalamin induces the iHsps significantly. The result in this chapter showed that 
30M GSCbl or 30M NACCbl has significantly induced iHsps compared to control 
cells (P0.001, as determined by one-way ANNOVA), (Figures 6.7 & 6.8). However, 
Tukey pairwise showed that induction of iHsp27 by cobalamin was significantly more 
than GSCbl (P0.001) and NACCbl (P0.001), although GSCbl induced iHsp27 
significantly more than NACCbl (P0.001). The iHO-1 was highly induced by GSCbl 
compared to cobalamin (P0.01) and NACCbl (P0.001). Moreover, NACCbl induced 
iHO-1 significantly less than cobalamin (P0.001); (Figure 6.7). The iHsp72 was 
induced significantly more by GSCbl than cobalamin (P0.001), whereas there was 
no significant difference to NACCbl (P0.05). Finally GSCbl induced iHsp90 
significantly more than NACCbl (P0.01) and cobalamin (P0.01), however, there 
was no significant difference in the iHsp90 induction between NACCbl and cobalamin 
(P0.05), (Figure 6.8).   
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Figure 6.7: Effect of cobalamin, NACCbl and GSCbl on iHsps level. Sk-hep1 cells were 
pre-treated with 25M cobalamin or 30M NACCbl and GSCbl for 2 hours, control cells were 
non-treated. Then cells were stained with monoclonal mouse A. Anti-Hsp27 or B. Anti-HO-1 
FITC lantibodies were abelled and analyzed using Flow cytometry. The Data are means ± SD 
n=4, p< 0.001 as determined by one-way ANOVA. Baseline (control) vs Cbl (p<0.001), GSCbl 
(p<0.001), NACCbl (p<0.001), as determined by Tukey post hoc.    
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Figure 6.8: Effect of cobalamin, NACCbl and GSCbl on intracellular Hsps. SK-hep1 cells 
were pre-treated with 25M cobalamin or 30M NACCbl and GSCbl for 2 hours, control cells 
were not treated. Cells were then stained with monoclonal mouse anti-Hsp72 FITC or anti-
Hsp90 PE labelled antibodies and analyzed using Flow cytometry. The Data are means ± SD 
n=4, p< 0.001 as determined by one-way ANOVA. Baseline (control) vs Cbl (p<0.001), GSCbl 
(p<0.001), NACCbl (p<0.001), as determined by Tukey post hoc.    
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6.3.4 The NACCbl and GSCbl and signal transduction pathways: 
 
6.3.4.1 The impact of signal transduction inhibitor on NACCbl and GSCbl-
apoptosis protection: 
 
In the previous chapter, it was demonstrated that cobalamin apoptosis protection 
prevented by signal transduction pathways inhibitors. In order to examine the effect of 
signal transduction inhibitors, cells were incubated with 5M Bay-117082 for 2 hours 
prior to treatments with 25M cobalamin or 30M NACCbl or GSCbl for 2 hours 
followed by 3.125M Hcy for another 2 hours. Resulted in a significant effect on the 
caspase-3 activity (P<0.001, as determined by two-way ANNOVA), (Figure 6.9). The 
post-hoc comparison showed a significant increase in casapase-3 with bay-110782 
compared to cobalamin+Hcy or NACCbl+Hcy or GSCbl+Hcy alone (P<0.001). 
However there was no significant effect on caspase-3 at Hcy treatment with the 
inhibitor compared to Hcy alone (P>0.05),  
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Figure 6.9: Effect of Bay-117082 on NACCbl or GSCbl-apoptosis-protection. Sk-hep1 
cells were pre-treated with 5M Bay-117082 for 2 hours followed by 2 hours treatment with 
25M cobalamin or 30M NACCbl or GSCbl and 2 hours of 3.125M Hcy. Control cells were 
not treated with Bay-117802. Caspase-3 was measured at EX=496/EM=520. The Data are 
means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline (control) vs Cbl+Hcy 
(p<0.001), GSCbl+Hcy (p<0.001), NACCbl+Hcy (p<0.001), as determined by Bonferroni post 
hoc.          
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Moreover, The U0126 had a significant effect on protection provided by cobalamin, 
GSCbl and NACCbl (P<0.001, as determined by two-way ANNOVA), (Figure 6.10). 
The Bonferroni pairwise showed that inhibition of pERK1/2 by 1M U0126 for 1 hour 
followed by 2 hours incubation with 25M cobalamin or 30M NACCbl or GSCbl  and 
2 hours incubation with 3.125M Hcy, resulting in a significant increase in caspase-3 
compared to cobalamin+Hcy or NACCbl+Hcy or GSCbl+Hcy alone (P<0.001). The 
1M U0126 had no significant effect on caspase-3 at Hcy treatment as compared to 
Hcy alone (P>0.05). 
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Figure 6.10: Effect of U0126 on NACCbl or GSCbl-apoptosis protection. Sk-hep1 cells 
were pre-treated with 1M U0126 for 1 hour followed by 2 hours treatment with 25M 
cobalamin or 30M NACCbl or GSCbl and 2 hours of 3.125M Hcy. Control cells were not 
treated with U0126. Caspase-3 was measured at EX=496/EM=520. The Data are means ± 
SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline (control) vs Cbl+Hcy 
(p<0.001), GSCbl+Hcy (p<0.001), NACCbl+Hcy (p<0.001), as determined by Bonferroni post 
hoc.          
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Also, the Inhibition of AKT had a significant effect on the protection provided by 
cobalamin, GSCbl and NACCbl (P<0.001, as determined by two-way ANNOVA), 
(Figure 6.11). The pos-hoc comparison showed that when cells were treated with 
10M of LY294002 inhibitor for 1 hour prior treatment with 25M cobalamin or 30M 
NACCbl or GSCbl for 2 hours and 3.125M Hcy for 2 hours resulted in a significant 
increase in caspase-3 compared to cobalamin+Hcy or NACCbl+Hcy or GSCbl+Hcy 
alone (P<0.001). There was no significant difference to Hcy treatment as compared 
to Hcy alone (P>0.05).  
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Figure 6.11: Effect of LY294002 NACCbl or GSCbl-apoptosis protection. Sk-hep1 cells 
were pre-treated with 10M LY294002 for 1 hour followed by 2 hours treatment with 25M 
cobalamin or 30M NACCbl or GSCbl and 2 hours of 3.125M Hcy. Control cells were non-
treated with LY294002. Caspase-3 was measured at EX=496/EM=520. The Data are means 
± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline (control) vs Cbl+Hcy 
(p<0.001), GSCbl+Hcy (p<0.001), NACCbl+Hcy (p<0.001), as determined by Bonferroni post 
hoc.          
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The inhibition of Nrf2 by 1M Wortmanin had a significant effect on NACCbl or 
GSCbl-apoptosis protection (P<0.001, as determined by two-way ANNOVA), (Figure 
6.12). The post-hoc analysis showed that the inhibition of Nrf2 led to increase in 
caspase-3 significantly as compared to NACCbl+Hcy or GSCbl+Hcy alone (P<0.001). 
The wortmanin had no significant effect on caspase-3 at 3.125M Hcy as compared 
to Hcy alone (P>0.05).  
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Figure 6.12: Effect of wortmanin NACCbl or GSCbl-apoptosis protection. Sk-hep1 cells 
were pre-treated with 1M wortmanin for 1 hour followed by 2 hours treatment with 25M 
cobalamin or 30M NACCbl or GSCbl and 2 hours of 3.125M Hcy. Control cells were not 
treated with wortmanin. Caspase-3 was measured after at EX=496/EM=520. The Data are 
means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline (control) vs Cbl+Hcy 
(p<0.001), GSCbl+Hcy (p<0.001), NACCbl+Hcy (p<0.001), as determined by Bonferroni post 
hoc.          
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The P38 had a significant effect on the protection provided by the NACCbl and 
GSCbl (P<0.001, as determined by two-way ANNOVA), (Figure 6.13).  Moreover, the 
Bonferroni pairwise showed that cells were pre-incubated with 12M SB202190 for 1 
hour prior treatment with 25M cobalamin or 30M NACCbl or GSCbl for 2 hours and 
2 hours of 3.125M Hcy had a significant increase on caspase-3 as compared to 
NACCbl+Hcy or GSCbl+Hcy alone (P<0.001). Also SB202190 had a significant effect 
on Hcy treatment, since there was a significant reduction on caspase-3 as compared 
to Hcy alone (P<0.001). 
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Figure 6.13: Effect of SB202190 on NACCbl or GSCbl-apoptosis protection. Sk-hep1 
cells were pre-treated with 12M SB202190 for 1 hour followed by 2 hours treatment with 
25M cobalamin or 30M NACCbl or GSCbl and 2 hours of 3.125M Hcy. Control cells were 
not treated with SB202190. Caspase-3 was measured at EX=496/EM=520. The Data are 
means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline (control) vs Hcy 
(p<0.001), Cbl+Hcy (p<0.001), GSCbl+Hcy (p<0.001), NACCbl+Hcy (p<0.001), as determined 
by Bonferroni post hoc.          
. 
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The SP600125 effect on caspase-3 activity (P<0.001, as determined by two-way 
ANNOVA), (Figure 6.14). However, the inhibition of JNK had no significant effect on 
caspase-3 as compared to NACCbl+Hcy or GSCbl+Hcy alone (P>0.05). In the same 
time the inhibition of JNK had a significant effect on caspase-3 at Hcy treatment as 
compared to Hcy alone (P<0.001). 
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Figure 6.14: Effect of SP600125 on NACCbl or GSCbl-apoptosis-protection. Sk-hep1 
cells were pre-treated with 5M SP600125 for 2 hours followed by 2 hours treatment with 
25M cobalamin or 30M NACCbl or GSCbl and 2 hours of 3.125M Hcy. Control cells were 
not treated with SB202190. Caspase-3 was measured at EX=496/EM=520. The Data are 
means ± SD n=4, p< 0.001 as determined by two-way ANOVA. Baseline (control) vs Hcy 
(p<0.001), as determined by Bonferroni post hoc.          
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6.3.4.2 Impact of NACCbl and GSCbl on pNfkB, pERK1/2 and pAKT induction: 
 
In order to determine the effect of GSCbl and NACCbl on the pNfkB, pERK1/2 and 
pAKT induction, cells were subjected to 30M GSCbl, 30M NACCbl or 25M 
cobalamin for 2 hours. This resulted in a significant effect on the level of the pNfkB, 
pERK1/2 and pAKT induction (P<0.001, as determined by one-way ANNOVA), 
(Figures 6.15, 6.16 & 6.17). The Tukey comparison showed that there was a 
significant increase of NfkB at 30M NACCbl more than GSCbl and cobalamin 
(P<0.001), and GSCbl induced NfkB more than cobalamin (P<0.001), (Figure 6.15). 
On the other hand, the pERK1/2 was significantly more induced by GSCbl than 
NACCbl (P<0.001) and cobalamin (P<0.01). Also cobalamin induced pERK1/2 
significantly more than NACCbl (P<0.01), (Figure 6.16).  Additionally, GSCbl induced 
pAKT significantly more than NACCbl and cobalamin (P<0.001). And the cobalamin 
treatment induced pAKT significantly more than NACCbl (P<0.001), (Figure 6.17). 
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Figure 6.15: Effect of GSCbl, NACCbl and cobalamin on pNfkB induction. Sk-hep1 cells 
were subjected to 25M cobalamin, 30M GSCbl and 30M NACCbl for 2 hours, control cells 
were not treated. Following incubation, cells were stained with specific monoclonal pNfkB 
antibody and analyzed by flowcytometry using FACSDiva software. The Data are means ± SD 
n=4, p< 0.001 as determined by one-way ANOVA. Baseline (control) vs Cobalamin (p<0.001), 
GSCbl (p<0.001), NACCbl (p<0.001), as determined by Tukey post hoc.          
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Figure 6.16: Effect of GSCbl, NACCbl and cobalamin on pERK1/2 induction. Sk-hep1 
cells were subjected to 25M cobalamin, 30M GSCbl and 30MNACCbl for 2 hours, control 
cells were not treated. Following incubation, cells were stained with specific monoclonal 
pERK1/2 antibody and analyzed by flowcytometry using FACSDiva software. The Data are 
means ± SD n=4, p< 0.001 as determined by one-way ANOVA. Baseline (control) vs 
Cobalamin (p<0.001), GSCbl (p<0.001), NACCbl (p<0.001), as determined by Tukey post 
hoc.  
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Figure 6.17: Effect of GSCbl, NACCbl and cobalamin on pAKT induction. Sk-hep1 cells 
were subjected to 25M cobalamin, 30M GSCbl and 30MNACCbl for 2 hours, control cells 
were not treated. Following incubation, cells were stained with specific monoclonal pAKT 
antibody and analyzed by flowcytometry using FACSDiva software. The Data are means ± SD 
n=4, p< 0.001 as determined by one-way ANOVA. Baseline (control) vs Cobalamin (p<0.001), 
GSCbl (p<0.001), NACCbl (p<0.001), as determined by Tukey post hoc. 
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6.3.4.3 Impact of NACCbl and GSCbl on Nrf2 induction: 
 
Previously, we showed that GSCbl and NACCbl had significantly induced pNfkB, 
pERK1/2 and pAKT, so further investigation was carried out on their effect on Nrf2 
induction, which resulted in a significant effect (P<0.001, as determined by one-way 
ANNOVA), (Figure 6.18). The pos-hoc analysis showed that cells were subjected to 
30M GSCbl, 30M NACCbl or 25M cobalamin for 2 hours, which resulted in 
significantly inducing Nrf2 at 30M GSCbl, 30M NACCbl but the Nrf2 induction at 
30M GSCbl was higher than at cobalamin and NACCbl (P<0.001). Also cobalamin 
induced Nrf2 significantly more than NACCbl (P<0.001). 
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Figure 6.18: Effect of GSCbl, NACCbl on Nrf2 induction. Sk-hep1 cells were subjected 
to 25M cobalamin, 30M GSCbl and 30MNACCbl for 2 hours, control cells were not 
treated. Following incubation, cells were stained with specific monoclonal Nrf2 antibody and 
analyzed by flowcytometry using FACSDiva software. The Data are means ± SD n=4, p< 
0.001 as determined by one-way ANOVA. Baseline (control) vs Cobalamin (p<0.001), 
GSCbl (p<0.001), NACCbl (p<0.001), as determined by Tukey post hoc. 
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6.3.4.4 Impact of GSCbl and NACCbl on iNOS induction: 
 
In order to investigate the effect of GSCbl, NACCbl and cobalamin on iNOS 
induction, cells were exposed to 30M GSCbl, 30M NACCbl or 25M cobalamin for 
2 hours. The result in Figure 6.19 showed that iNOS was significantly induced by 
GSCbl, NACCbl and cobalamin compared to control cells (P<0.001, as determined 
by one-way ANNOVA). However, post-hoc comparison showed that NACCbl induced 
iNOS more significantly than GSCbl and cobalamin, and that iNOS was significantly 
higher at 30M GSCbl than cobalamin (P<0.001). Moreover, under protection 
condition there was a further induction of the iNOS as compared to cobalamin, GSCbl 
and NACCbl alone (P<0.001). The histogram in Figure 6.20 demonstrated the 
significant increase in the fluorescent intensity of iNOS at 30M GSCbl, 30M 
NACCbl or 25M cobalamin. 
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Figure 6.19: Effect of GSCbl, NACCbl on iNOS induction. Sk-hep1 cells were subjected to 
25M cobalamin, 30M GSCbl and 30MNACCbl for 2 hours. Following incubation, cells 
were stained with specific monoclonal iNOS antibody and analyzed by flowcytometry using 
FACSDiva software. The Data are means ± SD n=4, p< 0.001 as determined by one-way 
ANOVA. Baseline (control) vs Cobalamin (p<0.001), GSCbl (p<0.001), NACCbl (p<0.001), 
Hcy+Cobalamin (p<0.001), Hcy+GSCbl (p<0.001), Hcy+NACCbl (p<0.001), as determined by 
Tukey post hoc. 
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Figure 6.20: Effect of GSCbl, NACCbl on iNOS induction. Sk-hep1 cells were subjected 
to 25M cobalamin, 30M GSCbl and 30MNACCbl for 2 hours. Control cells were not 
treated. Following incubation, cells were stained with specific monoclonal iNOS antibody 
and A-D were analyzed by flowcytometry using FACSDiva software.  
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6.4 Discussion: 
 
The aim of this chapter was to evaluate the efficiency of the GSCbl and NACCbl 
oxidative stress protection, and compare the mechanisms to those identified in the 
previous chapter.  
 
Recently, it was reported that GS and NAC partially protect Sk-hep1 from oxidative 
stress, while the GSCbl and NACCbl provided a significant protection from oxidative 
stress injury (Birch et al., 2009). These findings are consistent with the results in this 
chapter, since there was a significant protection from apoptosis and necrosis induced 
by Hcy. Moreover, the GSCbl and NACCbl have the ability to scavenge the super 
oxide and ROS generation more than cobalamin.  
 
It has been suggested that the antioxidant role of cobalamin might be due to the 
ability to stimulate the methionine synthase activity (McCaddon et al., 2002) and their 
direct interaction with reactive oxygen and nitrogen species (Ling & Chow, 1953). 
Also, it has been suggested that cobalamin might stimulate signalling molecules such 
as NfkB to mediate the gene expression of the antiapoptotic proteins (Veber et al., 
2008).  These suggestions are in line with the previous result in chapter 5, which 
showed that cobalamin-apoptosis protection involved induction of signal transduction 
pathways. In this chapter GSCbl or NACCbl- apoptosis protection condition was 
associated with a significant induction of pNFkB, pERK1/2 and pAKT. However, 
pERK and pAKT were more significantly induced with GSCbl pre-treatment when 
compared to cobalamin or NACCbl pre-treatments. Furthermore, GSCbl pre-
treatment induced Nrf2 to a greater degree, while NACCbl induced iNOS more 
significantly. Additionally the induction of the pNfkB, pERK1/2 and pAKT are essential 
for the apoptosis protection. Since the inhibition of these proteins by their specific 
inhibitors lead to loss of the protection and cells were apoptotic. On the other hand, 
the inhibition of P38 prevents the protection partially but it had a significant effect on 
apoptosis induced by Hcy. Also the inhibition of JNK had an effect on apoptosis 
induced by Hcy but JNK is not essential for the NACCbl or GSCbl apoptosis-
protection.  
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As cobalamin treatment showed a significant induction of the Hsps, GSCbl or 
NACCbl-apoptosis protection has also induced iHsps significantly. More specifically, 
GSCbl induced iHO-1, iHsp72 and iHps90 more than cobalamin and NACCbl. Also 
NACCbl induce iHsp72 more than cobalamin. 
 
It is clear that cobalamins are utilising the same pathways but they vary in the effect 
on these pathways to provide an efficient protection. For instants, GSCbl induced 
pERK/12 and pAKT and those pathways lead to activate the Nrf2 which in turn, 
induced the expression of the antioxidant genes, HO-1 and Hsp72. In this way GSCbl 
protects the cells from the oxidative stress induced. In contrast, NACCbl induces NfkB 
which in turn leads to induction of the iNOS and several antiapoptotic proteins, 
resulting in apoptosis protection.  
 
The conclusion of this chapter is that GSCbl and NACCbl provide a better protection 
from apoptosis induced by oxidative stress, due to their ability to induce the anti-
apoptotic proteins more than the cobalamin in two different pathways. NACCbl 
protect cells from apoptosis mainly through NfkB/iNOS pathway, while GSCbl take the 
ERK1/2-AKT/Nrf2 pathway to provide apoptosis protection.  
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Chapter 7 
 
General Discussion 
 
Oxidative stress is a result of the imbalance between the oxidant and the antioxidant 
production (Sies, 1999). It has been proposed that oxidative stress induces damage 
to cells and that might lead to cardiovascular disease and neurodegenerative disease 
(Refsum et al., 1998; Diaz-Arrastia, 2000). The high level of Hcy, generation of ROS 
and superoxide are three important factors associated with oxidative damage and all 
can lead to cell death. The first objective of this thesis was to characterise cell death 
caused by oxidative stress (Chapter 3). At the same time, several studies have 
demonstrated the mechanism of oxidative stress cell death in different cell lines such 
as; Jurkat cells (Hampton & Orrenius, 1997), endothelium cells (Liu et al., 2005; 
Obeid & Herrmann, 2006), smooth muscle cells (Buemi et al., 2001), primary human 
bone marrow stromal cells and the HS-5 cell line (Duk et al., 2006). The mode of cell 
death induced by oxidative stress is dose dependent and varies from cell to cell. For 
example, Sk-hep1 cells were apoptotic when treated 3.125M Hcy or H2O2 and were 
necrotic at 50M of either compound (chapter 3). These data were obtained following 
2 hours of treatment, whereas Jurkat cells died by apoptosis at 3.125M Hcy or 
0.01mM H2O2 and by necrosis with 100M Hcy or 10mM H2O2 in experiments that 
required 6 hours treatment. 
  
Due to the different in the content of the antioxidant enzymes in the peripheral blood 
cells (Pietarinen-Runtti et al., 2000), so they had different sensitivity to the oxidative 
stress. For example, monocyte cells required higher concentrations of H2O2 to induce 
apoptosis and necrosis compared to the concentrations required for neutrophils and 
lymphocytes. Similar to Jurkat cells the peripheral blood cells were more sensitive to 
Hcy than H2O2 in terms of apoptosis or necrosis. These differences might be due to 
the ability of Hcy to generate intracellular H2O2 (Harker et al., 1976; Malinow, 1990). 
 
The results of chapter 3 reflect other studies findings that, low concentrations of 
oxidative stress induce apoptosis while high concentrations induce necrosis (Saito et 
al., 2006), a finding consistent with other stressors such as temperature (Lione PhD 
thesis, 2009).  
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The second objective of this thesis was to examine if the cells protect themselves 
from apoptosis and necrosis induced by oxidative stress as it is known that the 
generation of ROS is a natural cellular process. However, cells prevent the 
accumulation of the ROS via production of antioxidants (Chen & Kunsch, 2004), such 
as glutathione peroxidase and glutathione that reduces accumulated H2O2 
(Pietarinen-Runtti et al., 2000). In recent years research strategies of antioxidant 
against oxidative stress have received great intentions, since folate is an antioxidant 
molecule and cobalamin is co-factor enzyme in Hcy metabolism (Figure 1.3).  In 2006 
McNulty and colleagues suggested that riboflavin, which in its coenzymatic form 
(flavin adenine dinucleotide) required as a cofactor for the MTHFR enzyme, reduce 
Hcy level significantly in individuals with homozygous for the MTHFR 677C3T 
polymorphism. Accumulated evidence has shown that folate treatment reduces 
hyperhomocysteimia that is associated with several diseases such as cardiovascular 
diseases (Woo et al., 1999; Ward, 2001; McNulty et al., 2008). It has been suggested 
that folate can reduce the risk of neural tube defects (McNulty et al., 2000). Also, 
folate treatment provides a protection against cell death induced by oxidative stress 
in smooth muscle and endothelial cells (Buemi et al., 2001).  The results in chapter 3 
confirmed this protective role of folate against both apoptosis and necrosis.   
 
 
In the literature, cobalamin has been suggested to provide indirect protection from 
apoptosis and necrosis induced by oxidative stress due to its classical function as a 
cofactor to the methionine synthase enzyme in Hcy metabolism cycle (Figure 1.3). 
However, it has been reported recently that cobalamin had the ability to scarvenge 
super oxide directly and provide protection against chronic inflammation (Suarez-
Moreir et al., 2006). Also cobalamin deficiency increases the synthesis of tumor 
necrosis factor (TNF)- (Scalabrino, 2005).  Interestingly the results in chapter 3 
demonstrate a novel role of cobalamin as an antioxidant molecule, which provided a 
significant protection against apoptosis and necrosis induced by Hcy and H2O2 in Sk-
hep1 and Jurkat cells. Cobalamin-apoptosis protection correlated with a significant 
reduction in the superoxide and ROS generation as demonstrated by another study 
(Birch et al., 2009). 
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Moreover, the novel thiolatocobalamins GSCbl and NACCbl provided superior 
protection against apoptosis and necrosis induced by oxidative stress when 
compared to protection provided by cobalamin (chapter 6).  
 
Folate and cobalamin have been suggested to reduce hyperhomocysteimia in 
oxidative stress associated diseases, and as discussed above they protect cells from 
apoptosis and necrosis induced by oxidative stress. However the mechanism is not 
known. So the third objective of the thesis was to determine the mechanism of 
cobalamin apoptosis protection.  Knowing the mechanism of cobalamin protection 
could be a useful tool for clinical application.  
 
It is known that amongst the natural processes, cells have to provide protection from 
any stressor by the activation of Hsps. It has been demonstrated that Hsp27, HO-1 
and Hsp72 are induced under oxidative stress (Mehlen et al 1993; Oesterreich et al., 
1993; Arrigo, 2001). The overexpression of Hsp72 and HO-1 protected cells from 
apoptosis induced by Hcy (chapter 4) is consistent with previous studies (Huot et al., 
1991; Mehlen et al., 1993; Ohkawara et al., 2006). However, whether cobalamin 
induces the Hsps was not investigated previously.  
 
The novel induction of Hsps by cobalamin was presented in Chapter 4. Also, under 
apoptosis-cobalamin protection, the level of Hsps increased further (chapter 4).  The 
induction of Hsps was essential for the cobalamin-apoptosis protection, since 
inhibition of Hsp72 or HO-1 prevented cobalamin-apoptosis protection. These 
observations indicated that Hsp72 and HO-1 are involved in the mechanism of 
cobalamin protection. The suppression of apoptosis by the Hsps is in agreement with 
other studies that investigated the protective potential role of Hsps in cells 
overexpressing these proteins (Mosser, et al., 1997).  
 
The important question leading on from this work is how cobalamin induces Hsps, 
which was the fourth objective in this thesis. It is important to identify at what level 
cobalamin regulates the induction of the Hsps and whether this alone is responsible 
for the protection mechanism. 
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It has been proposed that cobalamin treatment decrease synthesis of TNF- and 
increase synthesis of epidermal growth factor (Buccellato et al., 1999; Scalabrino et 
al., 1999) but the understanding of the mechanisms was limited. Also recently Surez-
Moreira et al (2006) suggested that the direct interaction of cobalamin with the 
superoxide can be the molecular mechanism that activates the signals transduction 
to provide the protection. Interestingly, the cobalamin-apoptosis protection was 
prevented when gene transcription inhibited by actinomycin (chapter 5).  This 
suggested that cobalamin-apoptosis protection mechanism involves signal 
transduction pathways to induce the Hsps. The inhibition of the NfkB, ERk1/2 and 
AKT, anti-apoptosis signal pathways prevented cobalamin-apoptosis protection by 
increasing the caspase-3 level, ROS and superoxide (Chapter 5). Moreover, 
activation of pNfkB, pERK1/2 and pAKT was induced significantly by cobalamin, and 
this level increased further under cobalamin-apoptosis protection. Conversely, the 
inhibition of the apoptosis signal transduction pathway (JNK and P38), had no 
significant impact on the cobalamin apoptosis protection. While the results confirmed 
their apoptosis induction role, since the inhibition of JNK and P38 reduced apoptosis 
significantly (Chapter 5). It is obvious that the anti-apoptosis signal transduction 
pathways and the Hsps are essential for the cobalamin apoptosis protection (chapter 
4 &5). So, there are three pathways that involved in the cobalamin-apoptosis 
protection.  
 
In the literature it has been suggested that NfkB regulates the transcription of HO-1 
(Maines, 1997; Choi et al., 2004). Interestingly NfkB has a significant impact on the 
induction of the Hsp72 and HO-1 under cobalamin-apoptosis protection. There was 
no significant effect on the Hsp72 and HO-1 level under apoptosis level (chapter 5). 
Theis indicates that induction of the Hsp72 and HO-1 under cobalamin apoptosis-
protection is regulated by NfkB.  
 
Also, it was observed that cobalamin induced iNOS and the level increased further 
under cobalamin-apoptosis protection (chapter 5). It is known that NfkB regulates the 
induction of iNOS, and the result in chapter 5 showed that inhibition of NfkB has a 
significant impact on the iNOS induction. NfkB inhibition also had a significant effect 
on the Nrf2 induction under cobalamin-apoptosis protection (chapter 5). Therefore 
under apoptosis protection conditions; cobalamin induces the activation of NfkB. In 
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turn, NfkB induces mainly iNOS also effect on the expression of Hsp72, HO-1, and 
Nrf2 expression as illustrated in (Figure 7.1).   
 
 
 
Figure 7.1: The mechanism of cobalamin-apoptosis protection. Cobalamin treatment 
leads to activate NFkB and phosphorylation of ERK1/2 and AKT. This leads to induce the 
Nrf2, iNOS, Hsp72 and Hsp27, which provides protection against oxidative stress.  
 
 
 
 
 
 
 
 
 
The second signal transduction pathway that is involved in the cobalamin apoptosis 
protection is ERK/12.  Previously it was shown that cobalamin activated ERK1/2 and 
that ERK1/2 is essential for the cobalamin apoptosis protection.  Furthermore, 
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inhibition of ERK1/2 has a significant impact on the induction of the Hsp72 and HO-1 
under cobalamin apoptosis protection, But ERK1/2 mostly effects the Hsp72 
expression. There was no significant effect on the induction of the Hsp72 and HO-1 
under apoptosis condition (chapter 5). These observations mean that induction of the 
Hsp72 and HO-1 under cobalamin-apoptosis protection is regulated by ERK1/2 
activation which is induced by cobalamin. These results are consistent with pervious 
studies which reported that the induction of the Hsp72 by ERK1/2 signalling pathways 
(Chen et al., 2001) and that inhibition of ERK1/2 decreased Hsp72 induction under 
different stress conditions (Chen et al., 2001; Yang et al., 2004).  It has been 
suggested by Huang et al., 1998, that ERK1/2 acts on the phosphorylation of HSF1 
to increase the expression of the Hsp72. Also it has been reported that ERK1/2 might 
regulate the expression of Nrf2 (Chen et al., 2001; Yang et al., 2004). Inhibition of 
ERK1/2 has an impact on iNOS and Nrf2 level under cobalamin-apoptosis protection. 
So the ERK1/2 signal pathway, which is activated by cobalamin, induces Hsp72, HO-
1, Nrf2, and iNOS expression and through this provides protection against apoptosis 
induced by oxidative stress (Figure 7.1).  
 
The third signal transduction pathway involved in the cobalamin-apoptosis protection 
is AKT as demonstrated previously. The role of AKT in upregulation of Nrf2 in 
response to different stimuli is well investigated in rat hepatoma cells and human 
neuroblastoma cells (Kang et al., 2001; Lee et al., 2001). Also the upregulation of 
HO-1 via AKT has been demonstrated in several studies (Chung et al., 2005; Martin 
et al., 2003; Pischke et al., 2005; Salina et al., 2003). In the cobalamin-apoptosis 
protection, AKT regulated mainly the expression of the Nrf2 and HO-1 (chapter 5).  
Additionally, AKT was also involved in the regulation of the expression of Hsp72 and 
iNOS as the inhibition of the AKT leads to lose the protection. So activation of the 
AKT signal pathway by cobalamin leads to upregulation of the expression of the Nrf2, 
HO-1, Hsp72 and iNOS. The upregulation of these proteins provides the protection 
against apoptosis induced by oxidative stress (Figure 7.1).  
Taken together the above findings suggest that cobalamin has a novel impact on the 
signal transduction pathways (Figure 7.1). Consequently, NfKB, ERK1/2 and AKT 
together mediate the upregulation of Nrf2, HO-1 Hsp72 and iNOS which provide 
protection against apoptosis induced by oxidative stress. More specifically first NfkB 
mainly upregulate the iNOS, this finding is supported by pervious study suggest that 
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NfkB regulate the iNOS (Xia et al., 2001). Secondly Erk1/2 mainly increases the 
expression of the Hsp72. Finally, AKT mostly up regulates HO-1 through Nrf2. As it 
has been well document that AKT can mediate the expression of the HO-1 via Nrf2 
providing protection against oxidative stress (Park et al., 2007). Moreover, it has been 
recently reported that Nrf2 is activated via AKT/ERK1/2, thus increasing the 
expression of the HO-1 and antioxidant enzymes (Kim et al., 2008).  
 
Together the induction of the Nrf2, HO-1, Hsp72 and iNOS provide a significant 
protection against apoptosis induced by oxidative stress and each one has its own 
pathway to provide the protection.  
 
The activation of Nrf2 and translocation to the nucleus leads to bind with the ARE. 
The common function of the ARE is to regulate the expression of proteins that 
mediate the cellular ROS level, detoxification reaction and cell protection against 
oxidative stress (Alam & Cook, 2003; Lee & Surh, 2005; Nguyen et al., 2003; Jaiswal, 
2004). Nrf2 induce several antioxidant proteins to provide protection such as 
glutathione, glutathioneperoxidase, superoxide dismutase (Alam & Cook, 2003; Lee 
& Surh, 2005; Lee et al., 2003; Kwak et al. 2001; McMahon et al., 2001).  
 
The protective role of HO-1 against oxidative stress has been reported in the 
literature (Chio et al., 2002; Brouard et al., 2000). The ability of HO-1 to provide 
protection from oxidative stress is possibly due to the generation of CO and bilirubin, 
since there is a direct link between scavenging of ROS and the activity of bilirubin 
and CO (Choi et al., 2002; Morse et al., 2002; Ryter et al., 2002; Kim et al., 2006).  
 
Earlier it was demonstrated that induction of the Hsp27 and Hsp72, has a vital role in 
cobalamin-apoptosis protection. It also showed that the anti-apoptosis signalling 
transduction pathways are involved in upregulation of these proteins. The protective 
role of the Hsp27 and Hsp72 is suggested to be due to the ability of the Hsp72 to 
prevent formation of the apoptosome, and to block caspase activation (Beere et al., 
2005; Saleh et al., 2000). The overexpression of the Hsp27 protects cells from 
oxidative stress by reducing ROS generation and increasing glutathione induction 
(Mehlen et al., 1995; Ito et al., 1998; Concannon et al., 2001; Liu et al., 2007; Preville 
et al., 1999). It is believed that protection activity of Hsp27 is glutathione dependent 
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(Mehlen et al., 1996) in addition to its ability to suppress the cytochrome c (Garrido et 
al., 1997; Samali et al., 1996). In the same time the inhibition of the Hsp27 decrease 
the glutathione level and increase apoptosis (Aloy et al., 2008). The overexpression 
of Hsp27 is associated with the induction of the glucose-6-phosphate dehydrogenase 
and increase in the reduced form of the glutathione in murine L929 fibroblast cells, 
HeLa cells, C6 rat glioma cells and NIH 3T3-ras cells (Mehlen et al., 1996; Ito et al., 
1998; Perville et al., 1999). So Arrigo in 2001 suggested that the expressed glucose-
6-phosphate dehydrogenase via Hsp27 increased the upholding of reduce 
glutathione and that leads to reduced level of the ROS which forms as a result of the 
oxidative stress.  
 
Further more, as been demonstrated in chapter 4, the heat shock increases 
expression of Hsp72. Also, it is believed that heat shock induces glutathione (Li & 
webb, 1982) and the suppresser of the glutathione induction leads to prevent the 
Hsp72 protection role (Mitchell & Russo, 1983). Also under oxidative stress, Hsp72 is 
believed to bind to dihydrofolate reductase and prevent the thiol oxidation of 
dihydrofolate reductase to function normally in one carbon cycle (Mark et al., 2004).  
 
The iNOS is also observed to be upregulated by cobalamin and under cobalamin-
apoptosis protection. Adding to this, NfkB, ERK1/2 and AKT are involved in mediating 
the expression of the iNOS under cobalamin-apoptosis protection as been mentioned 
before. The iNOS is commonly regulated by the NfkB and believes to have pro-
inflammatory responses (Kleinwort et al., 2003). The iNOS induction leads to 
production of NO. The induction of NO provides protection against cell death (Pinsky 
et al., 1997). There is negative feedback mechanism that controls the level of iNOS 
expression through NO/IkB to avoid the accumulation of NO. Thus the recent NO 
synthesis might acts with the recent IkB synthesis to suppress the DNA binding 
activity of NfkB and inhibit the transcription of the iNOS gene (Peng et al., 1995b). 
However it was recently reported that hydroxycobalamin and dicyanocobinamide 
inhibit the enzyme activity of the iNOS where cyanocobalamin, methylcobalamin, and 
adenosylcobalamin have less effect (Weinberg et al., 2009) 
 
In the addition to the objectives to determine the mechanism of cobalamin novel 
antioxidant role, the last objective of this thesis was to examine the protection role of 
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GSCbl and NACCbl and the possible mechanism they acts on. The work in chapter 6 
showed that the superior protection GSCbl and NACCbl provide against apoptosis 
induced by oxidative stress. These findings support the recent finding present the 
proactive role of GSCbl and NACCbl from cell death induced by oxidative stress 
(Birch et al., 2009). Moreover, GSCbl and NACCbl significantly induced the NfkB, 
ERK1/2 and AKT and there were further induction of these proteins at apoptosis 
protection condition.  Also these signal transduction pathways were essential for the 
protection, as the inhibition of NfkB, ERK1/2 and AKT leads to lose the protection 
(chapter 6). Since, Under GSCbl-apoptosis protection the expression of AKT/ERK1/2 
increased more than under cobalamin or NACCbl-apoptosis protection (chapter 6), so 
the superior protection provided by GSCbl against apoptosis induced by oxidative 
stress might be due to the ability of GSCbl to upregulate the Nrf2, HO-1 and Hsp72 
through AKT/ERK1/2 signalling pathway. The pharmaceutical  available form of 
cobalamins are required to be converted to GSCbl otherwise it wont be utilized by the 
neurons under oxidative stress, so GSCbl can be used in treatment of 
neuropsychiatric disorders oxidative stress related such as Alzheimer’s disease  
(McCaddon & Cobalz Limited, 2001) 
 
On the other hand, NfkB was significantly activated under NACCbl-apoptosis 
protection more than its level at cobalamin or GSCbl-apoptosis protection (chapter 6). 
As a result, iNOS expression increased significantly more than at GSCbl-apoptosis 
protection. And also the Hsp72 induction was induced by NACCbl more than at 
cobalamin treatments.  Interestingly, cobalamins acts on the three suggested 
protection pathways but their effect were different which explain the superior 
protection provided. 
 
The ability of cobalamin to induce the signal transduction cascades can be applied to 
be used in the drug development of related diseases. Muslin in 2008 reported that 
signal transduction might have an effective role in cardiovascular diseases. Since the 
cardiomyocytes growth increased by the activation of ERK1/2, while the activation of 
JNK and P38 led to increased cardiomyocytes dysfunction (Muslin, 2008). Moreover 
the induction of the Hsps can be used to reduce the severity of the diseases. Such as 
the overexpression of Hsp72 in transfect heart cells reduced the mitochondrial 
dysfunction after ischemia reperfusion injury (Jayakumar et al., 2001).  Most of 
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elderly diseases are associated with hyperhemocietmia and cobalamin deficiency 
such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, active 
multiple sclerosis and cardiovascular disease (Mattson et al., 2001; Memet, 2006, 
Ward, 2001) knowing the molecular mechanism by which cobalamins provides 
protection against oxidative stress can be a useful tool to be applied in the drug 
development to reduce the severity and treat these diseases.   
  
In conclusion, the ideas presented in this discussion are summarised in Figure 7.1. 
Cobalamin provides a protection against oxidative stress. Cobalamin does this by 
multiple pathways which include direct antioxidant stimulation and induction of signal 
transduction pathways. Different cobalamins derivatives have superior protections 
and they can be useful for clinical implication for most of oxidative stress related 
diseases. These findings can act as a base for further studies such as per-clinical 
researches applying the antioxidant properties of cobalamin on oxidative related 
diseases such as Alzheimer and cardiovascular diseases.  Since several studies 
referred to the ability of cobalamin to reduce Hcy, our findings may support the on 
going researches in this field in order to reduce the risk of these diseases. 
Furthermore, it might be important to determine the cause of cobalamin deficiency. 
i.e. to determine whether the deficiency is due to lack of cobalamin, the lack of  the 
cobalamin transport protein, an imputation in the receptor of the cells, or just a 
genetic mutation. These further studies will have an impact on the treatment of 
oxidative related disease. 
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